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Abstract 
This thesis describes a study of 1,252 Aborigines who were living in 4 
rural communities, two in Cape York and two in central Australia. The ai1n 
was to define normal lung function and to determine the prevalence of and risk 
factors for current asthma, bronchial h yperreacti vi ty (BHR) and chronic 1 ung 
disease. The participation rates ranged from 51 to 87%. Current asthma was 
diagnosed in subjects with a history of wheezing in the last 12 months and 
coexisting BHR (PD20FEV 1 < 3.9 micromols of histamine). Chronic lung disease 
was diagnosed if a subject's FEV1, FVC or the FEV1 /FVC ratio was greater than 
two standard deviations below that in a reference population of 593 participants 
without signs or symptoms of lung disease. Subjects with chronic lung disease 
and an abnormal FEV 1 /FVC ratio were diagnosed as having chronic 
obstructive pulmonary disease (COPD) and those with a normal ratio were 
diagnosed as having non-obstructive lung disease. 
The prevalence of smoking ranged from 1-78% in women and from 51-75% in 
men. "Knowledge" about the heal th consequences of smoking was poor. In 
one community the prevalence of self-reported petrol sniffing was 44o/o among 
15-25 year old males and 33% among females. 
The prevalence of asthma among adults was low in comparison with non-
Aboriginal Australians and in children asthma was almost non-existent. The 
only significant risk factor identified for asthma was allergy to cats. The 
prevalence of BHR among adults was similar to that in non-Aboriginal 
Australians but in children the prevalence was low. The risk factors for BHR 
were house dust mite allergy, feline allergy and cigarette smoking. The low 
prevalence of asthma in the children may be secondary to a reduced atopy 
acquisition rate. 
The values predicted for FEV1 were approximately 20% lower than those 
predicted for Caucasians of the same height, age and gender. In contrast the 
values predicted for FVC v-.rere approximately 30% lower. Consequently the 
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FEV 1 /FVC ratio was high in comparison with Caucasians. Asymptomatic 
cigarette smokers had higher predicted values of FEV 1 and FVC than non-
smokers. The rate of decline of FEV1 and FVC with age in healthy smokers and 
non-smokers appeared comparable to that observed in non-smoking 
Caucasians. 
The prevalence of chronic 1 ung disease in 7-19 year old males was 7.1 o/o and 
among 20-84 year old males was 19.3%. The prevalence of chronic lung disease 
in females was lower: 2.2% among 7-19 year olds and 5.9% among 20-84 year 
olds. Respiratory symptoms and signs were not useful for identifying or 
characterising subjects with COPD or non-obstructive lung disease. 
The prevalence of COPD was 11 .8% in males and 4.5% in females. COPD was 
not detected in children. Ex-smokers were at increased risk of having COPD. 
Increasing age was an independent risk factor for COPD. The lifestyle in one 
"traditional" community was associated with an independent reduction in the 
risk of having COPD. Twelve percent of subjects with COPD had asthma. 
EHR was associated with COPD but the prevalence of BHR among those with 
COPD was low compared with non-Aboriginal people with this disease. 
The prevalence of non-obstructive lung disease was 7% in males and 2% in 
females. Petrol sniffing and male gender were significant independent risk 
factors for non-obstructive lung disease. Age was not an independent risk 
factor for this abnormality. Subjects from the community with the most 
adequate housing were significantly less likely to have non-obstructive lung 
disease than subjects from communities where the housing was of a poor 
standard and where serious lower respiratory tract infections in childhood 
were said to be common. 
The findings suggest that initiatives that lead to more Aboriginal people living 
in decentralised family groups in adequately maintained houses have the 
potential to reduce the burden of COPD and non-obstructive lung disease. The 
mechanisn1s by which these factors might influence the prevalence of chronic 
lung disease need further investigation. 
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Definitions and Abbreviations 
CY1 Cape York 1 An Aboriginal community on the eastern 
11 
seaboard of Queensland near Cook town. 
,, 
I: CY2 Cape York 2 An Aboriginal community on the western 
side of Cape York at a latitude north of 
Cooktown, Queensland. 
CA3 Central Australia 3 An Aboriginal community several hundred 
kilometres north-east of Alice Springs in the 
Northern Territory. 
CA4 Central Australia 4 An Aboriginal community several hundred 
kilometres sou th of Alice Springs in Sou th 
Australia. 
Regional variation Variation between communities. 
ATS American Thoracic Society. 
BTPS Body temperature and pressure, saturated 
with water vapour. 
FEV 1 Forced expiratory volume in one second 
(expressed in terms of BTPS). 
FVC Forced vital capacity (expressed in terms of 
BTPS). 
Asthma The combination of recent wheeze and 
bronchial h yperresponsi veness (BHR). 
Atopy A wheal reaction of 3mm or more to a skin 
test using standardised allergens. 
BHR Bronchial hyperresponsiveness, defined as 
PD20FEV1 less than or equal to 3.9 µmols of 
histamine. 
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Chronic cough 
CLO 
COPD 
NOLD 
Crepitations 
DP 
Der P1 
OF 
Ever-smoker 
HOM 
HLA 
IgE 
Loose cough 
MRC 
Petrol sniffer 
Recent wheeze 
Rhonchi 
SMR 
A history of daily coughing for more than 
two years. 
lX 
Chronic 1 ung disease was diagnosed if a 
subject's FEV1 , FVC or the FEV1 /FVC ratio 
was greater than two standard deviations 
below that in a reference population of 593 
participants without signs or symptoms of 
I ung disease. 
Chronic obstructive pulmonary disease was 
diagnosed in people with CLO who had an 
abnormal FEV1 /FVC ratio . 
Non-obstructive lung disease was diag-
nosed in people with CLO who had a 
normal FEV1 /FVC ratio. 
Crackling sounds on auscultation which 
may be associated with disease of the 
pulmonary parenchyrna or fluid in alveoli. 
Dermatophagoides pteronyssinus 
Dermatophagoides pteronyssinus 1 allergen. 
Dermatophagoides farinae 
A person who is a current smoker or an ex-
smoker. 
House dust mite. 
Histocompatability locus antigen. 
Immunoglobulin E 
The quality of looseness (moistness) 
observed 1n a cough; correlates with 
productive cough. 
Medical Research Council (British). 
Dose of histamine required to produce a 
20% percent fall in FEV1 during a histamine 
challenge test. 
Person who regularly inhales petrol fumes. 
A form of substance abuse. 
A history of wheezing in the last 12 months. 
A musical sound heard on auscultation of 
the chest which may be observed in asthma 
and other airway diseases. 
Standardised mortality ratios. 
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CHAPTERl 
Introduction 
1.1 Introduction 
Australian Aborigines are significantly more likely than non-Aboriginal 
Australians to die or be hospitalised as a result of respiratory disease. Little is 
known about the nature or causes of chronic lung disease (CLD) in Aborigines. 
The principal objective of this study was to document the nature and 
prevalence of CLD in four Aboriginal communities and to consider the role of 
several known risk factors for respiratory disease. 
Respiratory health was assessed by determining whether subjects had chronic 
cough, recent wheeze, basal crepitations, basal rhonchi, loose cough, bronchial 
hyperreactivity or abnonnal spirometric function. 
As there were no published reference values for lung function in healthy 
Aboriginal children and only one set in adults (1) it was necessary to measure 
spirometric function in healthy subjects so that equations for determining 
reference values could be developed. 
Issues related to cigarette smoking were explored because there is a belief that 
smoking is a serious public health problem in Aboriginal communities and 
because little is known about Aboriginal smoking (2). Data were also collected 
about tobacco chewing and alcohol consumption because in the author's 
expenence these substances are commonly used in some Aboriginal 
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communities and because any associations between tobacco smoking and other 
substance use could be of public health significance. 
It is readily apparent when one visits most Aboriginal communities that the 
prevalence of chronic cough and "fruity cough" (loose cough) are high. Health 
practitioners have no rational way of interpreting the significance of these 
observations because it is not known if they are associated with a specific , 
respiratory disease. An important additional objective of the present study was 
to examine the associations between common respiratory symptoms and signs 
and CLD. 
In the present study, the research process was used as an opportunity for 
Aboriginal health worker training and community health development. This 
was done because the National Health and Medical Research Council 
guidelines for the conduct of Aboriginal health research (3) require researchers 
to conduct their work in a manner that leads to tangible community benefits. 
The guidelines also emphasise the need for meaningful comn1unity 
consultation and participation in research. Because these guidelines are 
relatively new the research process is documented in detail. 
1.2 Potential Risk Factors for CLO in Aboriginal Communities 
1.2.1 Lower Respiratory Tract Infection 
Before the age of three years many Aboriginal children commonly 
require repeated hospitalisation (4) for severe episodes of lower respiratory 
tract infection. In non-Aboriginal children lower respiratory tract infections 
have been shown to be associated with reduced forced expiratory volumes and 
reduced lung growth (5). Whilst it is well recognised that some Aboriginal 
children develop bronchiectasis as a consequence of early lower respiratory 
tract infection (6), it is not known if some infections are 1nore subtly affecting 
lung growth and development. In the present study the author did not seek to 
relate specific episodes of lower respiratory tract infection to abnormalities of 
ventilatory function but rather sought to broadly exanline the possibility they 
might be associated with the development of CLO. 
1.2.2 Environmental Factors 
Although many clinicians believe that substandard housing and 
crowding are associated with increased morbidity frorn respiratory disease, 
there is little "hard" evidence to support this notion (7-9). Living conditions for 
Australian Aborigines vary considerably from region to region . While some 
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live in adequately maintained housing, this is the exception (10). More often 
they live in poorly maintained or derelict houses, without access to running 
water or functioning showers and toilets (11). Many Aboriginal people live in 
shelters constructed from corrugated iron, branches or tarpaulins. Assessing 
the impact of housing and environmental factors on respiratory health is 
complicated because there are many potential confounders (12-14) and because 
the mechanism by which substandard housing and crowding might cause lung 
disease is unclear. Important factors associated with these conditions might be 
respiratory infections, dust and smoke exposure. The present study examined 
people from different regions thus providing an opportunity to consider the 
impact of different housing conditions on respiratory health. 
1.2.3 Cigarette Smoking 
Although cigarette smoking in Aboriginal people has been studied by 
several investigators (15-17) little is known about their patterns of smoking, 
their understanding of the heal th consequences of smoking, or the ef feet of 
smoking on their lung function (2). The present study afforded an opportunity 
to explore these issues. It was hypothesised that current smokers would have 
poorer lung function than non-smokers, that health knowledge would be low 
in comparison with non-Aboriginal Australians and that there would be a 
significant relationship between health knowledge and current smoking status. 
1.2.4 Asthma 
Asthma is an important health problem for non-Aboriginal Australians 
(18) and may be associated with fixed abnormalities of lung function and atopy 
to common aero-allergens. The few reports that refer directly or indirectly to 
the prevalence of asthma in Aborigines provide varying estimates for its 
prevalence (19-28). Anecdotal reports from Cape York by Dr John Thompson, 
Thoracic Physician, Cairns Base Hospital, suggested that the prevalence of 
asthma in adults and children was low (0 to So/o). Dr Thon1pson also observed 
regional variation in the prevalence of asthma in these areas. The present study 
allowed the first formal documentation of the prevalence of asthma in 
Aboriginal adults and children. 
Evidence has been accumulating that house dust mite allergy and asthma are 
causally associated (29). The prevalence of house dust mite allergen exposure 
and its relationship to asthma in Aborigines has not been investigated 
previously. In addition, the importance of atopy to other common aero-
allergens has not been assessed in Aborigines. 
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Bronchial hyperreactivity (BHR), an a1rway abnormality associated with 
asthma and chronic obstructive airways disease, can be detected by assessing 
the fall in FEV1 that may occur following increasing doses of inhaled histamine 
(30). This procedure is known as a histamine challenge test. The test has 
proven reliability and has now been used extensively in epidemiological 
studies of asthma. There is only one report assessing bronchial hyperreactivity 
in Aboriginal children and there are none in adults. The present study 
provided an opportunity to study the prevalence and associations of BHR in 
Aborigines . 
1.2.5 Genetic Factors 
Dr Thompson hypothesised that the emergence of asthma in one 
Aboriginal community located on the north Queensland coast (identified as 
CY1 in this study) might be related to the influence of "non-Aboriginal" genes 
associated with asthma or atopy, introduced as a result of racial mixing. 
Professor Sue Serjeantson (Department of Human Genetics, John Curtin School 
of Medical Research ACT) has an interest in using the human leucocyte antigen 
system gene complex to study human migration and admixture in the pacific 
region. The present study afforded an opportunity to determine if there was 
any association between the presence of asthma (or atopy) and HLA subtypes 
not usually found in Aborigines. 
1.2.6 Petrol Sniffing 
In some Aboriginal communities children spend many hours each day 
inhaling fresh petrol vapour, so called petrol sniffing (31). It is well recognised 
that long term petrol sniffing may result in serious neurological and liver 
disease but it is not known if petrol sniffing is an important cause of CLD. 
1.3 The Participating Communities 
All the indigenous residents over the age of 4 years in four rural 
Aboriginal communities were invited to participate in the present study. 
1.3.1 Cape York 1 (CYl) 
CYl had the longest history of contact with Europeans of the four 
communities studied and its residents generally lived in well maintained 
houses . The level of literacy and numeracy was relatively high and English 
was the principal language. The living conditions in CYl were more 
westernised than those in the other three communities. Lower respiratory tract 
infections in children were said to be uncommon but asthma was reported to be 
prevalent. Data from this community were examined to see if there was any 
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evidence that these apparently healthy living conditions were associated with a 
prevalence of CLO that was lower than that in the other three communities. 
1.3.2 Cape York 2 (CY2) 
CY2 is more isolated than CYl, the standard of housing at the time of the 
present study was less adequate and alcohol abuse was also a serious problem. 
' 
' 
The community comprised two main tribal groups that lived together uneasily. · 
Tior and Munkin were the dominant languages. Lower respiratory tract , 
infections in children and asthma were said to be uncommon but CLD was 
' 
thought to be prevalent. 
1.3.3 Central Australia 3 (CA3) 
) 
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CA3 was the most "traditional" of the four communities and its 
members lived on a series of decentralised "outstations" or "homelands". As a 
consequence there was no central community. Housing ranged from simple 
shelters to free standing simple dwellings with running water and ablution 
facilities. Alyawarra and Anmatyerre were the main languages. This was the 
only community in the study not to have been a mission and significant contact 
with Europeans did not occur until the 1920s. It has been reported that 
childhood pneumonia although prevalent in this community was rarely serious 
enough to require evacuation to the regional hospital in Alice Springs (32). 
CA3 was selected to determine whether there was evidence that the traditional 
lifestyle in the community conferred some objective respiratory health 
advantages. 
I ' 
1.3.4 Central Australia 4 (CA4) 
CA4 is a community created in the 1960s com prising several related 
tribal groups who spoke Pitjantjatjara and Yankunytjatjara. At the time of the 
present study the housing in CA4 was grossly inadequate and overcrowding 
was widespread (11). The author and his wife worked as medical officers in the 
community during 1986 and 1987. This study had its origins in that experience. 
The author observed that at least one episode of childhood pneumonia in the 
first two years of life was universal and that adult lung disease appeared 
common. Petrol sniffing was prevalent among teenage children in this 
community. CA4 was selected to determine if there was objective evidence that 
either the poor living conditions or petrol sniffing were associated with a high 
prevalence of CLO in comparison with the other communities. 
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1.4 Aims 
In the four selected communities the aims were to determine: 
·,1 • The prevalence of smoking and the nature of any associations with 
• tobacco chewing and alcohol consumption; II: 
• The level of awareness about the dangers of smoking; ' 
-
• The prevalence of bronchial hyperreactivity, atopy and current asthma 
I 
in adults and children; 11 
Ii 
Ii 
• The relationship between house dust mite allergen exposure, house dust 
mite allergy and asthma; 
I 
• Whether asthma and atopy in Aborigines from Cape York are associated 
with "non-traditional" HLA alleles; 
• Whether asthma and atopy in Aborigines are associated with elevations 
I 
of Immunoglobulin IgE; 
• Prediction equations for FEV1 and FVC in "healthy" Aborigines; 
• The prevalence of chronic cough, recent wheeze, loose cough and 
crepi ta tions; I 
• The risk factors for chronic cough, loose cough and recent wheeze; 
I 
l 
• The prevalence of chronic obstructive pulmonary disease (COPD) and 
non-obstructive lung disease (NOLD) in adults and children by region, 
. age and gender; 
• The likely risk factors for COPD and NOLD; 
it 
• The clinical features of COPD and NOLD . 
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Methods 
All residents over the age of four, from each of the four communities, 
were invited: 
To answer questions about respiratory symptoms, alcohol consumption 
and smoking; 
To have measurement of their sitting height, standing height and 
weight; 
To be assessed for the presence of loose cough; 
To have auscultation of the posterior lung bases; 
To have their tidal carbon monoxide level measured; 
To have blood drawn for HLA class two antigen analysis and IgE 
estimation (selected subjects, Cape York only); 
To have house dust collected for house dust mite allergen load (selected 
subjects); 
• To have spirometry performed (FEV1 and FVC); 
• To have a histamine challenge test performed; 
• To have skin tests for atopy to common allergens. 
1.6 Organisation of the Thesis 
There are nine chapters that follow this introduction. In chapter two the 
studies that have relevance to Aboriginal respiratory disease are reviewed. In 
chapter three the ethical framework of the study, the history and current 
circumstances of the participating communities and the process of obtaining 
informed consent and feeding back the study's findings are summarised. In the 
next chapter the sampling procedure and details of participation are described. 
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The following five chapters present the findings regarding cigarette smoking, 
asthma and atopy, normal lung function, chronic and loose cough, COPD and 
NOLD. The thesis concludes with a chapter that highlights the important 
findings and addresses their public health implications. 
This research was conducted in order to develop a better understanding of the 
constellation of factors that influence "Aboriginal Heal th". The author 
particularly wanted to explore respiratory health issues in a way that would 
produce data suitable for use as a health development resource for Aboriginal 
people and their health services. The author has drawn on the insights and 
experience he gained from living and working in CA4 in 1986-87 and from 
discussions with many people. It is his hoped that the thesis will provide 
impetus for Aboriginal programs that lead to healthy change. 
II 
: 
I 
'11 
11 
, 11 
I 
I 
, 11 
I 
I 
I 
' 
1, 
' 
··1 
f 
~ 
' 
i 
I 
11 
I 
' 
9 
CHAPTER2 
Literature Review: 
Respiratory Health and Disease in 
Aborigines 
2.1 Introduction 
This chapter highlights the significance of respiratory disease as a cause 
of death and hospitalisation among Aboriginal people. The studies that 
specifically address lung disease and lung function are also discussed in 
chronological order. The chapter concludes with a summary. 
2.2 Mortality Studies 
In 1985 Hicks (33) published standardised mortality ratios (SMR) for 
Western Australian Aborigines . In males the SMR was 2.4 times the total 
Western Australian rate and in females the SMR was 2.9. Diseases of the 
respiratory system (ICD-9 Vl 11) were the second most prevalent cause of death 
for males, and the fourth most prevalent cause for females . Approximately half 
the respiratory deaths were due to pneumonia and half were attributed to 
chronic obstructive pulmonary disease (COPD) and emphysema (ICD-9: 492 & 
496). The numbers were too small to calculate standardised mortality ratios for 
each disease. 
In 1988, Plant (27) published an analysis of the 1,651 Aboriginal deaths that 
occurred in the Northern Territory (NT) from 1979 to 1983 inclusive. The total 
Australian population was used as the standard to calculate SMRs. Plant found 
the crude death rate in Aborigines to be 11 per thousand. The SMR for males 
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was 3.2 (95% CI 3.0-3.4) and females was 3.9 (95o/o CI 3.6--4.2). Respiratory and 
cardiovascular disease were the dominant causes of death after the age of 35. 
Plant calculated that the SMR for death from diseases of the respiratory system 
was 9 in males and 15 in females. The relative risk of death from pneumonia 
and influenza was 22 (95% CI 17-26) in men and 19 (95% CI 14-25) in women. 
The relative risk of death from COPD and asthma (ICD-9: 493) was 5 (95% CI 4-
6) in men and 11 (95% CI 8-14) in women. Plant's study is the most 
comprehensive Aboriginal mortality study to date. It shows that the death rate 
from pneumonia and COPD (or some type of chronic lung disease) in Northern 
Territory Aborigines is significantly higher than in the non-Aboriginal 
Australian population. 
The only other mortality study of significant size is that by Honari (34) who 
reported 967 Aboriginal deaths occurring in Queensland, Western Australia, 
South Australia and the Northern Territory in 1985. The study by Honari is not 
as powerful as that of Plant as it examined fewer deaths. However, the 
findings support Plant's work and indicate that the excess Aboriginal mortality 
from respiratory disease, identified in the Northern Territory, was not peculiar 
to that region. 
Perinatal and infant mortality rates in Aborigines have declined in the last 
twenty years but are still 2 to 3.6 times higher than for non-Aboriginal 
Australians (28). Respiratory diseases in Northern Territory Aboriginal infants 
were the cause of 18.2% of infant deaths between 1979 and 1983. In the non-
Aboriginal population respiratory diseases caused only 5.6% of infant deaths 
during this period (24). Thus, whilst it is true that at all ages death from 
respiratory diseases are more common in Aboriginal than non-Aboriginal 
people, most of the excess deaths from these diseases are occurring in adults 
rather than inf an ts. 
2.3 Hospital Admission & Discharge Studies 
The most co1nprehensive Aboriginal hospitalisation study is that by 
Devaneson et al (1986) entitled Health indicators in the Northern Territory (24). 
Rate ratios (RR) for hospital separation were calculated by dividing the 
Aboriginal rates by the non-Aboriginal rates. The RR for hospital separations 
were highest among O to 4 year olds and 25 to 64 year olds (RRs >2.0). 
Respiratory diseases (ICD-9: 460-519) were the second most prevalent cause 
(16%) for hospital separations in Aboriginal men and the fourth in women 
(9o/o). Among non-Aboriginal people, respiratory diseases were also the second 
most prevalent cause of hospital separations in men (9%) and fourth in women 
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(6%). The Aboriginal male respiratory admissions comprised pneumonia 59%, 
upper respiratory tract infection (URTI) 11 o/o, COPD 8% and asthma 3%. The 
Aboriginal female respiratory admissions comprised pneun1onia 49%, URTI 
13%, COPD 10% and asthma 5%. Devaneson et al showed that when compared 
with the non-Aboriginal population the proportion of respiratory admissions in 
Aborigines for pneumonia was relatively high and for asthma was relatively 
low. The proportion of respiratory admissions due to COPD was similar in the 
Aboriginal and non-Aboriginal populations. These data concur with the 
findings from the mortality studies cited above as they suggest that pneumonia 
and COPD are the prevalent respiratory problems in Northern Territory 
Aborigines. 
2.4 Epidemiological Studies 
In 1967 Gandevia (22) reported findings from Papunya, an Aboriginal 
community in the Northern Territory with a population of approximately 800 
people. Subjects were examined for loose cough, crepitations and rhonchi. 
Subjects were also questioned regarding recent chest infections (defined as any 
chest infection in the preceding two and a half years that required antibiotics). 
The chest infection history was validated by examining the community's 
hospital/ clinic records. The community was free of industrial air pollution and 
cigarette smoking. Gandevia's study was the first population based study of 
respiratory disease in an Aboriginal community. The study had added interest 
because within the community there were three distinct Aboriginal groups. 
The participation rate among children was approximately 75% and among 
adults was 17%. 
Gandevia found the prevalence of recent chest infection in all three tribal 
groups was high (range in children 27-50%, adults 22-85%). The prevalence of 
loose cough was also high (range in children 50-79%, adults 28-79%), and basal 
crepitations were prevalent (range in children 24-65%, adults 11-71 %). The 
findings highlight the impact respiratory tract infections may have in small 
disadvantaged communities. The prevalence of chronic lung disease at the 
time of the study remains unknown because tests of pulmonary function were 
not performed. The significance of the basal crepitations is also unknown 
because repeat examinations and CXRs were not performed. It is noteworthy 
that rhonchi were not detected in any children as it suggests that the prevalence 
of asthma was low. 
In 1968 Maxwell et al (35) published the results of a study performed in 
Papunya. Maxwell et al X-rayed 271 of the 329 children obtaining postero-
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anterior views of their chests. They also examined the children for loose cough 
and auscultated the bases of their lungs . Maxwell et al found that 21 % of male 
children and 33 % of females had either a loose cough, crepitations or rhonchi 
(not cleared by coughing). These observations are consistent with those of 
Gandevia. He also noted that 27o/o of boys and 8% of girls had either signs of 
chronic lung disease (chest wall deformity, clubbing or impaired chest 
movement) or acute lower respiratory tract infection. It is unclear what 
proportion of children had signs of chronic lung disease without signs of acute 
lower respiratory tract infection. The predominant radiological abnormalities 
were bronchiectasis of the left lower lobe 1.8%, probable bronchiectasis 3.2%, 
accentuated basal shadows 3.6% and pulmonary consolidation 16%. Although 
the prevalence of these abnormalities in non-Aboriginal Australians is 
unknown, most medical practitioners would probably expect them to be 
significantly lower than that found by Maxwell et al. Although some of the 
children with consolidation may not have had pneumonia (because half of 
them had no signs of lung disease) the study still provides compelling evidence 
that the prevalence of pneumonia was high. This remains the only published 
(population based) radiological study of Aboriginal children. It showed that 
the prevalence of pneumonia and bronchiectasis in Papunya was high and that 
loose cough and crepitations were also prevalent. 
In 1972 Maxwell (6, 36) investigated 118 Aboriginal children from communities 
around Alice Springs who were thought to have chronic lung disease on 
clinical grounds. The investigations showed that 83 had bronchiectasis and 35 
had chronic bronchitis (criteria for diagnosis not defined) . Both groups of 
children gave similar histories. Sixty percent of the bronchiectatics reported 
symptoms since at least the age of two. Of the children with bronchiectasis, 
47% had a history of bronchiolitis, 37% pneumonia and 11 % recurrent chest 
infections. Fifty-five percent of those with bronchiectasis had been dehydrated 
at the time of at least one of these respiratory episodes. These illnesses remain 
prevalent in rural Aboriginal children (4). Most (84%) of the children with 
bronchiectasis reported chronic productive cough and on examination loose 
cough was universal. Twenty-eight percent of the children with bronchiectasis 
had no abnormality on repeated physical examination. None of the children 
had cystic fibrosis, hypo-gammaglobulinaemia or evidence of alpha-1-
antitrypsin deficiency (37). Half of the children were said to have abnormalities 
of pulmonary function but the details were not reported. The anatomical 
distribution of the bronchiectasis was similar to that seen in non-Aboriginal 
children. 
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Maxwell opined that bronchiolitis, particular! y if associated with dehydration, 
was an important cause of chronic respiratory disease in Aboriginal children. 
He also asserted that chronic lung disease in Aboriginal children was a result of 
environmental rather than genetic factors . He observed that most children with 
chronic lung disease lived in simple overcrowded shelters with constant 
opportunity for cross-infection. Maxwell's paper is valuable because it 
describes the features of a selected group of patients with chronic lung disease 
and forwards some hypotheses regarding aetiology. 
In 1973 Moodie (21) observed there were no studies of asthma in Aborigines. 
He studied 320 Aboriginal children living in a New South Wales coastal 
community and documented a history of wheeze in 3.4o/o. He also observed 
that on examination "very few" of the children had signs of asthma. The 
prevalence of wheeze was low when contrasted with Peat et al who found that 
24.2% of 1,668 non-Aboriginal children aged 8-10 years had wheezed in the 
previous 12 months (38). Moodie concluded that in the community he 
examined the prevalence of asthma was less than 4%. 
In 1975 Hiller reported a one year survey of chest X-rays performed in the Alice 
Springs Hospital on children aged one month to 14 years (39). An attempt was 
made to distinguish between "full blood" Aboriginal and "part Aboriginal and 
Caucasian" children. The X-rays were taken in both the antero-posterior and 
lateral positions. A total of 988 X-rays were reported and 61 % were from "full 
blood" children. Hiller found the peak frequency for CXRs occurred in children 
aged one month to one year. Seventy-five percent of those X-rayed were less 
than three years old. Fifty-two percent of the films of the "full blood" children 
and 27% of the films of the "part Aboriginal children" were abnormal. Most of 
the abnormalities were due to pneumonia or atelectasis. Hiller made much of 
the point that acute bronchiolitis with over-inflated lungs was seldom found 
but he did not acknowledge that children with bronchiolitis may have normal 
X-rays (40). He described four children with non-resolving pulmonary collapse 
or definite chronic lung disease. Although 37% of the children had no follow 
up X-rays Hiller asserted that "there is very little chronic lung disease in the 
population". This was not a valid conclusion because the study reported 
incident disease and because the proportion lost to follow up was high. 
However the study did show that most paediatric pneumonia requiring 
hos pi talisa tion in Aborigines occurred in children under three years of age. 
In 1976 Hiller reported the CXR changes and radiological course for 19 of 
Maxwell's bronchiectasis patients following lobectomy (41). The progress of 
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the lobectomy patients was compared with that of 16 Aboriginal patients with 
bronchiectasis who were treated conservatively. The follow-up period was 2-8 
years. Valid conclusions cannot be drawn from this paper because appropriate 
matching for severity of disease did not occur. 
In 1976 Bateson et al (42) described the radiological findings in four Aborigines 
with bronchiectasis and total destruction of a lung. A second paper by Bateson 
in 1978 (43) reviewed 18 Aboriginal people with lobar or total lung destruction 
secondary to bronchiectasis. In nine of the bronchiectatic children (aged 2-10 at 
presentation) the mean interval from a previously normal CXR to unequivocal 
chronic lung disease was 2.7 years. Seven of the adult bronchiectatics (aged 28-
60 at presentation) had a mean interval of five years from their last normal X-
ray. Three of the adults and two of the children did not have specific 
respiratory symptoms at the time of diagnosis . Many presented with serious 
lung infection and cystic changes on their CXRs. Others had a history of 
pneumonia with incomplete resolution. Bateson et al's cases highlight one end 
of the spectrum of post-suppurative lung disease and, with Maxwell's series 
(6), provide the only published descriptions of bronchiectasis in Aborigines. 
In 1976 Kamien reported a study of all the 0-15 year old Aboriginal children 
(n=410) living in Bourke, New South Wales (20). Each child's past medical 
history was ascertained from a semi-structured interview with the mother and 
perusal of their medical records in the Bourke District Hospital. The children 
were also examined for abnormalities of auscultation. Kamien found that 56% 
of 1-4 year old children had a history of "recurrent upper respiratory tract 
infection" (not defined), as did 21 o/o of 5-9 year olds and 8% of 10-14 year olds. 
Adventitious sounds were heard in 32% of 0-4 year olds and 6.4% of 5-14 year 
olds. None of the children had a history of asthma. Although Kamien's 
findings differed from those of Gandevia (22), who found the prevalence of 
adventitious sounds remained high in 8-15 year olds, they demonstrated that 
the high prevalence of respiratory tract infections found in Papunya was not an 
isolated finding. 
In 1976 Kamien also reported a study of the Aboriginal adults (aged 15 and 
over) in Bourke (44) . The total adult population was 320. The participation 
proportion in men was 91 % and women 93%. Seventy-eight percent of the 
adults were current smokers. A history of chronic or recurrent respiratory 
disorder was obtained from 22% (58/264) of the adults. Specifically, 13% had a 
history of chronic bronchitis, 3% recurrent upper respiratory tract infections, 
2% tuberculosis, 2% asthma, 2% recurrent pneumonia and 1 person had a 
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history of actinomycosis. The prevalence of loose cough averaged 20o/o and 
increased with age. Ad ven ti tious sounds were present in 17% and the 
prevalence also increased with age. In addition Kamien found that 24% of the 
adults had been admitted to Bourke District Hospital with respiratory disease 
at least once between 1967 and 1971. In itself this is an extraordinary finding. 
Kamien established that mass CXR screenings in Bourke of adults in 1968 and 
1971 had found changes consistent with chronic bronchitis or emphysema in 
6%, and tuberculosis in 2%. 
Kamien's studies were the first complete epidemiological survey of respiratory 
disease in an entire Aboriginal Community and produced the first formal 
estimates of the prevalence of asthma and chronic lung disease in Aborigines. 
The radiological findings suggested at least 6% of adults had chronic lung 
disease. This was high as most studies of Caucasian adults reveal that the 
prevalence of chronic obstructive airways disease is 1-3% in women and 4-6% 
in men (45). Kamien's findings also suggested that the prevalence of asthma 
was approximately 0% in children and 2% in adults. This is low when 
contrasted with Peat et al who found the prevalence of current asthma in non-
Aboriginal Australians to be 11.4% in children (38) and 6.3% in adults (46). 
None of the asthmatics Kamien identified were atopic. The author concludes 
from this study that the prevalence of asthma was low in Bourke and that the 
prevalence of chronic lung disease in adults was high. 
In 1979 Chandler et al (26) investigated the respiratory function of 203 school 
age Aboriginal children living in Cherbourg Aboriginal community, 250 
kilometres north-west of Brisbane. The study was designed to look for 
evidence of chronic lung disease (residual from childhood lower respiratory 
tract infections) and to develop models to predict PEV1 and PVC. The study 
was restricted to 5-13 year old children attending school. Spirometry was 
performed using a Vitalograph dry spirometer. Only those with 
"consistent/ satisfactory results" were recorded and an unknown number were 
rejected. Children with symptoms or signs of lung disease were not excluded. 
A group of 38 children had FEV1 and PVC measured before and after 
bronchodilator. It was not reported how these children were selected. PEV1 
and PVC were presented as a percentage of the values published by Polgar and 
Promadhat (for Caucasian children) . The PEV 1 /PVC ratio was averaged for 
children by age group. 
Chandler et al found that the PEV1s in Cherbourg children ranged from 79 to 
89 % predicted. The PVCs ranged from 72 to 89% predicted. The mean 
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FEV 1 /FVC ratio at all ages was greater than 97o/o. Three children had evidence 
of reversible airflow obstruction (not defined). Chandler et al concluded that 
widespread chronic airways disease and asthma were not present. Linear 
regression was used to model FEV 1 and FVC. The final models used height as 
the predictor. The R-squared values for the models and the standard error of 
the estimates were not reported. 
In 1980 Chandler et al (47) reported the results of pulmonary function tests in 56 
children from Mornington Island. Children were recruited from the schools as 
in the previous study and similar methods were used. Of the 92 children at 
school, 36 failed to perform satisfactory spirometry. The FEV 1s ranged from 
75% to 89% predicted. The FVCs ranged from 76 to 87% predicted. The lowest 
mean FEV1 /FVC ratio was 92%. Chandler et al concluded that this study did 
not reveal any evidence of lung damage in children. 
In the absence of any study reporting FEV1 and FVC in healthy asymptomatic 
Aboriginal children Chandler et al had no accurate way of assessing the 
prevalence of abnormal lung function in the two studies described above (48). 
Therefore it cannot be concluded that Chandler et al found no evidence of 
chronic lung disease. In addition, the selection process for the two studies and 
the high rejection rate, may also have biased the findings towards healthier 
children. The prediction equations developed by Chandler et al (26) for FEV1 
and FVC cannot be assumed to predict "normal" lung function in Aboriginal 
children because they were not developed in children free of signs or 
symptoms of lung disease (48). However the studies do clearly suggest that 
FEV 1 and FVC in Aboriginal children are lower than corresponding predicted 
values for Caucasian children. 
In 1983 Torzillo et al (23) studied 1,287 Aboriginal people living in the Pilbara, 
Western Australia . Most of the residents of seven communities participated. 
Subjects were examined for a loose cough, using the method of Gandevia (22), 
and auscultation of the lung bases was performed. Abnormal auscultation was 
defined as the presence of adventitae that did not clear with coughing. Lower 
respiratory tract abnonnality was defined as the presence of loose cough 
and/ or abnormal auscultatory findings (at two or more sites). The mean 
prevalence of loose cough was 17.6% (range 11.7-21.1), abnormal auscultation 
was 21.8% (range 10.0-30.2) and lower respiratory tract abnormality 28.5% 
(range 15.9-36.6). The prevalence of smoking in these communities was not 
reported. Torzillo et al' s observations were similar to Gandevia's at Pa pun ya. 
Both studies indicate widespread respiratory ill health. Without lung function 
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data it is not possible to fully assess the implications of these observations. As 
none of the children were reported to have rhonchi, the prevalence of asthma 
was probably low. 
In 1984 Harris et al reported the incidence of childhood pneumonia for 
Aboriginal and non-Aboriginal children in Bourke (49). The records of 270 
children (103 Aboriginal and 167 non-Aboriginal) born at the Bourke District 
Hospital in 1980 and 1981 were reviewed to record the number that had 
pneumonia in the first three years of life. Pneumonia was defined as an acute 
respiratory illness with symptoms, signs and radiological evidence of lobar or 
multilobar consolidation. Children with signs and symptoms of pneumonia 
but only "patchy" consolidation were excluded. Perinatal data and neonatal 
observations were also recorded. 
Harris et al found that 25o/o of the Aboriginal children and 3% of the non-
Aboriginal children had one or more episodes of pneumonia. Nine of the 26 
Aboriginal children with pneumonia had experienced multiple episodes. The 
pneumonia in the Aboriginal children involved the right upper lobe in 77% of 
cases and other lobes were involved in 62%. The mean age of the first 
pneumonic episode was 14 months, and in more than half of the Aboriginal 
children the first episode occurred during the first year of life. Thirty-nine 
percent of the Aboriginal children with pneumonia ,.veighed less than the tenth 
percentile for age. There was no correlation between birth weight, current 
weight, prematurity, breast feeding and pneumonia. The authors were not able 
to reach any conclusions regarding the impact of overcrowding and 
substandard housing because the numbers of children were small but the 
prevalence of pneumonia in children from substandard housing areas was 
relatively high (38%). This study clearly showed a differentially high 
cumulative incidence of pneumonia in Bourke Aboriginal children and was 
consistent with the anecdotal reports of similar problems in many Aboriginal 
communities (4). 
In 1984 Clark et al (50) published an abstract which reported findings in 166 
Aboriginal children (aged 7-16) from the Northern Territory. Clark et al 
performed histamine inhalation tests (for bronchial hyperreactivity) using the 
rapid method, and skin tests for atopy. The target population, sampling 
process, cumulative dose of histamine administered, criteria for BHR and the 
criteria for atopy were not reported. The allergens used were house dust, 
house dust mite, grass mix, cat, dog, and Aspergillus. The mean FEV 1 using 
(Caucasian based reference equations) was 84% predicted and the mean FVC 
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was 77o/o. Bronchial hyperresponsiveness was present 1n 16% (23/139) of 
children, and 42% were a topic. The prevalence of wheezing was not reported. 
The study suggested that prevalence atopy and bronchial hyperreactivity in 
Aboriginal children was similar to that in the non-Aboriginal population. 
In 1984 Harris (51) reported examinations of nasal mucosa from 15 Aboriginal 
children with chronic lung disease. Samples of cilia were obtained by 
brushings from the nasal mucosa. All samples were examined immediately by 
direct microscopy and subsequently by electron microscopy. No immotile cilia 
were seen on the direct microscopy. In seven subjects minor abnormalities of 
cilial structure were seen by electron microscopy, and one subject had 
abnormalities consistent with the immotile cilia syndrome. Sampling details 
and the nature of the subject's chronic lung disease were not described and so 
the significance the findings is uncertain. 
In 1986 Watson et al (52) reported lung function tests on 151 Aboriginal children 
aged 11-15 attending several schools in East Arnhem Land, in the Northern 
Territory. After a trial blow, the mean FEV1 and FVC of the three subsequent 
blows was recorded using "the spirometer". The criteria for the acceptability of 
blows was not reported, nor if the results were in ATPS or BTPS. Children with 
symptoms or signs of acute or chronic lung disease were neither identified nor 
excluded. Data were also collected from 236 similarly aged non-Aboriginal 
children. Multiple regression was used to model FEV1 and FVC in the 
Aboriginal children. It was assumed that the relationship between height and 
the logarithm of FEV1 and FVC was linear. The R squared values for the 
equations were not reported, nor were the standard errors of the estimates. The 
FEV 1 values for the Aboriginal children were 15-17% less than those for the 
non-Aboriginal children. The FVC values in Aboriginal children were 17-22o/o 
lower than those of their non-Aboriginal counterparts . This study confirmed 
that spirometric values in Aboriginal children are probably lower than 
corresponding values in non-Aboriginal children. However these models (like 
Chandler et al's) cannot be assumed to define lung function in healthy 
Aboriginal children because children with signs or symptoms of chronic lung 
disease were not excluded. 
In 1990 Harris et al (53) published a review of the changes that occurred in 
morbidity and mortality among the 0-14 year old Aboriginal children in 
Bourke between 1971 and 1984. Medical records were reviewed to establish the 
reason for hospital admission and to identify episodes of X-ray verified lobar 
pneumonia. In addition 100 households (representing 62% of Aboriginal 
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families resident in Bourke during 1984) were surveyed about their housing 
conditions. 
Harris et al found that respiratory illness was the most common reason for 
hospital admission of 0-5 year old Aboriginal children in 1971 (847 per 
thousand) and 1984 (833 per thousand). For the non-Aboriginal children the 
admission rates for respiratory illness in 1971 were 91 per thousand and 1984 
were 143 per thousand. Admissions for pneumonia in 0-5 year old Aboriginal 
children occurred with an annual incidence of 143 per thousand in 1968-1969 
and 80 per thousand in 1983-1984. The most common organisms cultured from 
children with lower respiratory tract infections in Bourke were Haemophilus 
infiuenzae and Streptococcus pneu111oniae. 
Harris et al found that from 1971 to 1984 the proportion of 0-2 year old children 
with a weight below the tenth percentile fell from 43% to 29o/o, and in 3-9 year 
old children the proportion fell from 36% to 31 %. A marked improvement in 
Aboriginal housing conditions also occurred from 1971 to 1984. The average 
number of persons per bedroom fell from 3.5 to 2.1, and the proportion with 
mains or septic sewerage increased from 59% to 75%. The proportion of houses 
with running water within five meters increased from 66% to lOOo/o, and the 
proportion with a shower or bath increased from 60% to 90%. The availability 
of running hot water also increased from 50% to 84%. Access to electricity rose 
from 59% to 91 % and refrigerator ownership rose from 27% to 93%. Harris et al 
hypothesised that the reduction in morbidity seen in Bourke Aboriginal 
children from 1971 to 1984 was related to improvements in housing conditions, 
increased access to running water (and other amenities) and improved 
nutrition. These findings are important because this is the only evidence to 
date that improved respiratory health in Aboriginal children might be 
associated with improved living conditions. 
In 1992 Thompson et al (1) measured ventilatory function in 70% of the adult 
population of an isolated Queensland Aboriginal community. A total of 288 
adults aged 20 and over had FEV 1 and FVC measured using a Vi talograph 
wedge spirometer. The aim of the study was to model ventilatory function in 
healthy adults. FEV1 and FVC were measured according to the ATS 
recommendations and all results were reported in BTPS. Subjects with known 
1 ung disease, loose cough, chronic cough, or ad ven ti tae on a uscul ta tion, or 
FEV1 /FVC ratio less than 60%, were excluded. Following the application of 
these exclusion criteria, 229 subjects were available for modelling. Eighty-one 
percent were smokers. Thompson et al found that the FEV 1 and FVC in the 
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Aboriginal adults were approximately 70o/o of that predicted by Caucasian 
equations. Thompson et al found that FEV1 declined with age in smokers and 
non-smokers but that the decline was apparently greater in non-smokers. The 
effect was sufficiently marked that by the age of 35 years smokers had better 
lung function than non-smokers. The authors were surprised by this finding 
because cigarette smoking is not generally believed to retard the decay of 
spirometric function. 
2.5 Summary 
2.5.1 Pneumonia 
In Aboriginal children there is good evidence that the incidence of 
pneumonia is high in comparison with non-Aboriginal Australian children (24, 
35, 39, 51, 53). Although pneumonia is an important cause of infant mortality 
in Aborigines it is more frequently a cause of premature mortality in adults 
(28). It has been shown that most Aboriginal childhood pneumonia occurs in 
the first three years of life (35, 39, 49, 53). Although there is some evidence to 
suggest that pneumonia in Aboriginal children is associated with substandard 
housing (49, 53) little is known about the cause(s) of the high attack rates. No 
adequate studies have been performed to determine if early childhood 
pneumonia in Aborigines is associated with abnormalities of lung function that 
persist into adulthood. 
In Aboriginal adults pneumonia is an important cause of premature mortality 
and hospitalisation (24, 27, 33). It is not known why the incidence of 
pneumonia is high or if these infections are a cause or a result of chronic lung 
disease. Chronic lung disease may be an important risk factor for pneumonia 
in Aboriginal adults. 
2.5.2 Bronchiectasis 
,, There is 25 year old evidence from one community to suggest that the 
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prevalence of bronchiectasis in Aboriginal children may have been as high as 
2% (35). It has been hypothesised that bronchiectasis in these children is due to 
lower respiratory tract infection and concurrent dehydration (6). There is no 
evidence that bronchiectasis in Aboriginal children is caused by ciliary defects, 
hypogammaglobulinaemia or cystic fibrosis (6, 51). The sensitivity and 
specificity of crepi tations in Aborigines for detecting bronchiectasis or other 
chronic lung diseases is unknown. The current prevalence of bronchiectasis in 
Aboriginal adults and children is also unknown as is the role of bronchiectasis 
in the aetiology of pneumonia. 
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2.5.3 Asthma 
Evidence from clinical studies suggests that the prevalence of asthma in 
Aboriginal children is less than 4% (20-23, 26, 35, 47). This means it is 
significantly lower than that found in non-Aboriginal children (see chapter 6). 
This is surprising because the only study of BHR and atopy in Aboriginal 
children suggests that the prevalence of these abnormalities (commonly 
associated with asthma) is very similar to that found in non-Aboriginal 
children (50). In adults, the only recorded estimate for the prevalence of 
asthma is 1.9o/o in Bourke by Kamien (44). Thus the prevalence of asthma in 
adults and children appears low when contrasted with that in non-Aboriginal 
Australians. There is a need for further research to confirm these findings and 
to explore the relationship between asthma, atopy and BHR in Aborigines. 
2.5.4 Normal Lung Function 
The three studies of ventilatory function 1n Aboriginal children all 
suggest that FEV1 values are approximately 11-25% lower than those found in 
non-Aboriginal children and that FVC values are 11-28 percent lower (26, 47, 
52). Although lung function was modelled in two of these studies (26, 52) the 
equations cannot be assumed to accurately predicted normal lung function 
because children with symptoms or signs of lung disease were not excluded. 
There is only one study of ventilatory function in clinically well Aboriginal 
adults (1). That study suggested FEV1 and FVC in Aboriginal adults are 30% 
lower than corresponding values for Caucasians and that spirometric function 
declined faster in non-smokers than smokers. Further research is required to 
confirm these findings and to explore the impact of cigarette smoking on 
spirometric function in Aborigines. 
2.5.5 Chronic Lung Disease 
Plant (27) has shown that Aboriginal males in the NT are 5 times and 
females 11 times more likely than their non-Aboriginal counterparts to die from 
COPD and asthma. Devaneson et al (24) showed that pneumonia, COPD and 
asthma were the main respiratory reasons for Aboriginal hospitalisation in the 
NT. It is likely that COPD and asthma are the most prevalent chronic lung 
diseases in NT Aborigines. The CXR component of Kamien's survey in Bourke 
(44) suggested that the prevalence of chronic lung disease in adults there was at 
least 6%. Also Maxwell's 1968 CXR survey (35) of children in Papunya 
suggested the prevalence of chronic lung disease in children could be at least 
6%. The nature and significance of the diseases identified in these CXR surveys 
is not known. The work of Maxwell and Kamien suggested that some of the 
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people with abnormal CXRs had bronchiectasis and some had COPD. Because 
clinical experience shows that CXRs have poor sensitivity for detecting people 
with mild ventilatory dysfunction it is likely that the prevalence of chronic lung 
disease(s) was even higher than that suggested by these surveys. 
2.6 Conclusion 
There is a large body of evidence to suggest that respiratory diseases are 
an important cause of morbidity and mortality in Aboriginal Australians. 
However almost nothing is known about the causes, nature and distribution of 
lung diseases within the Aboriginal population. 
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This chapter begins with a review of the important ethical issues in 
Aboriginal health research. The next section contains an overview of the 
participating communities and the rationale for their selection. The chapter 
concludes with a description of the process utilised to obtain informed consent 
and return results. 
3.2 Ethics 
Recently developed guidelines for heal th research in Aboriginal 
communities (3) emphasise the importance of consultation, community 
involvement, informed consent and providing feedback. The guidelines also 
stress the importance of ensuring that tangible con1munity benefits, such as 
employment for local people and health promotion, accon1pany research. The 
present study was conducted in accordance with these guidelines. 
The guidelines cited above were developed following a large Aboriginal health 
conference in 1986 in Alice Springs, NT. At that meeting Aboriginal people 
expressed distress and hostility about research activities in their cornmunities. 
Strong resentment was expressed because Aboriginal people were not being 
consulted about research. Examples were given of researchers proceeding with 
studies against the explicit instructions of community elders. It was also 
observed that once researchers had collected "their" data, Aboriginal people 
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rarely heard from the researcher again. Those performing research for the 
degree of Doctor of Philosophy were particularly singled out for criticism. It 
was against this background that formal guidelines for research in Aboriginal 
communities were developed. 
This project was approved and financially supported by the Australian 
Institute of Aboriginal and Torres Strait Islander Studies. The research was also 
approved by the Aboriginal Coordinating Council in Queensland and the 
appropriate community councils. In addition approval was given by the 
Australian National University ethics in human experimentation committee. 
3.3 Background & Rationale for Community Selection 
The diversity in living conditions and the small size of many Aboriginal 
communities pose problems for studying the epidemiology of chronic disease. 
The pooling of data from several communities potentially reduces these 
difficulties. To maximise numbers and to examine regional variation in the 
prevalence of abnormalities, the author selected four contrasting communities 
for the present study. For confidentiality the communities are referred to as 
Cape York 1 (CY1), Cape York 2 (CY2), central Australia 3 (CA3) and central 
Australia 4 (CA4). 
CY1 and CY2 were selected because a colleague, Dr Thompson observed that 
asthma was a significant health problem in CY1 but not in CY2. Puzzled by 
this observation and after discussing the issue with community representatives, 
he sought support to investigate asthma and other lung diseases in these 
comm uni ties . 
CA3 was approached because the members of this "traditional" community 
have been reported to be in relatively good health (32). It was also approached 
because the author had visited the community during the 1980's and personally 
knew several colleagues who had worked there for extended periods. 
CA4 was selected to assess the impact of particularly adverse living conditions 
and petrol sniffing on respiratory health. It was also a logical choice because 
the author and his wife were medical officers in its community controlled 
health service during 1986 and 1987. 
The following section contains a precis of life in each of the participating 
communities. Most of the information was obtained during discussions with 
Aboriginal community informants. A consideration of these varying 
circumstances led the author to deem that living conditions in CYl were 
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superior to those in the other three communities and tha t CA3 was better than 
CY2 and CA4. The author hypothesised that the prevalence of abnormal lung 
function (ALF) would reflect this by being relatively low in CYl and CA3 and 
high in CY2 and CA4. 
3.3.1 Cape York 1 (CYl) 
CYl is located in a rainforest on the eastern Queensland coast 
approximately 60 kilometres from Cooktown. The climate in CYl is tropical 
with a high rainfall, a long humid wet season and mild winters. At the time of 
the study the community had a population of approximately 700 people. The 
community comprised many Aboriginal tribes living on the traditional lands of 
the Guugu Yimidhirr. Its residents had good literacy and numeracy skills and 
English was the main language. 
The tribes from around CYl were some of the first Aborigines to encounter 
Captain Cook in 1770. The traditional people of the region were decimated 
during the Palmer River gold rush of the 1870s. In 1881 the land in the area 
was gazetted as an Aboriginal reserve to create a refuge and in 1885 the first 
missionary arrived. Since that time the residents of CYl have been coerced into 
adopting a European lifestyle. During the second World War all the residents 
were temporarily relocated further south. The community ceased to be a 
mission during the 1980s. At the time of the study the residents of CYl had no 
legal tenure over their land. 
At the time of the present study most people from CYl lived within the 
community in well maintained houses with functioning showers and toilets 
(see table 3.1 and illustration 3.1). Overcrowding was not prevalent. Generally 
the houses had three bedrooms with uncarpeted wood or concrete floors. Most 
people slept inside on mattresses placed directly on the floor. Electricity and 
gas were the principal energy sources for cooking and heating was not 
required. 
Despite the generally good standard, it was apparent that there was a range of 
living conditions in the co1nmunity. At one end of the spectrum were people 
who were more westernised, lived relatively well and ate every day. In 
contrast was a socially depressed group who frequently drank alcohol at week-
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Illustration 3.1 The upper photograph shows the main street in CYl and the 
lower one depicts an average house. 
27 
ends and often went without food. Alcohol was not available in the 
community but was obtainable within an hour's drive. Alcohol abuse was not 
generally considered to pose a threat to the maintenance of law and order or 
community cohesion. 
Although most food came from the community store, bush foods were an 
important source of weekend nutrition. Many people went fishing or hunted 
for kangaroo and pigs. During the week people generally ate bread and jam 
accompanied by tea and sugar for breakfast. For the main meal people 
generally ate hot stew, fish, chicken, or fried steak, with rice or fried chips or 
damper with jam. Take-away prepared meals such as pizzas and pies were 
also popular. 
Employment opportunities in the community were limited and primarily 
confined to clerical tasks in the community office or maintenance of community 
facilities. 
CYl had a small hospital that was staffed and run by the Queensland 
Department of Health. It employed local Aboriginal health workers but was 
not under community control. A doctor from Cooktown visited twice a week. 
Staff from the hospital rarely saw pneumonia in children. Asthma in adults 
was a commonly recognised problem. 
3.3.2 Cape York 2 (CY2) 
CY2 is located on the coast of the Gulf of Carpentaria at a similar latitude 
to CYl. Like CY1 the climate is tropical. At the time of the study the 
community had a population of approximately 400 people. The main 
languages were Tior and Munkin and compared with CY1 the people had 
relatively poor English literacy and numeracy skills. 
Significant contact with Europeans occurred later than for CY1 and coincided 
with the arrival of pastoralists in the 1880s. In 1897 the coastal lands of the Gulf 
were set aside as Aboriginal reserves and in 1938 a Church of England mission 
was established at the site that is presently CY2. By 1956 the majority of the 
indigenous population were living in simple palm thatched shelters within the 
mission. In 1964 a cyclone devastated the mission destroying most of the 
dwellings. The Queensland Government promptly rebuilt a community store 
and erected three bedroom prefabricated aluminium houses for most of the 
residents. 
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Illustration 3.2 The upper photograph depicts above average housing 1n CY2 
and the lower one shows inadequate housing in the same community. 
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The community remained a mission until 1967. At the time of the study the 
Tior and Munkin people did not have legal tenure of their land. The residents 
of CY2 lived in 87 houses and many of them were in poor condition. Less than 
50 per cent of the houses had functioning showers, but most had toilets (see 
table 3.1 and illustration 3.2). Most of the houses comprised three bedrooms 
and people slept inside on mattresses on the floor. The floors were made of 
concrete or wood and not carpeted. Electricity and gas were the principal 
modes of cooking and heating was not required. 
Since 1960 most food consumed by residents has been purchased from the 
community store but at the time of the present study bush foods remained an 
important source of food on weekends. Hunting for pigs and wallaby was 
popular sport and supplemented food supplies when money was scarce. For 
breakfast people generally ate bread, damper and jam or cereal with sugared 
tea. For the main meal people ate tinned meat and rice or pies and chips. At 
the time of the study alcohol was freely available within the community on 
three days each week. Alcohol abuse was considered a serious problem 
because it disrupted community cohesion and law and order. 
Employment opportunities in the community were limited and most jobs were 
low skilled. These included the maintenance of essential community facilities 
or community services such as the school, council office, store, women's 
resource centre and police. A near by crocodile farm, the community hospital 
and the canteen (pub) provided other sources of employment. 
The community hospital was run by professional staff from the Queensland 
Department of Health. It employed local health workers but was not under 
community control. Staff from the hospital reported that pneumonia in 
children was uncommon but that recurrent chest infections and bronchiectasis 
in adults was prevalent. Asthma was not known to be present among the 
indigenous people of this community. 
3.3.3 Central Australia 3 (CA3) 
CA3 is located 350 kilometres from Alice Springs in the NT. The climate 
is arid with subzero temperatures in winter. At the time of the study it had a 
population of approximately 800 people living in 14 small communities called 
outstations. These outstations were scattered over 1800 square kilometres of 
desert. Outstations comprised a group of houses and traditional shelters 
(called warles) where family groups and friends lived close to areas of 
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traditional significance. CA3 has never been a mission. The main languages 
spoken were Alyawarra and Anmatyerre and most people had only limited 
English literacy and numeracy. 
The lands of CA3 were expropriated to create a pas tor al lease in 1927. The 
traditional owners of the land remained and lived in strained coexistence with 
the pastoralists until 1979 when the community gained permanent legal title to 
the leasehold. 
The community houses were built on concrete slabs, had tin or brick walls and 
wide verandas (see illustration 3.3). Generally the houses had no floor 
coverings and minimal furniture. Most people slept on mattresses on the floor. 
Fire was both the principal source of heating and method of cooking. The 
author was unable to determine the number of houses with functioning 
showers and toilets . 
Bush foods have been shown to comprise approximately 40o/o of the diet in at 
least one of the outstations in this community (32). At the time of the present 
study native vegetables were collected when available and hunting for 
kangaroo was a regular activity. The remainder of the food came from the 
community store. The community has a long standing policy of ensuring 
healthy foods are available in the store. At the time of the study alcohol was 
not available throughout CA3 and alcohol abuse was not widespread. 
However increasingly, young men were engaging in episodic heavy drinking. 
There were very few employment opportunities in this community. However 
the community does have a strong tradition of painting and revenue from this 
and other artistic endeavours is valued. 
The community heal th service was run by the NT Department of Heal th and 
employed a doctor, several sisters and Aboriginal health workers . Staff from 
the health service reported that pneumonia in children under the age of two 
was common but rarely severe enough to warrant evacuation to Alice Springs. 
Asthma was recognised in adults but was unknown in children. 
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Illustration 3.3 The upper photograph shows typical housing in CA3. The 
lower photograph is an example of the type of housing that was gradually being 
introduced to the community at the time of the present study. 
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3.3.4 Central Australia 4 (CA4) 
CA4 is located 400 kilometres from Alice Springs on the Anangu 
Pitjantjatjara Lands in South Australia. The community lies in one of the most 
arid regions in Australia. The annual rainfall is less than 150 mm and the 
summers are long and hot (the mean temperature in January is 37 degrees 
Celsius). The winter temperatures fall below zero. At the time of the study 
CA4 had a population of approximately 350 people. The main languages 
spoken were Pitjantjatjara and Yankunytjatjara. The majority of the residents 
had poor English literacy and numeracy skills. 
Regular contact with Europeans began in the region of CA4 after the 
completion of the overland telegraph in 1872. In the early 1920s "inviolable 
reserves" were gazetted because of concern that European contact would 
"degrade" the traditional owners of the land. In 1937 a mission was created 
approximately 100 kilometres from the present site of CA4. After World War 
Two government intervention sought to end the nomadic existence of those 
living in the reserve. CA4 was one of many mission communities created on 
the reserve in the 1960s to "train the people to become useful ci tizens 0 (54). 
Since the 1970s there has been some government recognition of the adverse 
effects of forced concentration of Aboriginal people and some support for the 
decentralisation into smaller family units on "homelands". In 1981 the Anangu 
Pitjantjatjara won freehold title to their land. 
At the time of the present study approximately a third of the population lived 
on homelands within 50 kilometres of the central community. The residents of 
CA4 generally lived in inadequate poorly maintained houses or in traditional 
shelters called wiltjas. The quality of housing in the community varied from 
good to derelict (see table 3.1 and illustration 3.4). Most of the houses had two 
bedrooms but the majority of people preferred living and sleeping outside the 
house, when the weather permitted. The houses had wooden or concrete floors 
without coverings. Fire was the principal means of heating and cooking. At 
the time of the study only 31 % of the houses in CA4 had functioning showers 
and toilets. 
At the time of the study bush foods made a small but significant contribution to 
the daily diet in CA4. Honey ants and native vegetables were collected when 
in season and witchetty grubs (maku) were a sought after delicacy. Hunting 
for kangaroo (malu) was a regular activity because kangaroo meat is an import-
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ant part of the local diet. Most processed food was purchased from the 
community store although food was also available an hour' s drive from the 
community. For breakfast people generally ate cereal or porridge with sugar. 
Mid-morning people had grilled or stewed meat with bread or damper and jam 
with sweetened tea. Another meal was eaten before dusk if food was plentiful. 
Alcohol was not freely available in the community but it was obtainable within 
an hour's drive. Alcohol abuse has been increasing since 1986. The inhalation 
of petrol fumes (known as petrol sniffing) was a prevalent form of substance 
abuse among adolescents at the time of the study. Petrol sniffing has been 
occurring in the community for at least twenty years. 
Employment opportunities in this community were also lin1ited. 
At the time of the study the community had its own health service which 
employed three sisters and six community health workers. CA4 w as the only 
community to have a cornmunity controlled health service. The health staff in 
CA4 observed that nearly all children under the age of two years experienced at 
least one episode of pneumonia. Each year several cases were severe enough to 
warrant evacuation to Alice Springs Hospital. Some adults had asthma but 
childhood asthma was not a recognised problem. 
Table 3.1 Regional variation in the provision of basic facilities. 
CYl CY2 CA3 CA4 
Population 700 400 800 350 
Number of houses 111 87 * 26 
Number of wiltjas/warles 0 3-6 * 12 
% carpet 
-0% -0% * -0% 
% houses with water 100% 100% * 42% 
% with hot water 85% 55% * 21 % 
% with functioning showers 100% 100% * 31% 
% with toilet 100% 100% * 31 % 
% with washing machines 75% 33 % * <10% 
% with fridges 75% 63% * <10% 
* unknown 
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3.4 Informed Consent 
Each community was initially approached informally to explore their 
interest in a lung health study. The author then wrote directly to the 
appropriate community councils outlining the aims and methods of the 
proposed study. Permission was obtained to visit each community for a week 
to explain the proposal and to discuss the most appropriate way of obtaining 
informed community consent. 
3.4.1 CYl 
Initially Dr Thompson approached elders in CYl and CY2 to discuss the 
possibility of performing a respiratory health study. These discussions 
confirmed that general respiratory health issues (particularly asthma) were of 
interest to community members. Having received 11 in principle11 support for a 
study, Dr Thompson wrote to the Aboriginal Coordinating Council (ACC) in 
Cairns seeking permission to proceed with further consultation. 
In March of 1990, after receiving permission from the communities, the author 
arranged to visit CYl and CY2 for a week in May. The aim of the visit was to 
gauge community support for the proposed study and to assess the feasibility 
of the proposal. It was also an opportunity to arrange employment of local 
Aboriginal staff. The author developed and piloted the initial draft of the 
questionnaire during this preliminary visit. 
On arrival in CY1 the author first made contact with the health service. 
Following a suggestion made by the clinic staff he took an instamatic camera 
and art materials with him. The health workers photographed the author and 
themselves demonstrating each step in the proposed study protocol. The 
pictures were pasted onto brightly coloured cardboard and annotated by the 
health workers who displayed them around the community. The posters 
proved popular and created a focus for community interest and comment. 
The author was next introduced to the important community members by 
Aboriginal staff from the health service. An early meeting with the community 
chairman facilitated the consultation process. The community chairman 
suggested that the author discuss the proposal with the headmaster of the 
school and arrange for consents to be sent hon1e with children in the week prior 
to the study. He also suggested that provision be made for adults to sign 
consent forms on the day of testing and that the author make a video about the 
proposed study. This was subsequently done at the Australian National 
University's imaging resources unit. The community chairman then arranged 
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for the video to be broadcast before the children's consent forms were sent 
home, and again during the week prior to data collection. The video was 
available for viewing in the community hospital and was replayed several 
times during the data collection period. 
By the end of the initial visit the author was confident that the study proposal 
was understood and acceptable. Most people appeared to appreciate that 
asthma and lung disease were worthy of investigation because almost everyone 
knew somebody with respiratory symptoms. In this community many people 
told the author that asthma was caused by allergy to mango tree flowers and 
bush turkey dust. 
3.4.2 CY2 
The author also allocated a week for consultation in CY2 and Dr 
Kingsley Whitten bury, a general practitioner with experience in Aboriginal 
Health, accompanied him on the visit. 
As in CYl, the indigenous community health workers and other clinic staff 
played an important role in introducing the author to the community. Again, 
posters were made which included photographs of health workers simulating 
each step of the proposed study. The activity proved to be a relaxing way to 
initiate relationships with the health workers. 
The community adviser and chairman were both supportive and made many 
practical suggestions. The council also asked the author to produce a short 
video to explain the study. After speaking with the school's headmaster the 
author saw each class and discussed lung disease, smoking and the proposed 
study. Also the author was interviewed about the proposal on the community 
radio station. 
At the end of the week the author was convinced that the community was 
interested in the proposed study. However in CY2 it was clear that respiratory 
health issues were not viewed with as much importance as they were in CYl. 
3.4.3 CA3 
After informal discussions with two colleagues who had worked in the 
community, the author wrote to the administrator of the health service with a 
detailed outline of the proposed study. After obtaining "in principle" support 
the author arranged a visit to discuss the project in July 1991. 
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As CA3 is decentralised the author travelled to the various outstations with the 
health service staff on their routine visits. This facilitated introduction to key 
people in each of the camps. The author employed two people (one current 
and one former health worker) to interpret and facilitate the discussions. 
Generally the community members were enthusiastic about the study and 
showed a keen awareness of the importance of a high participation rate. 
(Several people said, "it is very important that you see everybody in each camp 
otherwise you may miss something.") The author received many helpful 
suggestions for overcoming practical problems posed by the lack of reticulated 
power and the rudimentary facilities. For example in some outstations we 
were invited to do the testing in the school (which had generators) and in 
others disused sheds or the shelters used by the health workers were made 
available. 
It was impossible to achieve consensus on the importance of written consent in 
this community as people felt it was unnecessary since "consent" was implied 
by participation . In deference to the Aboriginal and Torres Strait Islander 
Health Research Guidelines the author offered written consent forms to all 
participants at the time of enrolment but did not insist that the form was 
signed. 
3.4.4 CA4 
In CA4 the consultation process was facilitated by the author's 
familiarity with the community. In 1990 the author wrote to the director of the 
CA4 health service, the CA4 community council and to the regional office of the 
Nganampa Health Council Inc. (NHC) in Alice Springs. The research proposal 
was circulated to the Menzies School of Health Research and the Central 
Australian Aboriginal Congress (Congress medical service) in Alice Springs. 
Although the response to the proposal was generally favourable, Congress 
medical service expressed the view that the proposal contained little of 
immediate benefit to Aboriginal people. Finally the proposal was approved at 
a regional NHC rneeting and permission was granted for the author to proceed 
with the consultation process. 
In May 1991 the author visited the community for a week to discuss the 
proposal. The study was discussed at an open community meeting. This was 
the only community, of the four studied, that regularly held such meetings. 
The issue of informed consent was debated at length and it was agreed that a 
collective consent was appropriate because literacy skills were poor. It was 
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clear that individuals retained the right to decline. The author also visited the 
CA4 outstations to discuss the proposal with those who had not been able to 
attend the community meeting. 
3.4.5 Summary 
• 
• 
• 
• 
• 
• 
• 
• 
This research proposal was received favourably and finally accepted 
because: 
The author was known to each of the communities or their networks; 
The author was seen as credible having worked in an Aboriginal 
comm unity; 
Each community was given an opportunity to discuss and influence the 
research design; 
The proposal was presented to the communities via community councils 
and health services; 
Sufficient time was allowed for the consultation process; 
Respiratory health issues were of interest to each of the communities; 
Aboriginal people were employed throughout the consultations and 
plans to include Aboriginal health staff in data collection were made 
explicit; 
The proposal included prov1s1on for appropri a te individual and 
collective feedback . 
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3.5 Feedback 
The obligation to provide collective and individual feedback was 
addressed early because all communities saw this as an important objective. 
Initially each subject received a verbal summary of their respiratory health 
status at the time of the data was collected. In addition the health consequences 
of smoking were discussed with each participant (with an interpreter present) 
following the measurement of tidal carbon monoxide levels . Arrangements 
were made for referral and treatment of any urgent health problems revealed 
by the testing. Health staff in each community were informed about all 
subjects identified with chronic lung disease or asthma. 
Some months after the data collection each community was visited for a week 
to provide further feedback. Written reports were produced for each 
participant. The reports contained a technical section and a simple interpretive 
summary. A copy was made available to e-ach participant and a second copy 
was inserted into their clinic or hospital record. These reports contained a 
summary of the participant's findings. The author was available for 
individuals to discuss their results. Videos summarising the important health 
consequences of the research were made for CY1 and CY2 (as requested) and 
these were broadcast over the community television stations and retained for 
use as teaching aids in the clinics and schools. 
3.5.1 CYl 
In CYl it was suggested that the author set up a "feedback station1' in the 
Aboriginal Health Program office. During the week 180 people (33% of the 
participants) returned for their reports . This opportunity was used to explain 
the report and to reinforce the earlier discussion about the health effects of 
smoking with smokers . At least two people had given up smoking in the 
interval between the data collection and feedback visit. 
During the feedback visit the author spoke to members of the council, health 
workers and the sisters about the results of the study. He was invited to talk to 
the school children about respiratory health and disease. All classes received 
two lessons about basic lung structure and function, asthma and the health 
effects of smoking. Copies of a large diagram of the lung were used as a 
teaching aid and the children were given a chance to listen to each other's 
chests. 
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3.5.2 CY2 
In CY2 the author was advised to post the reports through the 
community mail service and display an explanatory poster in the community 
office. People were invited to the clinic during the week to discuss their own 
findings but few took this option. The other copy of the report was 
incorporated into the case notes. As in CYl, the author was encouraged to talk 
in the school, the clinic and to community elders. The hospital staff were very 
interested in the results and welcomed the video for teaching. 
3.5.3 CA3 
In CA3 the feedback process was complicated as the medical and 
nursing staff had completely changed since the time of the data collection. The 
new clinic staff welcomed the author's visit and found the respiratory health 
overview was helpful. As in CY2, most people showed little interest in 
receiving or discussing their written report but many wanted to be reassured 
that a copy was in their medical record. Many people took delight in recalling 
their tidal carbon monoxide level. Community elders were pleased to hear that 
the community had relatively good respiratory health by the present study 
standards. They interpreted this as vindicating their lifestyle. 
3.5.4 CA4 
In CA4 people were interested in the collective results and implications 
more than their individual results. Many people thought that the results 
should be used to challenge the community council and support agencies to 
improve living their conditions. The author was asked to write a letter to the 
council summarising the study's findings and the deficiencies in the 
community infrastructure. 
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3.5.5 Summary 
• Immediate feedback a t the time of data collection was appreciated; 
• Permanent reports for medical records were valued because they were 
seen as a resource for health service staff. In communities where literacy 
levels were low written reports for personal use were not valued; 
• Informal verbal feedback was the most appropriate feedback for many 
people; 
• With time interest in these data shifted from a focus on individual 
findings to a consideration of the collective implications; 
• Community elders placed a high priority on the education of children 
about health issues raised by the study; 
• Health service staff found the research process stimulating because they 
valued the insights it brought to health problems in the community; 
• 
• 
The potential for research to be used to lobby for lifestyle support or 
change was recognised; 
The provision of feedback is a necessary, rewarding and valued part of 
the research process but it is time consuming and requires planning and 
consultation to be appropriate. 
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CHAPTER4 
Sampling and Participation 
4.1 Introduction 
Defining "the population" in Aboriginal communities is difficult because 
Aboriginal people maintain their traditional mobility (55). Although most 
communities have population registers, experience shows that they tend to 
over-estimate the size because people are often registered in more than one 
community. In the present study the local health service estimates of the 
number of people "usually" living in each con1munity were used as the 
population denominator. Although these estimates were undoubtedly 
imprecise they were the best available. 
4.2 Sampling 
In the present study every Aboriginal person aged five years and over 
living in CYl, CY2 and CA4 was eligible to participate. The author anticipated 
this would minimise san1pling bias and maximise the power of the study. 
In CA3 it was not feasible (because of the decentralisation and rudimentary 
conditions for data collection) to study the entire community in the available 
time. Following discussions with community representatives a pragmatic 
decision was made to study half the outstations. During his preliminary visit 
the author accompanied CA3 health staff on their routine clinics and invited the 
residents of the first eight outstations to participate. Seven outstations accepted 
and one gave qualified approval because most of the residents were away at a 
land council meeting. In the selected outstations all people aged five years and 
over were dee1ned eligible for participation. During discussions held at the 
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commencement of the data collection visit (some months later) community 
informants reported that the outstation which had earlier given tentative 
approval no longer wished to participate*. This outstation was therefore 
excluded from the sampling frame. Although the selection process was not 
random, those studied were likely to be representative because community 
informants regarded the outstations of CA3 to be very similar. 
In CYl and CY2 a week was allowed for data collection in each community. In 
CA3 and CA4 two weeks were allocated because the communities were more 
decentralised than those in Cape York and because insufficient time in CY2 
contributed to a disappointing participation rate there (see below). 
4.3 Participation 
4.3.1 CYl 
In CYl the community response was positive and 80o/o (478/600) of those 
eligible were tested (see table 4.1). The age range of the sample was 5-80 years 
and the male to female ratio was 0.92. The age and gender structure of the 
sample suggested that 15-34 year old males and 15-19 year old females were 
under-represented (see figure 4.1). Several people with known lung disease 
did not participate because they believed that they had little to gain from 
further investigation since they had already seen Dr Thompson (who was part 
of the data collection team in CYl and CY2) on past visits . Many of the non-
responders were not present in the community and a few told the health 
workers that they did not wish to participate. 
4.3.2 CY2 
The community response in CY2 was less enthusiastic than that in CY1 . 
After a week of data collection 51 % (163/320) of those aged five and over were 
tested (see table 4.1). The age range was 5-60 years and the male to female ratio 
was 0.94. The age and gender structure of the sample suggested that 5-9 year 
old males, 15-19 year old males and females, and 25-29 year old males were 
under-represented (see figure 4.2). 
Numerous factors contributed to the low participation rate in CY2 but 
unexpected competition from other community activities was the principal 
problem. When the field team arrived on the Sunday prior to the appointed 
* It was not made explicit why this community chose to withdraw but it was probably because 
they didn ' t feel they knew enough about the proposal. 
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week for data collection we were disappointed to find that half the population 
was attending a football match in a second community two hour's drive away. 
No-one was certain when everybody would be back. We also learnt later that 
day that the visiting magistrate had also arrived and would be sitting for three 
days to hear charges against community members. To make matters worse the 
pivotal elder who had agreed to assist us was required in court because he was 
a Justice of the Peace. Thus for the first three days of the week the community 
was preoccupied with returning from football and attending the hearings. The 
final challenge to the study came from a religious convention that commenced 
on the Wednesday just as the court was recessing. It was Friday afternoon 
before there were no other competing activities in the community. 
4.3.3 CA3 
The community response in CA3 was supportive and 72o/o (358/500) of 
those aged five years and over were tested by the end of two weeks (see table 
4.1). The age range of those tested was 5-84 years and the male to female ratio 
was 0.98. The age and gender structure of the sample suggested a deficiency of 
males and females aged 20-24 years and males aged between 25-29 and 40-44 
years of age (see figure 4.3) . 
In one outstation the chairman sanctioned the commencement of data collection 
one afternoon but withdrew the permission on our return the following 
morning. He told the author that the residents were anxious about what the 
tests might reveal (eg cancer), so testing was abandoned in that outstation. In 
all the other outstations the response was positive with participation rates of 
approximately 90 % percent . When the residents of the "withdrawing" 
outstation were included in the sample the participation rate for CA3 fell to 
72%. 
4.3.4 CA4 
In CA4 the community response to the study was very positive. After 
two weeks of data collection 87% (260 /280) of all people aged five years and 
over had participated (see table 4.1). The age range of the sample was 5-76 
years and the male to female ratio was 0.92 (see table 4.1). The age and gender 
structure of the sample revealed a minor deficiency of children aged 10-14 
years and 20-34 year old males. Of those who were not tested some were away 
from the community and some declined without explanation. 
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4.4 Discussion 
Each community sample was divided into 5 yearly intervals for 
comparison with the 1986 census for Northern Territory Aborigines (see table 
4.2). This comparison confirmed the impressions regarding the deficiencies of 
the samples gained from examination of the population trees for each 
community (see above). That is, that under-representation occurred in CYl and 
CY2 among 15-19 year olds and in CA3 among 20-24 year olds. Otherwise the 
age structure of the samples reflected that of the wider Northern Territory 
Aboriginal population. 
In general non-participation was due to absence from the community, anxiety 
should disease be revealed or commitments to other activities of higher 
priority. In CYl a few people who were known to have lung disease did not 
present for testing as they had seen Dr Thompson on previous visits. However 
the participation rates of those with known lung disease in CYl matched the 
participation of those without known lung disease. Therefore it was unlikely 
that non-participation introduced significant bias in CYl. 
The generally high participation rates in this study partly reflected the time 
devoted to consultation and planning, the perceived importance of respiratory 
disease, the involvement of community members in the field team, and the 
promise of individual and collective community feedback. 
The relatively poor participation rate in CY2 was mainly due to the influence of 
other competing activities although it also probably reflected the author's early 
impression that respiratory health issues were not regarded with the same level 
of interest as the other communities. In retrospect allowing more time to offset 
the multiple activities competing for peoples' attention would have improved 
participation rates. The poor participation rate in CY2 means that one has to be 
cautious about interpreting the findings from this community. The potential 
effect of sampling bias on the results from CY2 are discussed in chapters 5-10 
where relevant. 
4.5 Summary 
Data were collected in four rural Aboriginal communities from 1,252 
individuals with an age range from 5 to 84 years and a male to female ratio of 
0.93. The proportion of 5-84 year olds participating in the four communities 
ranged from 51 o/o to 87%. The age breakdown of the sample from each 
community was similar to the Aboriginal population of the Northern Territory. 
However, 15-19 year olds (especially males) are under-represented in CYl and 
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CY2, and 20-24 year olds (especially males) were under-represented in CA3. 
The sampling problems encountered in the present study highlight the 
importance of adequate consultation in Aboriginal health research and the 
importance of allocating sufficient time for data collection. The precise effects 
of non-responses in the present study are unknown. The magnitude of the 
non-response in CY2 dictates caution with interpretation of the findings from 
this community. 
Table 4.1 
Participation by community. 
Participation Data Community 
CYl CY2 CA3 CA4 
Date of testing 8/90 8/90 8/91 9/91 
Population¥ 600 320 500* 290 
Males tested 229 80 177 119 
Females tested 249 83 181 134 
Total tested 478 163 358 253 
Participation 80% 51% 72%* 87% 
Age range 5-80 5-60 5-84 5-76 
M:F ratio 0.92 0.94 0.98 0.92 
* selected outstations 
¥ estimated population aged five years and over. 
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Table 4.2 
Comparison of the age structure of each community sample with that of the 
Northern Territory Aboriginal Population from the 1986 Census. 
CYl CY2 CA3 CA4 ABS 
Ages: 
5-9 19 17 14 15 14 
10-14 16 15 17 11 14 
15-19 8 7 17 15 13 
20-24 10 13 8 12 12 
25-29 10 9 9 8 12 
30-34 8 9 7 7 8 
35-39 5 6 8 6 7 
40-44 5 4 4 4 5 
45-49 4 6 3 7 5 
50-54 4 4 4 5 3 
55-59 5 4 3 3 2 
60-64 3 5 2 3 2 
65-69 1 1 1 2 1 
>69 2 0 3 2 2 
The proportion (in five yearly age groups) of each community sample is expressed as a 
percentage of the total number of 5-84 year olds in each community. 
The column ti tied Australian Bureau of Statistics (ABS) shows the corresponding estimate for 
the Northern Territory Aboriginal population aged 5-84 years in 1986 (55) . The ABS statistics 
were adjusted so that the denominator was those aged 5-84 years only. 
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Figure 4.1 
Stratification of the sample from CYl by age and gender. 
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Figure 4.2 
Stratification of the sample from CY2 by age and gender. 
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Figure 4.3 
Stratification of the sample from CA3 by age and gender. 
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Figure 4.4 
Stratification of the sample from CA4 by age and gender. 
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CHAPTERS 
Cigarette Smoking: 
Prevalence, Patterns and Associations 
5.1 Introduction 
Although cigarette smoking is an important public health issue in 
Australia (56) there are few studies of smoking patterns in Aborigines (15-17, 
57) 
In 1988, Watson et al (17) reported a study among 10% (1,764 people) of the 
adult Aboriginal population in the Northern Territory. They found that 70o/o of 
men and 43% of women smoked. In the northern part of the Northern 
Territory, "the top end", the prevalence increased with age. In the southern 
part of the Northern Territory, "the centre", the prevalence of smoking fell with 
age. Twelve percent of non-smokers were ex-smokers. Fifty-six percent of 
smokers smoked fewer than 10 cigarettes per day and 40% smoked 11-30 per 
day. Most people commenced smoking before the age of 15 years but that in 
the centre, "smoking began later". 
Watson et al argued that regional differences in the prevalence of smoking 
reflected the differing ways that tobacco was introduced. In central Australia 
prior to 1788 tobacco was chewed in the from of "native tobacco" (Nicotiana) or 
Pituri (Duboisa hopwoodiz} In "the top end" tobacco smoking was probably 
introduced before 1788 by Indonesian fishermen (58). 
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Watson et al noted that cultural factors as well as addictive factors played an 
important role in maintaining the high smoking prevalence in the top end (59). 
In addition most people reported that they liked the taste and the feeling 
associated with smoking and men reported it relieved boredom. This 
suggested that pleasure associated with smoking was also an important factor 
sustaining this behaviour. Non-smokers cited dislike of the taste and health 
concerns as reasons for not smoking. This suggested that some Aborigines are 
aware that smoking can be unhealthy and that this knowledge can influence 
smoking behaviour. 
In 1989 Lake (57) reported smoking and alcohol histories from 102 consecutive 
patients aged 16 years and over attending the Aboriginal medical service in 
Adelaide. Lake found that 78 o/o of the males and 64% of the females were 
smokers. There were no pipe smokers and very few "rolled their own". The 
males smoked an average of 22 cigarettes a day and the females 20. 
In 1990 Stephenson (16) reported a study of 210 Aboriginal people (83% of the 
Aboriginal population aged over 19 years) in Wilcannia Shire, NSW. He found 
that 71 % of the males and 75% of the females smoked. About half the non-
smokers were ex-smokers. The prevalence of smoking tended to increase with 
age in men and to decrease in women. Approximately 10% of smokers smoked 
fewer than 10 cigarettes daily, 30% smoked 10-19 per day, 35% smoked 20-29 
daily, and the remainder smoked more than 30 per day. The ex-smokers were 
asked their reasons for quitting. Fifty-three percent indicated that they had 
stopped smoking for health reasons, 16% stopped because they were "sick of 
smoking", 11 % because they "wanted to", 7% because of the expense, 4% 
because of family pressure and 9% gave other reasons. 
In 1992 Guest et al (15) reported the prevalence of smoking in 306 adult 
Aborigines living in a Victorian country town. In males the prevalence was 
67% and in females 63%. The prevalence peaked in 25-44 year olds and 
appeared to decline with age. Twelve percent of males were ex-smokers as 
were 13% of females. Cigarette consumption was evenly divided in three 
strata: 1-10 cigarettes per day, 10-20 per day and more than 20 per day. 
In 1990 a workshop was held in Perth, WA, on "Preventing Smoking Related 
Diseases Among Aboriginals" (2., 60). A majority of the participants were 
Aboriginal or were representatives from Aboriginal medical services. The lack 
of data regarding smoking in Aborigines was highlighted and evidence was 
presented (61) which showed there had been no systematic approach to anti-
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smoking education in Aboriginal communities. Those at "the workshop" 
developed recommendations regarding further research. 
These recommendations were: 
• 
• 
• 
That surveys be undertaken to assess the prevalence of tobacco smoking 
and chewing, and that regional and gender differences be documented; 
That morbidity data be collected on smoking related disease, and that 
attention be directed to assessing the impact of passive smoking on 
inf ants and children; 
That studies be undertaken with the object of understanding the 
aetiology of tobacco smoking and chewing, paying particular attention 
to socio-cultural and psychological factors. In particular a need for 
studies that investigate attitudes and beliefs regarding the health effects 
of tobacco smoking and chewing was identified. 
The studies reviewed above suggest that the prevalence of smoking in 
Aboriginal communities is generally high in comparison with that in non-
Aboriginal communities. However there is evidence that the prevalence may 
be lower in some regions such as central Australia. Regional variation in the 
volume smoked has also been documented. Urban smokers and smokers in the 
top end of the NT smoke more than smokers in "the centre". Whilst it has been 
acknowledged that the cultural aspects* of smoking are likely to be important 
other factors have been shown to play a role. If the prevalence of smoking is to 
be reduced in Aboriginal communities then a better understanding of smoking 
behaviour is required. "The workshop" recommendations highlighted the 
knowledge gaps in this area and provided a background and rationale for the 
aims of this component of the present study. 
* Cigarette smoking often occurs in the setting of a gathering of friends or family. Here the 
sharing of cigarettes (and/ or tobacco, alcohol etc) may strengthen social bonds and discharge 
obligations . An inquiry into these cultural aspects of smoking was beyond the scope of the 
present study. 
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5.2 Aims 
The aim was: 
• To determine the prevalence of smoking by age , region and gender; 
• To determine the age at commencement of smoking; 
• To determine what people smoke; 
• To determine how frequently and how much people smoke; 
• To explore the relationship between smoking and tobacco chewing; 
• To explore the relationship between alcohol use and smoking; 
• To explore the relationship between health knowledge and smoking. 
5.3 Methods 
Questions to investigate smoking behaviour were developed by the 
author and incorporated into the study questionnaire. Tidal carbon monoxide 
was measured to validate smoking status and to focus discussion about the 
health effects of smoking (see chapter 3). 
5.3.1 Questionnaire 
The questions (see figure 5.1) were developed following consultation 
with health workers in CYl and c;:Y2, Dr Thompson and Dr John Taylor. Dr 
Taylor is medical anthropologist with experience working with Cape York 
Aborigines (62). The questions were piloted for comprehensibility and 
modified where necessary. The sa1ne questions were used in all communities. 
Q2 was not used in CYl and CY2 as tobacco was not chewed in these 
communities. Q6 was an additional question developed for use in CA3 and 
CA4 to assist those with limited numeracy to estimate their age at smoking 
commencement. The answers to Q7 were converted to a number of cigarettes 
smoked daily. 
The questions were administered during an interview with the assistance of an 
Aboriginal translator. All the translators understood the purpose of the 
questions. Several questions were open-ended to encourage free responses. 
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~ Figure 5.1 
1£ Questionnaire to assess smoking, tobacco chewing, alcohol use and "knowledge" of 
the health consequences of smoking. I 
' I 
I 
i Ql Do you smoke? Yes/No 
I Q2 Do you chew tobacco? Yes/No 
Q3 What do you smoke? ( ) 
' Q4 Do you smoke every day? Yes/No 
QS How old were you (in years) when you started smoking? ( ) 
Q6 How old were you when you started smoking? Kid 0-13 
Young Fella 14-19 
Married >20 
I 
,; Don't Know 
Q7 How many cigarettes (or packs) do you smoke a day? ( ) 
Q8 How many tins of tobacco do you smoke each week? ( ) 
' 
Q9 Do you know of any sickness caused by smoking? Yes/No 
11 
Q10 If yes (to Q9) then what? ( ) 
Q11 Do you drink alcohol? Not at all 
A Ii ttle bit 
A moderate amount 
Heavily at times 
Every day 
*For non-smokers: 
Q12 Why don't you smoke? ( ) 
Q13 Did you ever smoke regularly? Yes/No I 
,, 
~: Q14 If yes (to Q13) why did you give up? ( ) 
1:i. 
'.l 
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5.3.2 Tidal Carbon Monoxide 
Tidal carbon monoxide was measured (blind to the participant's 
smoking status) using a recently calibrated Bedfont EC50 Smokerlyser (63). 
After the reading was co1npleted the author asked each participant about their 
smoking status. During the ensuing discussion information about the health 
effects of smoking was shared with all participants and smokers were 
encouraged to quit. The tidal carbon monoxide level was expressed in parts 
per million (ppm) and the results were expressed as the mean and standard 
deviation for each of several subgroups (by age and gender) of the population. 
5.3.3 Analysis 
The responses to the open ended questions (Q10, Q12 and Q14) were 
arranged into nominal groups by the author after an assessment of the range 
and nature of responses. All frequency data were tabulated with the number 
(N) of eligible subjects and the number of missing values (MV). Binomial 
dummy variables were created to distinguish those that drank no alcohol from 
those that drank any amount of alcohol. Similarly, dummy variables were 
created to distinguish those that had no health "knowledge" regarding the 
consequences of smoking from those that had any. Two by two cross-
tabulations were performed to examine the associations between several 
variables and unadjusted odds ratios were calculated to quantify the 
relationships. 
5.4 Results 
5.4.1 Prevalence and Commencement of Smoking 
The prevalence of smoking among 15-84 year old participants ranged 
from 51 to 75o/o in 1nen and 1 to 78% in women (see table 5.1). In all 
communities smoking was rarely reported under the age of 14 years. The 
prevalence of smoking peaked in 25-44 year old males and 15-24 year old 
females. In CA4 (males and females) and CY1 females the prevalence of 
smoking fell significantly with age (chi-square trend p<0.01). Among males 
there was no significant difference in the prevalence of smoking between the 
communities but among females there were significant differences (chi-square 
p<0.001). The prevalence of smoking in CA3 and CA4 women was relatively 
low, indeed in CA3 there was only one female smoker. When these data from 
all communities were combined the prevalence of smoking was higher in men 
than women. In addition the prevalence of smoking among men was relatively 
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stable with age but fell significantly with age in women (chi-square trend 
p<0.001). 
Q5 showed that most smokers commenced smoking between the ages of 14 and 
18 years (see table 5.2). In CA3 and CA4 the prevalence of missing values was 
relatively high for this question. There were a similar number of missing 
values for Q6 in CA4 but fewer in CA3. In CA3 and CA4 the findings for Q6 
concurred with those of Q5 and suggested that the majority of people 
commenced smoking during the mid- to late teenage years (see table 5.3). 
5.4.2 Smoking Pattern and Vol urne 
All smokers in CYl, CY2 and CA3, and 98.5% in CA4 smoked 
cigarettes. Less than 10 percent of smokers rolled their own and less than 2 % 
smoked pipes. 
The proportion of smokers smoking daily ranged from 42 % in CA3 to 86 o/o in 
CY2 (see table 5.4). There were no significant gender differences but daily 
cigarette consumption was significantly more prevalent among the Cape York 
smokers (p < 0.001). 
Table 5.5 shows the approximate number of cigarettes smoked daily by users. 
In Cape York 15% of smokers smoked 1-5 cigarettes per day and 45% smoked 
16-30 per day. In central Australia 69% smoked 1-5 cigarettes per day. Less 
than 12% of smokers in any community smoked more than 30 per day. There 
were no significant gender differences in the quantity of cigarettes smoked. 
5.4.3 Tidal Carbon Monoxide in Smokers and Non-smokers 
The mean tidal carbon monoxide level in non-smokers was 4 ppm (range 
1-23, SD 2 ppm). The mean tidal carbon monoxide level in smokers was 14 
ppm (range 2-43, SD 8 ppm). Twenty-seven people who described themselves 
as non-smokers had tidal carbon monoxide levels which were discrepant (more 
than 2 standard deviations above the non-smoking mean). The highest mean 
levels of tidal carbon monoxide (16 ppm) occurred in the 25-44 year old 
smokers. The mean number of cigarettes smoked each day was 18 (SD 15) with 
a range of 1 to 75. The correlation between the number of cigarettes smoked 
and the tidal carbon monoxide was significant (p < 0.0001) but weak (Pearson 
Correlation Coefficient 0.258) . 
5.4.4 Tobacco Chewing and Cigarette Use 
Table 5.6 shows that in CA3 and CA4 34% of men and approximately 
60% of women chewed tobacco. Table 5.7 shows the relationship between 
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tobacco chewing and tobacco smoking. The odds ratio for the association was 
0.34 (95o/o CI 0.22-0.54). The relationship between tobacco chewing and 
smoking did not differ by gender. 
5.4.5 Alcohol Consumption and Cigarette Use 
Table 5.8 details self-reported alcohol consumption in subjects over the 
age of 14 years. In males the prevalence of non-drinkers (teetotallers) ranged 
from 13% to 49%. In women the prevalence of teetotallers ranged from 40% to 
91 %. In both sexes the heaviest levels of self-reported alcohol consumption 
came from CY2 and the lowest levels were from CA3. 
Table 5.9 shows a cross-tabulation between alcohol consumption and cigarette 
smoking status. All subjects were coded as smokers or non-smokers and 
drinkers or non-drinkers using the answers to Ql and Ql 1. Forty percent were 
non-smoking teetotallers, 14% were smoking teetotallers, 14% drank alcohol 
but did not smoke and 32% both drank and smoked. The odds ratio for the 
association between smoking status and alcohol consumption was 5.74 (95% CI 
4.25-7.69). Stratification by community and gender did not reveal any regional 
or gender differences in the relationship between alcohol and cigarette 
consumption. 
5.4.6 Smoking and Health Knowledge 
Table 5.10 shows the regional variation in the prevalence of participants 
with "knowledge" of the health consequences of smoking. Subjects were coded 
as "knowledgable" if they answered yes to the question (Q9) "Do you know of 
any sickness caused by smoking?". In CYl 73% of subjects over the age of 14 
were aware of at least one adverse health effect of smoking. In CA3 and CA4 
less than 30% were "knowledgable". The prevalence of missing values for this 
question was 23% in CYl and 56% in CY2. Overall the prevalence of missing 
values was 20% in non-smokers and 16% in smokers. However in CYl the 
prevalence of missing values was 44% in non-smokers and 8% in smokers. 
Table 5.11 provides details of the illnesses that 11knowledgable" participants 
associated with smoking. The numbers of 1 'knowledgable" participants in CY2 
and CA4 were low (<40). Forty-seven to 88% of "knowledgable" participants 
were aware that smoking was associated with lung cancer. Two to 9% were 
aware that smoking was associated with heart disease. Four to 26 o/o associated 
illnesses not conventionally attributed to smoking. In CA3 and CA4 7% and 
31 % respectively recognised that lung diseases other than cancer could result 
from smoking. 
I 
' 
I 
I 
I 
jl 
I I 
,, 
I 
\ 
60 
When these data from the four communities were combined and a cross-
tabulation between smoking status and knowledge status was performed (both 
variables dichotomised 0/1) there was no relationship between individual 
knowledge and current smoking status. However table 5.12 shows that in CYl 
there was a modest reduction in the odds for being a current smoker among 
"knowledgable" participants (odds ratio 0.35, 95o/o CI 0.18-0.79). 
Table 5.13 lists the reasons non-smokers gave for not smoking (Q12). In all 
communities the most prevalent reasons given for not smoking were: "I don't 
like it" or ''because it makes you sick". Very few non-smokers attributed their 
non-smoking status to either the cost of cigarettes or medical advice. The 
prevalence of missing values was very high in CY2 and CA3. In CY2 the 
missing values were evenly distributed between men and women. In CA3 115 
of the 131 missing values were from women. The high prevalence of missing 
values in these women reflected a problem with the question. In the field it 
soon became apparent that the question was not appropriate for the CA3 
women because there were strong cultural restraints on women smoking in 
that community. "Just don't smoke" or blank puzzled looks were common 
responses to initial attempts to administer this question. With the 
encouragement of the Aboriginal assistants, the author withdrew this question 
for women in that community. 
The prevalence of ex-smokers among non-smokers is shown in table 5.14. It 
shows that 21 to 51 % of non-smokers were ex-smokers (except CA3 women). 
Table 5.15 lists the reasons given by ex-smokers when asked why they gave up 
smoking (Q14). There were 94 ex-smokers of whom 82 answered the question. 
In CY1, "got chest problems" and "don't like it" were the reasons given by 
approximately 40% of ex-smokers. A further 15% of ex-smokers in CYl 
reported that they stopped smoking because of medical advice and 11 % 
stopped because of the cost of cigarettes. The numbers of ex-smokers in CY2, 
CA3 and CA4 were small. Ex-smokers in these communities appeared to give 
up because they "didn't like smoking" or because "it makes you sick". 
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Table 5.1 
Prevalence of smoking by age, gender and community. 
Male CYl CY2 CA3 CA4 All 
Years 
10-14 0% 0/41 0% 0/13 2.7% 1/37 0% 0/13 1% 1/104 
15-24 79% 22/28 57% 8/14 50% 24/48 68% 21/31 62% 75/121 
25-34 58% 18/31 83% 10/12 86% 18/21 67% 8/12 71 % 54/76 
35-44 75% 21/28 86% 6/7 53% 9/17 58% 7/12 67% 43/64 
45-54 61% 8/13 67% 6/9 50% 7/14 33% 5/15 51 % 26/51 
>54 67% 26/39 91 % 10/11 43% 6/14 8%# 1/12 57% 43/76 
15-84 68% 95/139 75% 40/53 56% 64/114 51% 42/82 63 % 0 241/388 
Female 
Years 
10-14 3% 1/33 10% 1/10 0% 0/24 6% 1/17 4% 3/84 
15-24 74% 39/53 75% 12/16 0% 0/38 42% 17/38 47% 68/145 
25-34 68% 38/56 71 % 12/17 0% 0/35 18% 4/22 42% 54/130 
35-44 24% 6/25 89% 8/9 0% 0/26 29% 4/14 24% 18/74 
45-54 30% 7/23 83% 5/6 8.3% 1/12 0% 0/12 25% 13/53 
>54 40%# 6/15 86% 6/7 0% 0/19 0%t 0/15 21 %# 12/56 
56% 96/172 43/55 * 15-84 78% 1% 1/130 25% 25/101 36% 165/458 
Missing Values= 9 
o Chi-square for the difference between communities not significant. 
* Chi-square for the difference between communities p < 0.001 
t Chi-square trend for the change in prevalence with age p < 0.01 
# Chi-square trend for the change in prevalence with age p < 0.001 
Table 5.2 
Age of commencement of smoking (Q5) as the cumulative percentage. 
CYl CY2 CA3 CA4 
N 191 83 65 67 
MV 1 18 25 32 
Age in years % % % % 
12 3 8 7 7 
14 11 9 7 31 
16 47 26 34 57 
18 78 53 68 81 
20 88 70 90 98 
22 94 88 92 100 
30 98 97 98 100 
N = number of smokers over the age of 14 years 
MV = number of smokers that failed to answer this question (missing values) 
Table 5.3 
Age of commencement of smoking (Q6) expressed as the cumulative percentage. 
N 
MV 
Age in Years 
0-13 
14-19 
>20 
CYl 
191 
CY2 
83 
N = Number of smokers over the age of 14 years 
CA3 
65 
11 
5 
84 
100 
MV = number of smokers that failed to answer this question (missing values) 
CA4 
67 
32 
4 
82 
100 
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Table 5.4 
Proportion of smokers smoking daily by community in 15-84 year olds. 
CYl CY2 CA3 CA4 
N 191 83 65 67 
MV 4 10 3 2 
* % Smoking daily 85 86 42 54 
N = Number of smokers over the age of 14 years. 
MV = number of smokers that failed to answer th is question (missing values). 
* Chi-square for the significance of the difference between communities p < 0.001 
Table 5.5 
Number of cigarettes smoked each day (by community) expressed as the percentage 
of smokers in each stratum of usage. 
CY1 CY2 CA3 CA4 
N 191 83 65 67 
MV 5 37 25 6 
Cigarettes /day % % % % 
1-5 13 20 70 68 
6-15 30 26 17 11 
16-30 50 43 13 17 
>30 7 11 0 4 
N = Nu1nbcr of smokers over the age of 14 years. 
MV = number of smokers that failed to answer this question (missing values). 
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Table 5.6 
Prevalence of tobacco chewing in 15-84 year olds by community. 
Male N 
MV 
% chew tobacco 
Female N 
MV¥ 
% chew tobacco 
CYl* 
141 
0 
173 
0 
N = number of participants. 
CY2* 
56 
0 
53 
0 
CA3 
114 
4 
34 
131 
0 
56 
MV = number that failed to answer this question (missing value). 
* Q2 not required as tobacco chewing not practised in these communities . 
Table 5.7 
CA4 
85 
0 
34 
102 
0 
71 
64 
Relationship between tobacco chewing and cigarette smoking in 15-84 year olds in 
CA3 and CA4. 
Tobacco Chewer 
N=432 
No 
Yes 
Missing Values= 7 
No 
128 
169 
Tobacco Smoker 
Yes 
88 
40 
Odds Ratio for the association between tobacco chewing and cigarette use 0.34 
(95% CI 0.22--0.54). 
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Table 5.8 
Self-reported alcohol consumption in 15-84 year olds by community as a percentage 
in each community. 
Male (N) 
MV 
* Not at all 
A little bit 
Moderately 
Heavy at times 
Every day 
Female (N) 
MV 
* Not at all 
A little bit 
Moderately 
Heavy at times 
Every day 
CYl 
141 
4 
33 
27 
28 
9 
3 
173 
1 
60 
31 
8 
1 
0 
CY2 
56 
8 
13 
25 
37 
23 
2 
53 
5 
40 
33 
17 
10 
0 
CA3 
114 
1 
49 
42 
1 
6 
2 
131 
1 
91 
8 
0 
1 
0 
* Chi-square for the sig nificance of the difference between communiti es p < 0.001 
CA4 
85 
1 
43 
26 
11 
19 
1 
102 
0 
61 
22 
7 
10 
0 
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Table 5.9 
Relationship between alcohol consumption and cigarette use in 15-84 year olds. 
N=855 
Alcohol Drinker 
No 
Yes 
Missing Values= 11 
No 
319 
124 
Smoking 
Yes 
124 
277 
Odds Ratio for the association between alcohol and cigarette use 5.74 (95% CI 4.25-7.69) 
Table 5.10 
Prevalence of "knowledgable" participants by community. 
N 
MV 
N '1<.nowledgable" 
* % '1<nowledgable" 
CYl 
314 
71 
177/243 
73 
CY2 
109 
61 
21/48 
44 
N = Number of participants over the age of 14 years. 
CA3 
245 
18 
63/227 
28 
MV = Number of participants that failed to answer this question (missing values). 
* Chi-square fo r the significance of the difference between communities p < 0.001 
CA4 
187 
13 
39/174 
22 
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Table 5.11 
Details of the illnesses that "knowledgable" participants" associated with smoking. 
Results expressed by community as a percentage of those that answered the 
question. 
N 
MV 
Lung Cancer 
Heart Disease 
Both the above 
Other** 
Lung Disease*** 
CYl 
177 
1 
88 
4 
4 
4 
0 
CY2 
21 
0 
57 
9 
29 
5 
0 
N = number of "knowledgable" participants" 
CA3 
63 
9 
57 
6 
4 
26 
7 
CA4 
39 
0 
47 
2 
5 
15 
31 
MV = number of "knowledgable" participants that failed to answer question (missing values) 
** colds tuberculosis headaches "get sick" 
***Lung Disease± Lung Cancer 
Table 5.12 
Relationship between "knowledge" of the health consequences of smoking and 
current smoking status in CYl 15-84 year olds. 
"Knowledgable" 
No 
Yes 
N=314 
No 
10 
58 
Current Smoker 
Yes 
56 
119 
Missing Values= 71. The prevalence of m..issing values in non-smokers was 44 % and in 
smokers 8%. 
Odds Ratio for the association between "knowledge" of the health effects of smoking and 
current smoking status 0.36 (95% CI 0.18-0.79) 
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Table 5.13 
Reasons for not smoking given by 15-84 year old non-smokers (by community) 
expressed as a percentage of those that answered the question. 
N 
MV 
"Don't like it" 
"Makes you sick" 
Other t 
CYl 
120 
39 
63 
12 
25 
N = Number of non-smokers in each community 
MV = Number of missing values 
** 115 of missing values are female non-smokers 
CY2 
25 
20 
80 
20 
0 
CA3 
179 
154** 
72 
24 
4 
CA4 
116 
25 
43 
44 
11 
t Includes, high cos t of cigarettes, advice not to smoke, "caused coughing" and "unsure" 
Table 5.14 
Prevalence of ex-smokers in 15-84 year old non-smokers, by community expressed 
as a percentage. 
N 
MV 
* % Ex-smokers 
CYl 
120 
21 
51 
N = number of non-smokers in each community. 
MV = number of missing values . 
** 115 of missing values are female non-smokers. 
CY2 
25 
9 
50 
CA3 
179 
131** 
42 
* Chi-square fo r the significance of the difference between communities p < 0.001 
CA4 
116 
44 
21 
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Table 5.15 
Reasons for giving up smoking (Q14) in 15-84 year old ex-smokers, by community 
expressed as a percentage . 
CYl 
N 51 
MV 4 
"Got chest problems" 19 
"Don't like it" 19 
"Makes you sick" 
Advised not to smoke 13 
High cost of cigarettes 11 
Other "unsure"t 38 
N = number of ex-smokers in each community. 
N = number of missing values. 
CY2 CA3 CA4 
8 20 15 
3 4 1 
40 50 
43 64 
15 
40 
20 7 21 
t Includes subjects who gave up because of coughing which they attributed to smoking 
5.5 Discussion 
The prevalence of smoking 1n the two Cape York communities was 
similar to that found among white Australian males after World War Two (56) 
(see table 5.16) . This finding concurred with the reports by Watson et al, Lake 
and Stephenson (see table 5.16). The lower prevalence in central Australia was 
also consistent with Watson et al's observations and the remarkably low 
prevalence in CA3 women has been reported previously by Gault (32). The fall 
in the prevalence of smoking with age among men from CA4 and among 
women in CYl and CA4 suggested that the prevalence of smoking was rising in 
these comm uni ties as teenagers commenced smoking (a cohort effect). There 
appears to be an opportunity to prevent smoking becoming entrenched in 
central Australia (especially among women) if successful measures to reduce 
the up-take of smoking in teenagers can be instituted. 
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Table 5.16 
Prevalence of smoking in Aboriginal and non-Aboriginal Australian communities 
presented as a percentage of the populations studied. 
Non-Aboriginal 
Non-Aboriginal 
Top End* NT 
Katherine* NT 
Centre* NT 
Adelaide* SA 
Wilcannia * NSW 
CYl* 
CY2* 
CA3* 
CA4* 
* Aboriginal Communities 
Year 
1945 
1983 
1986 
1986 
1986 
1989 
1990 
1990 
1990 
1991 
1991 
Male 
72 
37 
81 
71 
59 
78 
71 
68 
75 
56 
51 
Female 
26 
30 
72 
35 
9 
64 
75 
56 
78 
1 
25 
Reference 
(56) 
(56) 
(17) 
(17) 
(17) 
(57) 
(16) 
These data presented in tables 5.1, 5.2 and 5.3 show that smoking initiation 
occurs around 14 years of age. This is younger than reported by Watson et al 
and may indicate a trend towards earlier commencement of smoking. Q6, the 
age for commencement of smoking question designed for CA3 and CA4 
increased the response rate in CA3 but had no effect in CA4. The high number 
of inissing values highlighted the difficulty of asking quantitative questions in 
comn1unities where most people have limited numeracy. Overall the findings 
indicated that interventions to reduce the initiation of smoking will need to 
target 10-13 year old children. 
Smoking patterns differed significantly between Cape York and central 
Australia (see tables 5.4 and 5.5). In Cape York most smokers were smoking 
more than six cigarettes every day. In central Australia approximately 50 o/o of 
smokers did not smoke every day and less than 30% of smokers smoked more 
than 5 cigarettes per day. These observations were important because people 
smoking infrequently are less likely to be addicted to nicotine than regular 
smokers. It is unlikely that cigarette smokers in CA3 and CA4 were obtaining 
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nicotine from tobacco chewing when cigarettes were not available because 
these different modes of tobacco use were essentially mutually exclusive (see 
table 5.7). These findings suggest that smoking intervention programs in CYl 
and CY2 will need to incorporate strategies for managing nicotine withdrawal 
but in the central Australian communities nicotine withdrawal is less likely to 
be a problem. 
Most smokers in CA3 and CA4 smoked intermittently and even then they only 
smoked 1-5 cigarettes a day. Possible explanations for both the irregularity of 
smoking and the relatively small numbers of cigarettes consumed are that 
community members only smoked when they felt like it or they were 
opportunistic smokers, smoking only when cigarettes were available. Personal 
access to cigarettes was not assessed in this study although the author noted 
that cigarettes were readily available from stores in all four communities*. 
The tidal carbon monoxide recordings suggested that most people answered 
the smoking question accurately. The correlation (Pearson R value 0.26) 
between the number of cigarettes smoked daily and tidal carbon monoxide 
levels suggested that these data regarding the number of cigarettes smoked had 
some validity. In men the prevalence of smoking and the mean tidal carbon 
monoxide levels both peaked in 25-44 year olds. This suggested that the 
frequency of smoking was highest in younger smokers. 
The prevalence of tobacco chewing in CA3 and CA4 and the relationship to 
smoking were similar to the findings of Watson et al . In the centre, tobacco 
chewing was the most prevalent form of tobacco consumption. It is not known 
to what extent people may shift from being principally tobacco chewers to 
tobacco smokers and vice versa. Although tobacco chewing is known to be 
associated with oropharyngeal cancers, the relative dangers of tobacco smoking 
versus chewing have not been investigated in Aborigines. Tobacco chewing in 
these communities could be suggested as a culturally acceptable alternative for 
those heavier smokers wanting assistance to quit. 
* In CA4 at the time of the data collection the new non-Aboriginal store manager had just 
completed the installation of a cigarette vending machine in the foyer of the store. This gave 
children with money ready access to cigarettes. In the author's experience store managers in 
Aboriginal communities often make decisions based on economic imperatives with little regard 
for the public health consequences of the decisions. 
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These data regarding alcohol consumption were collected to examine 
associations with smoking (see table 5.9). The scale for alcohol consumption 
combined notions of frequency and volume (see table 5.8). It was interesting to 
note that the regional variation in self-reported alcohol consumption reflected 
access to alcohol. Access to alcohol by community in descending order of 
availability was CY2, CYl, CA4 and CA3. CY2 with ready alcohol availability 
had the highest self-reported levels of consumption and CA3, with the most 
restricted access had the lowest levels. This observation was consistent with 
Watson et al' s conclusion that, "In all locations, community types and liquor 
status's (sic), it appears that the more available alcohol was, the higher the 
percentage of drinkers and the more often they drank". The present study 
highlights the importance of supporting Aboriginal efforts to control access to 
alcohol in their communities. 
The relationship between alcohol consumption and cigarette smoking was 
strong (see table 5.9). Watson et al found a similar association. Cigarette 
smoking and alcohol drinking are activities that often occur when friends and 
relatives meet. Cognisance of the relationship between the use of these two 
substances and an understanding of their wider social role is necessary if 
programs designed to reduce their use are to be successful. 
The question seeking knowledge of the health consequences of smoking (Q9) 
suffered from a design problem that meant that if the instructions were 
followed only smokers were asked this question. This fault was recognised 
prior to the field work so the questionnaire teams were asked to ignore the 
errant instructions. However the responses from CYl suggested that the 
revised instructions were not always followed (see section 5.4.6). In CY2 we 
had different Aboriginal assistants each day and many, not having a health 
background, had difficulty understanding the purpose of Q9. This contributed 
to the low response rate for the question (see table 5.10) . As a result of the two 
problems described above the present study had fewer responses for Q9 from 
non-smokers in CYl and both smokers and non-smokers in CY2. This reduced 
the power of the study to examine the regional variation in the prevalence of 
knowledge and the relationship between "knowledge" and smoking status . 
Despite the problems described above, significant variation in the prevalence of 
"knowledgable" participants was detected (see table 5.10). Interpreting these 
differences was complicated by the cultural, language and educational 
diversity between the communities. Nevertheless these data suggest that a 
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high proportion of the population in CYl had some awareness of the dangers 
of smoking and that very few in CA3 and CA4 displayed this knowledge. 
The reasons for the variation in prevalence of "knowledgeable"participants are 
not known but it was probably significant that "knowledge" was most 
prevalent in CYl where English literacy was relatively common. It is likely that 
English literacy allows Aboriginal people to be influenced by the health 
messages written on cigarette packets and other health promotion material 
designed for the wider Australian population. Hill et al (56) in an Australia 
wide survey of 5,580 adults (age 16 and over), found that only 14% of the 
sample were unaware that smoking was a health hazard. Hill et al also found 
that the higher an individuals educational level the more likely illness was 
attributed to smoking. In adults with only primary school education nearly a 
third did not believe smoking was unhealthy. The present study suggests that 
in Aboriginal communities there is a relationship between educational 
attainment and health knowledge. 
The relative frequency of specific conditions attributed to smoking (see table 
5.11) was similar to that found by Hill et al. In Hill et al' s study it can be 
deduced that 81 o/o of "knowledgable people" were aware smoking could cause 
lung cancer, 24% other cancers, 27% heart disease, 27% bronchitis, 24% 
emphysema and 9% associated smoking with strokes and other vascular 
disease. It is interesting that lung cancer was the most frequently recognised 
disease to be associated with smoking in both Hill et al's and the present study. 
This observation suggests that health messages regarding the hazards of 
smoking have had some impact in the study communities. However the 
findings suggest that the educational messages recalled by Aboriginal people 
have focussed on lung cancer to the exclusion of the other associations. This 
emphasis should be changed because diseases other than lung cancer (such as 
ischaemic heart disease) are numerically more frequent consequences of 
smoking and thus have greater public health importance (64) . 
In the present study there was no overall relationship between "knowledge" 
and smoking status. However when the data for CYl were examined 
independently there was a significant inverse relationship (see table 5.12) . This 
suggested that even though knowledge was very limited there may have been a 
relationship between health knowledge and smoking behaviour in CYl. 
Although the effect was not strong, the observation suggests that health 
promotion initiatives designed to increase Aboriginal awareness of the dangers 
of smoking have the potential to reduce the prevalence of its use. 
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The reasons given by never-smokers and ex-smokers for not smoking were 
similar and frequently interrelated as many people stated that they "didn't like 
it" because "it makes you sick" (see figures 5.14 and 5.15). The observation that 
20-50% of non-smokers were ex-smokers (except among women in CA3 where 
none were) suggests that each community had a small but significant core of 
ex-smokers. A strong cultural barrier to smoking initiation was evident among 
CA3 women. The present study indicated that Aboriginal people chose not to 
smoke or quit smoking because either it was not culturally acceptable, they 
didn't like it, or because it was perceived to be unhealthy. 
It has been shown by Hill et al in the general Australian population that, "a 
predisposition to quit smoking can be induced by increasing smoker's beliefs 
that smoking causes disease, and by raising the perceived probability that their 
smoking will lead to a fatal illness" (56). Hill et al also noted that, "Our findings 
indicate it is not true that there is not a child or adult in Australia who does not 
know that cigarette smoking is bad, and that neither is it true that all smokers 
take a risk they fully understand, nor that basic health education in these 
matters is redundant". This present study suggests that Hill et al's conclusions 
are also relevant for Aboriginal people. 
Discussions revealed that it was not self evident to people living in these small 
communities that smoking is dangerous. This may be because the absolute risk 
of dying from lung cancer (the most commonly identified adverse effect of 
smoking) in smokers is approximately 140/100,000/year (64). In an Aboriginal 
community of 330 smokers, this rate would manifest as one death every two or 
three years. However, the absolute risk of dying from ischaemic heart disease 
in smokers is 669 /100,000 /year (64). This would manifest as 2 deaths per year 
in a community of 330 smokers. The high prevalence of chronic lung disease in 
Aboriginal communities (see chapter 9), together with the high prevalence of 
hypertension, diabetes and obesity which are also risk factors for heart disease 
(28), means that the mortality attributable to smoking in Aboriginal 
communities undoubtedly exceeds 669 /100,000 per year. If Aboriginal people 
linked smoking with death from ischaemic heart disease, the adverse 
consequences of smoking would be more frequently observed as deaths from 
this cause are relatively common in Aboriginal communities. 
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5.6 Conclusion 
• The prevalence of smoking among males and females in Cape York and 
among males in central Australia was high when compared with that of 
non-Aboriginal Australians. In comparison with non-Aboriginal 
Australians the prevalence of smoking among women in central 
Australia was low. 
• The prevalence of smoking among some groups appeared to be rising 
due to high smoking initiation rates among teenagers. 
• Most smokers in Cape York consumed more than 15 cigarettes daily 
whereas in central Australia most smoked fewer than 6 cigarettes daily. 
• 
• 
• 
• 
• 
• 
• 
Younger smokers were probably smoking more frequently than older 
smokers. 
In central Australia tobacco chewing and smoking were usually 
mutually exclusive habits. 
There was a strong association between cigarette smoking and alcohol 
consumption. 
Expressed knowledge of the health consequences of smoking was 
limited. 
In CY1 knowledge of the health consequences of smoking was 
associated with a reduction in the odds for being a current smoker. 
Not liking smoking or concern about the health consequences were 
common explanations for never smoking or for quitting smoking. 
There is an urgent need for appropriately designed educational 
programs in Aboriginal communities to significantly reduce the 
prevalence and uptake of smoking. 
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CHAPTER6 
Asthma and Atopy 
6.1 Introduction 
The literature suggests that the prevalence of asthma in Aborigines is 
less than 4% (see chapter 2). This is low when contrasted with the prevalence 
of asthma in non-Aboriginal Australians (38, 46). 
There is evidence to suggest that exposure to house dust mite allergen (Der pl) 
may be important in the genesis of asthma (29, 65), and levels of Der pl above 
10 micro grams/ gram of fine dust have been shown to cause sensitisation and 
symptoms (66). House dust mites vary in prevalence throughout Australia 
because they require humidity above SSo/o to flourish (67). The present study 
provided an opportunity to study the role of house dust mite allergy in the 
aetiology of asthma in Aborigines. 
The role of genetics in the development of atopy and asthma remains uncertain. 
Dr Thompson observed that CYl, a community with a history of much greater 
contact with European and Chinese people than CY2, had a relatively high 
prevalence of asthma compared with CY2. He had not identified any 
Aboriginal asthmatics in CY2. Dr Thompson hypothesised that asthma and or 
atopy in CY1 could be linked to introduced genes. 
Allergic or atopic people produce immunoglobulin E (IgE) in response to 
ingested or inhaled allergens . The prevalence of atopy is known to increase 
with age until approximately the age of 24, and serum IgE levels parallel this 
rise (68). Atopy has been shown to be associated with asthma (69). The 
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relationships between asthma, atopy and elevated IgE have not been 
investigated in Aborigines. 
Bronchial hyperresponsiveness (BHR) is an airway abnormality associated with 
asthma and chronic obstructive pulmonary disease (70). BHR may be reliably 
detected by measuring the changes in FEV1 that occur following the inhalation 
of histamine (30). BHR in conjunction with recent wheezing is an accepted 
definition for asthma in epidemiological studies (71). 
The need for research relating to asthma is recognised 1n the National 
Aboriginal Health strategy (28). 
6.2 
• 
• 
• 
• 
• 
• 
6.3 
Aims 
To determine the prevalence of asthma and its associations in adults and 
children by determining the prevalence of: 
Ever wheeze and recent wheeze; 
Bronchial hyperresponsiveness; 
Atopy to common aero-allergens; 
House dust mite allergen exposure; 
Elevated total IgE in asthmatics and controls (CYl and CY2); 
Non-Aboriginal HLA DR and DQ alleles in asthmatics and controls from 
(CYl and CY2). 
Definitions 
The following definitions have proven utility in studies of the 
epidemiology of asthma (71): 
•Recent wheeze (RW) 
•Ever wheeze 
•PD20FEV1 
A history of wheeze in the last 12 
months. 
A history of wheeze at any time since 
birth. 
Dose of his ta mine required to 
produce a 20 o/o fall in FEV1 during a 
histamine challenge test. 
PD20FEV 1 less than or equal to 3. 9 
µmols of histamine. 
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The coexistence of recent wheeze and 
BHR; or recent wheeze and a greater 
than 15o/o increase in FEV1 following 
bronchodilator. 
A wheaL reaction of 3mm or more to 
a skin test using standardised 
allergens. 
All subjects aged five years and over answered a respiratory symptom 
questionnaire that included questions about ever and recent wheezing. In 
addition, all subjects were examined for rhonchi (blind to the questionnaire 
responses). Skin tests to common allergens and a histamine challenge test were 
also performed. In CYl and CY2 blood was collected from 96 people (all 
asthmatics and selected controls) for estimation of total IgE and HLA DR sub-
typing. 
Inter-observer agreement regarding the presence of rhonchi was assessed to 
validate the rhonchi observations. The association between rhonchi and recent 
wheezing was examined because one would predict that rhonchi would be 
more prevalent in subjects with a history of recent wheeze than in those 
without. A significant association between "recent wheeze" and rhonchi would 
imply the "recent wheeze" question had predictive validity. The association 
was assessed by calculating an odds ratio and the sensitivity and specificity of 
rhonchi for recent wheeze. 
6.4.1 Questionnaire 
The questions regarding wheeze are listed in Table 6.1. The questions 
"''ere developed in consultation with health workers from CYl and CY2, and 
they were piloted in all four communities. In all communities (except CY2 
where there were no known Aboriginal people with asthma), health workers 
were familiar with the terms wheeze and asthma. In all con1munities the 
questionnaire was administered by a pair comprising a local Aboriginal health 
worker (or community member) and a member of the technical staff. Members 
of the technical staff demonstrated wheeze to assist interpretation of the 
questions. In CA3 and CA4 a tape recording of wheezy breathing was also 
used to assist the history taking. The tape was not available when data were 
collected from CYl and CY2. Generally children answered the questions with 
an adult family member or guardian present. 
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Table 6.1 
Asthma Questions 
Question 
Some people have wheezy, noisy breathing from time to time. Are you like this? 
If yes to wheeze question then .. Was it in the last 12 months? 
6.4.2 Skin Tests 
To assess the prevalence of atopy, skin prick tests to common allergens 
were performed using the method of Pepys (72). The arm was initially cleaned 
and a white grid was applied to the forearm to facilitate identification of the 
allergens. A small drop of each allergen was placed in the grid and a sterile 
lance was passed through the droplet into the epidermal skin layer. The lance 
was wiped clean of allergen with an alcohol swab between each prick. The arm 
was then blotted dry and the time of testing was recorded on the arm. The skin 
tests were read 15 minutes after application of the allergens. The length of the 
longest axis of the wheal and the perpendicular were recorded. Histamine 
lmg/ml was used as a positive control and saline was used as a negative 
control. 
In Cape York the following allergens were used: cockroach, house dust, 
Dermatophagoides farinae (DF), Dermatophagoides pteronyssinus (DP), cat, dog, 
horse, feathers, ragweed, plantain, timothy grass, rye grass, Aspergillus 
fumigatus and Alternaria tenuis. All allergens were supplied by Hollister-Stier, 
Miles Inc.. In central Australia, a modified regime was used that included 
golden acacia, bottle brush tree, eucalyptus, melaleuca and Australian pine but 
did not contain dog, horse, feathers, ragweed, timothy grass or Aspergillus 
fumigatus. This modification was made because it was proposed these 
allergens were more appropriate for desert vegetation. 
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6.4.3 Bronchial Hyperresponsiveness 
Forced expiratory volume in one second (FEV,) and the forced vital 
capacity (FVC) were measured using Mijnhardt VRS 2000 (Mijnhardt B.V., 
Bunnik, Holland) dry rolling seal spirometers. The spirometers were connected 
to IBM compatible laptop computers running Scientific and Medical data 
acquisition software (S&M Instrument Company Inc., Doylestown, 
Pennsylvania, USA). Baseline lung function was measured while standing 
without a noseclip. Translators were available to assist with the forced 
expiratory manoeuvre instructions and subjects could see the tracing as they 
blew. Forced expiratory manoeuvres were repeated until they were 
reproducible to within 100 mls and the highest values were recorded. If the 
FEV 1 / FVC was <60 % a bronchodila tor response test was performed instead 
(see below). Challenge tests were not performed if subjects looked too frail (eg 
needed assistance to stand and walk) to complete the test. 
Histamine challenge tests were performed using the method of Yan et al (30). 
Once a reproducible baseline FEV, and FVC had been recorded the subject was 
taught to inhale from a De Vilbiss No. 40 glass nebuliser containing normal 
saline. Having mastered the technique for inhalation, a post-saline FEV1 and 
FVC was recorded. The subject then inhaled increasing doses of histamine 
from four stock solutions. FEV1 was recorded at 60 second intervals between 
the doses of histamine. The challenge was stopped if the FEV, fell by 20o/o or 
more or when the highest dose of histamine had been administered. The doses 
of histamine were doubled incrementally from 0.03 to a cumulative dose of 3.9 
µmols. The higher dose of 7.8 micromols was not used in this study because 
this causes hoarseness of voice in about 10% of subjects, and may have 
discouraged participation. 
Subjects who had an FEV1/FVC <60% were given a bronchodilator test. Two 
puffs (200 micrograms) of salbutamol was administered via a Volumatic spacer 
and the spirometry was repeated after ten minutes . The response was 
expressed as the percentage increase in FEV, . An increase of 15% or more was 
regarded as positive. 
6.4.4 House Dust Mite Allergen Levels 
In CYl and CY2, dust was collected from houses of randomly selected of 
subjects . A two square metre area of floor or mattress was vacuumed with a 
hand held cleaner and the dust collected in a small bag. In central Australia 
people were uncomfortable with the proposal to collect dust from their houses 
and beds. A blanket exchange scheme was developed whereby the field team 
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offered a new blanket in exchange for one in current use. This program proved 
very popular, and allowed us to collect adequate samples of dust by 
vacuuming. The "old" blankets were subsequently washed and left in the 
clinics for community use. 
In the laboratory the dust samples were sieved through a s425 stainless steel 
mesh by Dr Euen Tovey at Sydney University, and 0.2 gm aliquots of fine dust 
were examined microscopically for Dermatophagoides mites. Mite allergen was 
measured as Der pl allergen by Eliza. The result was expressed as micrograms 
of allergen/ gram of fine dust. 
6.4.5 IgE Measurement 
In CYl and CY2 each asthmatic, the subject immediately following and 
some selected arbitrarily, had blood collected for estimation of total IgE (and 
HLA DR typing). Total IgE was measured by Eliza at Sydney University. The 
results are reported in international units (iu). 
6.4.6 HLA Analysis 
Blood samples were centrifuged and the buffy coat was separated for 
storage and transportation in dry ice. The analysis was performed at the John 
Curtin School of Medical Research at the Australian National University in 
Canberra under the supervision of Professor Sue Serjeantson. Genetic systems 
that could be implicated in susceptibility to atopy and asthma were examined. 
The blood was analysed with HLA class II cDNA probes for DR beta, DQ 
alpha, DQ beta, DP alpha and DP beta using southern blotting and amplified 
fragment length polymorphisms (73). 
6.4. 7 Statistics 
Dummy dichotomous variables were created to identify subjects with 
IgE levels greater than 200 uni ts and 999 units, atopy, asthma and foreign 
alleles. Sample statistics were used to calculate confidence intervals for the 
summary figures in the prevalence data. Chi-square tests were performed to 
assess the regional variation in prevalence data and Chi-square trend tests were 
performed to assess changes with age. Unless otherwise stated, significance 
tests were regarded as positive if the probability was less than 0.05. Chance 
adjusted Kappa scores were used to assess the inter-observer agreement 
regarding rhonchi. Odds ratios were used to assess the significance and 
magnitude of the relationships between recent wheeze and rhonchi, the 
presence of elevated IgE levels and asthma/ atopy, and the presence of non-
Aboriginal HLA alleles and asthma/ atopy. Odds ratios were calculated using 
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standard techniques (74). The sensitivity and specificity of rhonchi for recent 
wheeze was assessed using the method reviewed by Sackett et al (75). 
Logistic regression was used to calculate adjusted odds ratios for BHR and 
asthma (coded 0/1: O=not present,. l=present) using proc catmod on SAS®. 
Age (treated as continuous),. gender (coded 0/1),. smoking status (coded 0/1) 
and atopy (to each allergen (coded 0/1)) and dummy variables for each 
community were initially included in the model. The least significant variable 
was removed sequentially. The significance of the models was assessed using 
maximum likelihood. 
6.4.8 Comparison with Non-Aboriginal Data 
During the time of this study data were collected from non-Aboriginal 
Australian children using similar methods (38). These data and data collected 
by the same epidemiological unit from adults in Busselton, Western Australia 
(46) were used for comparison. 
6.5 Results 
6.5.1 Ever Wheeze, Recent Wheeze and Rhonchi 
There was significant regional variation in "ever wheeze" (Chi-square 
p< 0.05) with the prevalence ranging from 7.9% of 5-84 year olds in CA3 to 
15.3o/o in CA4 (see table 6.2). The prevalence of "ever wheeze" significantly 
increased with age (Chi-square trend p < 0.001). 
There was significant regional variation in the prevalence of "recent wheeze" 
(Chi-square p < 0.001) with the prevalence ranging from 3.1 % of 5-84 year olds 
in CA3 to 12.4% in CA4 (see table 6.2). The prevalence of "recent wheeze" 
significantly increased with age (Chi-square trend p < 0.001) . 
There was significant regional variation in the prevalence of rhonchi (Chi-
square p < 0.001) with the prevalence ranging from 2% of 5-84 year olds in CA3 
to 9.2% in CA4 (see table 6.2). The prevalence of rhonchi did not significantly 
increase with age. 
The author and another respiratory physician, working independently, 
examined 235 subjects for rhonchi. The chance adjusted Kappa score for the 
level of agreement was 0.47 (95 % CI 0.28-0.69). 
Table 6.3 shows a cross-tabulation of the recent wheeze and rhonchi findings 
using the combined data from all communities. The odds ratio for the 
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association was 7.6 (95 % CI 4.4-13.2). Table 6.3 also shows that rhonchi 
predicted recent wheeze with a sensitivity of 0.24 and a specificity of 0.96. 
6.5.2 Bronchial H yperresponsiveness 
Table 6.4 shows the prevalence of BHR and current asthma by age and 
community. The table is stratified so that the findings in the entire population 
(5-84 years), adults (20-84 years) or children aged 5-7, 8-12 and 13-19 years can 
be distinguished. 
Most 5-7 year old children were unable to perform spirometry to ATS criteria 
and so did not receive a histamine challenge test. Over the entire age range a 
total of 85 histamine challenges were technically unsatisfactory (see table 6.4). 
The highest proportion of unsatisfactory tests occurred in CY2 (18.5%). 
There was significant regional variation in the prevalence of BHR (Chi-square p 
< 0.05) with the prevalence ranging from 2.2o/o of 5-84 year olds in CY2 to 7.5% 
in CA4 (see table 6.5). The prevalence of BHR significantly increased with age 
(Chi-square trend P < 0.05). 
Multivariate analyses revealed that feline allergy, house dust mite allergy (DF 
or DP) and smoking were significant risk factors for BHR. The adjusted (for 
each variable in the model) odds ratio for BHR associated with feline allergy 
was 1.7 (95% CI 1.01-2.30), HDM allergy was 1.6 (95% CI 1.2-2.2), and smoking 
was 1.4 (94% CI 1.1-1.9). Age was not significantly associated with BHR when 
it was adjusted for atopy. 
6.5.3 Asthma 
There was significant regional variation in the prevalence of asthma 
(Chi-square p < 0.05) with the prevalence ranging from 0% of 5-84 year olds in 
CY2 to 3.4% in CA4 (see tables 6.4 and 6.5). Chi-square trend testing did not 
show a significant rise in the prevalence of asthma with age but the 95% 
confidence intervals around the estimates for the prevalence in 8-12 year olds 
and 20-84 year olds did suggest that the prevalence rose significantly with age 
(see table 6.5). 
The mean age of the 19 asthmatics was 43 years and the only one under the age 
of 20, was aged 11 years. Nine were males and ten were females . Seven of the 
asthmatics were current smokers, seven had rhonchi and eight had a loose 
cough. Twelve of the asthmatics (63%) were atopic to one or more allergens, 
with eight being a topic to DF and seven a topic to DP. Four were a topic to dust, 
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six to cockroaches, one plantain and one to rye grass. Three asthmatics were 
allergic to cats. 
The multivariate analysis with variables for age, gender, community, smoking 
status and each allergen revealed that the only significant predictor of asthma 
was allergy to cat. The odds ratio for asthma in subjects allergic to cats 
(controlling for house dust mite, Alternaria and rye grass allergy) was 2.5 (95% 
CI 1.3 - 5.0). 
6.5.4 Atopy 
There was significant regional variation in the prevalence of atopy (Chi-
square p < 0.001) with the prevalence ranging from 21 % of 5-84 year olds in 
CA3 to 34o/o in CA4 (see table 6.5). Figure 6.1 shows that the prevalence of 
atopy increased significantly with age (Chi-square trend p< 0.001). Figure 6.2 
shows the prevalence of atopy to the five most frequently positive allergens 
(OF, DP, cockroach, dust, cat) by age. Appendices 1-5 contain a detailed 
analysis of atopy to all the allergens by age and community. 
6.5.5 House Dust Mite Sensitivity and Der pl Allergen Load 
Dust samples were collected from 35 houses in CY1, 20 houses in CY2, 
26 blankets in CA3 and 29 blankets in CA4. The geometric mean Der pl level in 
CY1 was 11.8 µg/g/fine dust and in CY2 was 14.9 µg/g/fine dust. In CA3 and 
CA4 the mean Der pl levels were less than 0.05µg/ g/ fine dust. In table 7.6 the 
mean Der pl levels are presented with a breakdown of the prevalence of atopy 
to DP by age and community. There was significant regional variation in the 
prevalence of atopy to DP (Chi-square p < 0.001) with the prevalence ranging 
from 14% of 5-84 year olds in CA3 to 25% in CY1 and CA4. 
6.5.6 Total IgE 
In CY1 and CY2, 83% of 93 subjects had IgE levels >200 units (normal< 
200) and 40 % had levels >999 units. Further dilutions were not performed for 
subjects with IgE levels greater than 1200 units . The odds ratio for the 
association between elevations of total IgE > 200 units and skin test atopy was 
1.5 (95% CI 0.5-4.4) (see table 6.7). There was no significant association between 
elevated IgE above 200 units and asthma (odds ratio 1.2 (95% CI 0.1-5.8) . 
Similarly, when subjects were divided into those with IgE levels above and 
below 999 units, no association could be demonstrated between elevated IgE 
and atopy (odds ratio 1.1 95% CI 0.5-2.5) or asthma (odds ratio 1.1 95% CI 0.3-
4.9). 
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6.5. 7 HLA Assays 
Seventy-one subjects from CYl and 25 from CY2 had blood collected for 
HLA DR and DQ subtype analysis. Foreign alleles were significantly more 
prevalent (p <.05) in CYl where they were present in 23 subjects (32%) vs CY2 
where they were present in 2 subjects (8%). Seven different foreign alleles were 
identified. They were 0301, 07, 1301, 1602, 1001, 0101 and 0103. Table 6.8 
shows that the odds ratio for the association between the presence of any 
foreign allele and atopy (any skin test positive), was 1.2 (95% CI 0.5-3.1). Table 
6.9 shows that the odds ratio for the association between the presence of foreign 
allele and asthma was 0.94 (95o/o CI 0.23-4.97). 
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I Table 6.2 
Prevalence of ever wheeze, recent wheeze and rhonchi by age group (in years) and I 
community expressed as a percentage. 
I 
' 
CY1 CY2 CA3 CA4 All 95% CI 
Number 
Ill 5-7 51 17 28 23 119 
8-12 95 28 58 31 212 
13-19 54 16 86 50 206 
1, 
20-84 278 102 186 149 715 
5-84 478 163 358 253 1252 
Ever wheeze t 
/ 5-7 8.0 0 0 4.8 4.4 0.7-8.0 
I 
8-12 2.2 0 1.7 3.3 1.9 0.1-3.7 
13-19 11.3 18.8 10.6 12.0 11.8 7.4-16.2 
20-84 19.9 14.3 9.7 20.9 16.6# 13.8-19.3 
* 5-84 14.2 11.0 7.9 15.3 12.2 10.4-14.1 
1, 
Recent wheeze t 
I I 
I 5-7 6.0 0 0 4.8 3.5 0.2-6.8 
8-12 2.2 0 1.7 3.3 1.9 0.1-3.7 
13-19 7.5 0 4.7 8.0 5.9 2.7-9.1 
20-84 15.4 5.1 3.2 16.9 11.1 # 8.8-13.4 
** 6.5-9.5 5-84 10.9 3.2 3.1 12.4 8.0 
I Rhonchit 
5-7 8.3 0 0 4.5 4.4 0.7-8.1 
8-12 9.7 0 0 13.3 6.3 3.0-9.6 
13-19 7.5 6.3 2.3 6.0 4.9 1.9-7.8 
20-84 5.5 5.0 2.7 10.1 5.6° 3.9-7.3 
** 4.2-6.7 5-84 6.8 3.7 2.0 9.2 5.5 
Number. .. Number in each age group 
All. .. ....... Prevalence (or numbers) when data from all communities are combined 
R 95% CI.. .. Confidence interval around prevalence estimate for all 
II 
* Chi-square fo r the difference between communities p < 0.05 
I 
.... .. ...... 
** Chi-square for the difference between communities p < 0.001 II ..... ... ... 
1, 
It # 
············ 
Chi-square trend fo r the significance of the increase with age p < 0.001 . 
:: a ........ .... Chi-square trend fo r the significance of the increase with age not significant 
;( t ............ Prevalence of missing values was not greater than 2% I 
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Table 6.3 
Relationship between recent wheeze and rhonchi in 5-84 year olds. 
Rhonchi 
No 
Yes 
Odds ratio = 7.56 (95% CI 4.4-13.2) 
No 
1095 
45 
Sensitivity of rhonchi for recent wheeze is 0.24 
Specificity of rhonchi for recent wheeze is 0.96 
Missing values = 15 
Recent Wheeze 
Yes 
74 
23 
87 
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Table 6.4 
I Bronchial hyperresponsiveness and current asthma by age. 
I 
Nl tt2 u3 (%) 4 TS 5 BHR 6 (%) 7 CAB (%) 9 
' 
5-84* 
' CYl 478 390 22 (5.6) 368 22 (5.9) 10 (2.7) 
CY2 163 113 21 (18.5) 92 2 (2.2) 0 (0) 
CA3 358 310 27 (8.7) 283 7 (2.5) 3 (1) 
11 
' CA4 253 188 15 (7.9) 173 13 (7.5) 6 (3.4) 
All 1252 1001 85 (8.5) 916 44 (4.8) 19 (2) 
5-7* 
CYl 51 2 1 (50) 1 0 (0) 0 (0) 
CY2 17 0 0 (0) 0 0 (0) 0 (0) ' 
CA3 28 9 1 (11) 8 0 (0) 0 (0) 
1, CA4 23 4 1 (25) 3 0 (0) 0 (0) 
All 119 15 3 (20) 12 0 (0) 0 (0) 
8-12* 
CYl 95 89 5 (5.6) 84 1 (1.2) 0 (0) 
11 CY2 28 24 3 (12.5) 21 1 (4.7) 0 (0) 
• 
• CA3 58 54 3 (5.5) 51 0 (0) 0 (0) 
CA4 31 29 0 (0) 29 1 (3.4) 1 (3.4) 
All 212 196 11 (5.6) 185 3 (1.6) 1 (0.5) 
1, 
13-19* 
CYl 54 51 1 (1.9) 50 1 (2) 0 (0) 
CY2 16 14 2 (14.3) 12 0 (0) 0 (0) 
CA3 86 84 2 (2.4) 82 0 (0) 0 (0) 
CA4 50 43 6 (13.9) 37 0 (0) 0 (0) 
All 206 192 11 (5.7) 181 1 (0.5) 0 (0) 
20-84* 
I• 
CYl 278 248 15 (6) 233 20 (8.6) 10 (4.3) 
CY2 102 75 16 (21) 59 1 (1.7) 0 (0) 
CA3 186 163 21 (12. 9) 142 7 (4.9) 3 (2.1) 
CA4 149 112 8 (7.1) 104 12 (11.5) 5 (4.8) 
All 715 598 60 (10) 538 40 (7.4) 18 (3.3) 
1 Number of participants 2 Number of histamine challenges (HCs) 
3 Number of technically unsatisfactory HCs 4 % technically unsatisfactory HCs 
I 
5 Number technically satisfactory HCs 6 Number with BHR (positive HC) 
7 % of satisfactory tests with BHR 8 Number with current asthma 
9 % with current asthma (BHR and RW) * Age in Years 
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Table 6.5 
Prevalence of BHR, asthma (BHR plus recent wheeze) and atopy by age group and 
community expressed as a percentage of those tested. 
Number 
5-7 
8-12 
13-19 
20-84 
5-84 
BHR 
5-7 
8-12 
13-19 
20-84 
5-84 
Asthma 
5-7 
8-12 
13-19 
20-84 
5-84 
Atopy¥t 
5-7 
8-12 
13-19 
20-84 
5-84 
Number.. .. 
All .......... 
95% CI.. ... 
¥ ........... 
t ............ 
* ....... .... .. . 
** ........... 
y 
··· ······· ·· 
# 
·········· ·· 
0 ............ 
CYl 
51 
95 
54 
278 
478 
0 
1.2 
2.0 
8.6 
5.9 
0 
0 
0 
4.3 
2.7 
14 
24 
28 
40 
33 
CY2 
17 
28 
16 
102 
163 
0 
4.7 
0.0 
1.7 
2.2 
0 
0 
0 
0 
0 
0 
18 
31 
43 
33 
umber in each age group 
CA3 
28 
58 
86 
186 
358 
0 
0 
0 
4.9 
2.5 
0 
0 
0 
2.1 
1.0 
7 
14 
28 
23 
21 
CA4 
23 
31 
50 
149 
253 
0 
3.4 
0 
11.5 
7.5 
0 
3.4 
0 
4.8 
3.4 
26 
29 
36 
36 
34 
All 
119 
212 
206 
715 
1252 
0 
1.6 
0.5 
7.4 y 
* 4.8 
0 
0.5 
0 
3.3° 
* 2.0 
13 
21 
30 
35# 
** 30 
95% CI 
0--2.4 
0--3.3 
0--1.5 
5.4-9.3 
3.6-6.0 
0--2.4 
0--1.5 
0--1.4 
1.9-4.6 
1.2-2.8 
6.9-19.0 
15.5-26.4 
23 .7-36.2 
31.0-38.0 
27.0-32.0 
Prevalence (or numbers) when data from a11 communities are combined 
Confidence interval around prevalence estimate fo r all 
Atopy to one or more allergens 
Missing values= 8 
Chi square fo r the difference between co mmunities p < 0.05 
Chi-square fo r the difference be tween communities p < 0. 1 
Chi-square trend for the significance o f the increase with age p < 0.05 
Chi-square trend for the significance of the increase with age p < 0. 1 
Chi- quare trend for the significance of the increase with age not significant 
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Table 6.6 
Geometric mean Der pl levels and prevalence of atopy (percent) to DP by age group 
(in years) and community. 
CYl CY2 CA3 CA4 All 95% CI 
Mean Der pl* 11.8 14.9 < 0.05 < 0.05 
Age 
5-7 10 0 4 22 10 4 .6-15.4 
8-12 16 18 10 16 15 10.2-19.8 
13-19 24 25 17 24 21 15.4-26.6 
20-84 31 30 16 27 26# 22.8-29.2 
5-84 25 24 14 25 22 ** 19.7-24.2 
All.. .. ...... Prevalence when data from all communities are combined 
95% CL. ... Confidence interval around prevalence estimate for all 
* µg/ gm of fine dust 
·········· ··· 
** Chi-square for the difference between communities p < 0.001 ............ 
# .............. Chi-square trend for the significance of the increase with age p < 0.001 
Table 6.7 
Relationship between elevated IgE and atopy. 
Atopy 
Yes No 
IgE>200 iu 32 43 
IgE<200 iu 5 10 
Odds ratio for the associati on between atopy and IgE > 200 units 1.5 (95% CI 0.5-4.4) 
N=90 
Missing values = 3 
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Table 6.8 
Relationship between non-Aboriginal HLA DR and DQ alleles and atopy. 
Foreign Alleles Yes 
Foreign Alleles No 
Yes 
11 
28 
Atopy 
No 
13 
41 
Odds ratio for the association between Atopy and foreign alleles 1.2 (95% CI. 0.5-3.1) 
N=93 
Missing values = 3 
Table 6.9 
Relationship between non-Aboriginal HLA DR and DQ alleles and asthma. 
Foreign Alleles Yes 
Foreign Alleles No 
Odds Ratio= 0.94 (95 % CI 0.23-4.97) 
N=96 
Yes 
2 
6 
Asthma 
No 
23 
65 
91 
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Figure 6.1 
Regional variation in atopy by age. 
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Figure 6.2 
Atopy to DP, OF, cockroach, dust, cat, by age group (in years). 
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Figure 6.3 
Atopy, recent wheeze, BHR and asthma in 8-12 year old Aboriginal children and 8-
10 year old non-Aboriginal children. Non-Aboriginal data from Wagga Wagga, 
NSW (38). 
-C: 
(l) 
() 
... 
(l) 
a. 
40 
Atopy Recent Wheeze BHR 
[ill Non Aboriginal 
fa Aboriginal 
Asthma 
., 
95 
Figure 6.4 
Atopy, recent wheeze, BHR and asthma in Aboriginal and non-Aboriginal adults in 
Australia. Non-Aboriginal data from Busselton, WA (46). 
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6.6 Discussion 
The prevalence of recent wheeze, BHR, atopy and asthma in the 8-12 
year old Aboriginal children was low when contrasted with the findings of Peat 
et al (38)(see figure 6.3) who studied 1,668 non-Aboriginal children aged 8-10 
years in Wagga Wagga, NSW. 
The prevalence of recent wheeze, asthma and atopy in the Aboriginal adults 
was also low when contrasted with the findings of Peat et al (46)(see figure 6.4) 
who studied 1,028 Caucasian adults aged 18-55 years in Busselton, WA. 
However the prevalence of BHR among the adults in the present study was 
similar to the Busselton findings. 
It was valid to compare the findings of the present study with the findings of 
the two studies by Peat et al (38, 46), because the data for all three studies were 
collected by the same epidemiological unit (Institute of Respiratory Medicine, 
Royal Prince Alfred Hospital, Sydney). 
These data regarding the prevalence of rhonchi were collected to examine the 
relationship between rhonchi and recent wheeze. The Kappa score of 0.47 
indicated a moderate level of inter-observer agreement for rhonchi (76). The 
odds ratio (7.6) for the association between recent wheeze and rhonchi, and the 
specificity of rhonchi for recent wheeze suggested that the wheeze questions 
were valid and therefore it was unlikely that the low prevalence of recent 
wheeze was an artefact of the questionnaire design or difficulty with 
translation. The low sensitivity of rhonchi for detecting recent wheeze was 
expected because rhonchi are evanescent with disease activity. 
The present study shows that asthma in rural Aborigines is predominantly a 
disease of adults. This pattern has been described by Dowse et al in PNC (77), 
Warrell et al in Nigeria (78), and in other tropical environments. Despite 
several hypotheses regarding the importance of genetic, immunological and 
environmental factors the reasons for the low prevalence of asthma in these 
areas remain unknown (79). 
Although the prevalence of asthma was generally low there was significant 
regional variation (prevalence high in CYl and CA4 and low in CY2 and CA3) 
(see table 6.5). The participation rate from CA3 was high, so it is unlikely 
sampling bias explains the low prevalence of asthma there. Al though the 
participation rate was relatively poor in CY2, Dr Thompson has never seen a 
person with asthma there (despite ten years of regular visits to conduct chest 
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clinics) so it is unlikely that poor participation explains the low prevalence in 
CY2. The two communities with a relatively high prevalence of asthma had 
starkly contrasting living conditions and climates. Although the cause of 
regional variation in asthma prevalence is unknown some possible 
explanations are discussed below. 
The high mite allergen levels in Cape York and the low levels in central 
Australia were predicted from their climates (67). Surprisingly the prevalence 
of HDM atopy in CA4 was similar to CY1 and CY2 despite CA4 having 
essentially undetectable levels of Der pl. It has been shown that cross-
antigenicity exists between Sarcoptes scabiei (scabies) and Dermatophagoides 
pteronyssinus (80). Scabies is common in Aboriginal communities (54), so 
perhaps cross-antigenicity may explain the high prevalence of atopy to DP in 
CA4. However scabies infection also occurs in CA3 so it is not clear why there 
was a lower prevalence of sensitivity to HDM in this community. This putative 
cross-reaction is important because it could have reduced the power of the 
study to detect an association between HDM atopy and BHR or asthma (see 
below). 
The contribution of HDM allergen exposure to the development of atopy, BHR 
and asthma was unclear in this study. Mean levels of Der pl in CY1 and CY2 
were high enough to cause sensitisation and wheezing (66), and HDM atopy 
was a risk factor for BHR. However, the prevalence of asthma atopy and BHR 
among children was low. This finding suggested that Aboriginal children are 
protected from the pulmonary effects of high Der pl exposure. Aboriginal 
children also appear to be "protected" from developing sensitivity to other 
allergens (see below) . One possible mechanism and some conclusions 
regarding the importance of this observation are also discussed below. 
The distribution of the non-Aboriginal HLA DR and DQ alleles supported the 
hypothesis that the people of CY1 have experienced relatively more genetic 
mixing than those in CY2. However, there was no evidence that asthma or 
atopy in CY1 were linked to the foreign genes . These findings suggest that 
environmental, rather than genetic factors, should be invoked to explain the 
higher prevalence of asthma in CY1 com pared with CY2. As the people in both 
these communities lived in houses with similar levels of HDM allergen 
exposure it is unlikely differences in exposure to Der pl account for the 
findings. Other possible environmental factors therefore need to be considered. 
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It is likely that the high levels of total IgE found in CYl and CY2 reflected a 
high prevalence of intestinal parasite infection with Trichuris trichuria and 
Ascaris lurnbricoides (68, 81). This putative association with parasite infestation 
may explain why there was no relationship between elevated IgE levels and the 
prevalence of atopy or asthma. Presumably parasite-specific IgE "swamped" 
any elevations of IgE associated with allergy to aero-allergens. These data are 
consistent with the observation of Carswell et al (82) who showed that parasite 
infestation did not protect Tanzanian children from developing asthma. 
The finding that BHR was significantly associated with atopy to cats and house 
dust mites (DF or DP) (see 6.5.2) was consistent with the findings of Peat et al 
(46). They found that the adjusted odds ratio for BHR in Caucasians was 5.5 for 
house dust mite allergy and 3.1 for feline allergy. The finding was important 
because the apparently low prevalence of BHR in Aboriginal children may be 
secondary to the low prevalence of atopy (see figure 6.3). In adults the 
association between BHR and atopy was important because the regional 
variation in the prevalence of atopy may explain the regional variation in BHR 
(and asthma) (see table 6.5). A weak association between smoking and BHR is 
well recognised (45) but it is unlikely that regional variation in the prevalence 
of smoking is significantly affecting the prevalence of BHR because in CY2, 
where smoking was most prevalent, the prevalence of BHR was low. 
In the present study the low prevalence of atopy in children (see figure 6.3) was 
unlikely to have been due to the use of inappropriate allergens because the 
prevalence of adult atopy to the same allergens was significantly higher and 
similar to that found in non-Aboriginal Australians (see figure 6.4). Therefore 
Aboriginal Australians appear to have a slower rate of atopy acquisition than 
non-Aboriginal Australians. Because atopy has been associated with BHR in 
many studies (including the present study) this slow rate of atopy acquisition 
ma be an important factor explaining the generally low prevalence of asthma 
among Aborigines. 
One possible cause for the slow acquisition of atopy in children is chronic, 
profuse, purulent nasal discharge . Perhaps chronic nasal discharge is 
attenuating the presentation of aero-allergens to the naso-bronchial mucosa 
thus retarding sen iti ation. 
The finding that feline allergy v as a risk factor was similar to the findings of 
Pea et al (-16). Cats li e in each of the four study communities. The 
multivaria e anal sis performed to exp lore the associations with asthma was 
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necessarily hindered by the small numbers (19 asthmatics) . Therefore the 
power to detect associations with asthma was limited. Peat et al (46) also 
demonstrated an association with HDM allergy that was not present in the 
Aboriginal asthmatics. This lack of association between HDM allergy and 
asthma in the present study was unexpected because there was an association 
between HDM allergy and BHR. It is possible that a cross-reaction between 
Sarcoptes scabiei and Dermatophagoides pteronyssinus (see above) reduced the 
strength of any relationship between house dust mite allergy and asthma, and 
that this, combined with the low power of the study resulted in the negative 
finding . A large case-controlled study of Aboriginal asthmatics could clarify 
whether HDM allergy is an important risk factor for asthma. 
It is not clear why the findings in the present study regarding the prevalence of 
atopy and BHR do not concur with the findings of Clarke et al (see chapter 2) 
(50). It is possible that the differences seen with the comparison between the 
two studies are a result of confounding by age or differences in the criteria used 
to assess atopy and BHR. 
Discussions with Aboriginal medical service staff in Melbourne and Sydney 
suggest that asthma occurs commonly in urban Aboriginal children. In other 
cultures changes in the prevalence of asthma have been found in association 
with migration to new environments. For example Waite et al found that the 
prevalence of clinically diagnosed asthma amongst Tokelauen children aged 0-
14 was 11.0% in Tokelau and 25.3% in New Zealand (Clinical Allergy 
1980;10:71-75). In addition Waite et al found evidence to suggest that atopic 
eczema and allergic rhinitis were more prevalent amongst the Tokelauen 
children living in New Zealand. The reasons for these changes with migration 
are unknown. A study of asthma among urban Aboriginal children is needed 
to determine the prevalence of asthma and explore the associations with atopy. 
Urban Aboriginal children may develop atopy at an earlier age than their rural 
counterparts and as a consequence have a higher prevalence of BHR and 
asthma. 
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6.7 Conclusion 
• The prevalence of asthma in adults was low in comparison with that 
found among non-Aboriginal Australians and in children it was almost 
non-existent. 
• The only significant risk factor for asthma was allergy to cats . 
• The prevalence of asthma in Cape York children was low despite 
exposure to high levels of Der p 1 allergen. 
• 
• 
• 
The prevalence of BHR among adults was similar to that found in non-
Aboriginal Australians but in children the prevalence was low. 
The risk factors for BHR were HDM allergy, feline allergy and cigarette 
smoking. 
There was significant regional variation in the prevalence of atopy and 
asthma. 
• The prevalence of atopy in adults was similar to that found among non-
Aboriginal Australian adults but in children it was significantly lower 
than that found among non-Aboriginal children of the same age. 
Aboriginal children may have delayed atopy acquisition. 
• 
• 
• 
There was no evidence that asthma or atopy in CYl and CY2 were 
associated or linked with non-Aboriginal HLA DR and DQ alleles. 
IgE levels were not helpful in identifying those at risk for BHR or 
asthma. 
The low prevalence of asthma in Aborigines is unexplained but the 
regional variation is possibly due to environmental factors that affect the 
acquisition of atopy. 
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CHAPTER 7 
Normal Lung Function 
7.1 Introduction 
Little is known about normal lung function in Aborigines. Studies by 
Chandler et al ( 26) and Watson et al (52) showed that FEV1 and FVC in 
Aboriginal children were approximately 25o/o lower than those predicted for 
Caucasian children. However children with signs or symptoms of lung disease 
were not excluded from the reference populations in these studies so the 
equations published by these authors may not predict "normal" lung function 
(48). 
Thompson et al have published equations for normal lung function in 
Aboriginal adults but further studies are required to confirm the findings (1). 
They measured FEV 1 and FVC in 229 Aboriginal adults and found them to be 
25% lower than values predicted by equations developed for Caucasians. They 
also found that age related decline in lung function appeared higher than that 
found in Caucasians, and most surprisingly, that smokers appeared to have less 
age related decline in lung function than non-smokers (see chapter 2). 
It is recognised that there are racial variations in lung function (83-85). Lung 
function equations derived from Caucasian populations usually over-estimate 
values in black subjects by 7-20%. Some of these differences may be secondary 
to anthropometric differences between races because when compared with 
Caucasians, some indigenous peoples have relatively long legs (or relatively 
short chests) per unit of standing height (86). Standardisation using sitting 
height rather than standing height has been shown to reduce but not eliminate 
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racial differences in ventilatory function (48). Also environmental factors have 
been postulated to explain racial differences in lung function (48). 
No unified approach has been adopted for modelling pulmonary function 
using cross-sectional data (87). Multiple linear regression using age and height 
as the main independent variables has been the method adopted by most 
investigators (48, 88). However linear models cannot describe adequately the 
changes in FEV1 and FVC that occur during the transition from lung growth in 
the late teenage years, to the plateau in the early twenties and then the 
subsequent decline with age (88). Recently spline smoothing has been used to 
portray the growth and decay of FEV1 and FVC with age. Unfortunately this 
technique does not yield reference values (89). 
7.2 Aims 
The aim here was: 
• To develop equations to predict FEV1 and FVC in children and adults; 
• To estimate the rate of decline of lung function with age for adults; 
• To examine the influence of smoking on lung function in asymptomatic 
smokers to determine whether they have less age related decline than 
non-smokers. 
7.3 Methods 
A reference population was identified by excluding those subjects with 
known lung disease, chronic cough, recent wheeze, loose cough, crepitations, 
rhonchi and BHR. Subjects with BHR were excluded because BHR may be 
associated with abnormalities of ventilatory function (90). 
7.3.1 Measurement of FEV1 and FVC 
FEV 1 and FVC were measured using Mijnhardt VRS 2000 (Mijnhardt 
B.V., Bunnik, Holland) dry rolling seal spirometers while subjects were 
standing (without noseclips). The tests were performed using ATS criteria (91) 
by technicians from Professor Woolcock's epidemiological unit (see 6.4.3). The 
spirometers were calibrated twice daily and all values were converted to BTPS. 
7.3.2 Height 
Standing height was recorded in centimetres with footwear removed. 
Sitting height was measured using a bench and a vertically mounted tape 
measure. The base of the tape measure was set level with the top of the bench. 
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7.3.3 Analysis 
Visual inspection of plots of FEV1 and FVC with age confirmed that 
spirometric growth was complete by the age of 19 years. Therefore these data 
were divided into 7-19 year olds and 20-80 year olds and analysed separately. 
Smoking and gender were coded as dichotomous variables. Standing and 
sitting height (measured in cm) and age in years were treated as continuous 
variables. 
Multiple linear regression was utilised to develop equations to predict FEV1 
and FVC using SAS® (92). Gender, smoking, age, standing height and sitting 
height were used as the independent variables. The models were fitted using 
the least squares technique. Non-linear effects of age and height were 
examined by using height squared, age squared, loge height and loge age. 
Interactions between gender, smoking, age and height were also examined. 
Statistical significance was assessed at the 0.05 level. Plots of residual values 
against predicted values were examined for all models to assess trends in the 
unexplained variance. The 95% percent confidence intervals for the modelled 
values of FEV1 and FVC were calculated by taking account of the point variance 
of the residuals as well as the variance of the parameter estimate. 
7.4 Results 
7.4.1 Data Base Summary 
After the exclusion criteria were applied, the reference population 
comprised 261 subjects aged 7-19 years, and 332 subjects aged 20-80 years. 
Table 7.1 shows the structure of the reference population by age, gender and 
smoking status. The mean values of the dependent and independent variables 
in 7-19 year olds (plus SD and range) are detailed in Table 7.2, and Table 7.3 
shows these data for 20-80 year olds. The crude correlations (Pearson R values) 
between the dependent and independent variables for 7-19 year olds are 
presented in table 7.4, and table 7.5. shows these data for 20-80 year olds. 
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Table 7.1 
I Reference population stratified by age, gender and smoking status. j 
I Males Females 
I 
7-19 Year olds (N=261) 
,, 
I 
I ' 
:i Smokers 25 11 
Non-smokers 108 117 
; 
Total 133 128 
1, 
20-80 Year olds (N=332) • 
I 
I 
I Smokers 72 59 I 
Non-smokers 58 143 
• 
I Total 130 202 
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Table 7.2 
Mean values of the dependent and independent variables and FEV1/FVC ratio in the 
childhood reference population. 
7-19 Year olds Mean SD Minimum Maximum 
MALE 
Age 12.9 3.2 7 19 
Height 153.0 16.6 119 181 
Sitting height 75.2 8.3 58 91 
FEV1 2.3 0.8 0.97 4.02 
FVC 2.5 0.89 1.08 4.59 
Ratio FEV1/FVC 93.1 5.3 78 100 
FEMALE 
Age 12.8 3.8 7 19 
Height 148.2 14.7 115 176 
Sitting height 73.7 7.3 58 88 
FEV1 2.0 0.6 0.8 3.4 
FVC 2.1 0.7 0.8 3.5 
Ratio FEV 1/FVC 94.2 4.9 80 100 
Height was measured in centimetres. 
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Table 7.3 
Mean values of the dependent and independent variables and FEV 1/FVC ratio in the 
adult reference population. 
20-80 Year olds Mean SD Minimum Maximum 
MALE 
Age 38.1 13.8 20 80 
Height 173.9 6.2 159 195 
Sitting height 85.8 3.8 74 97 
FEV1 3.05 0.7 1.3 4.9 
FVC 3.4 0.8 1.5 6.2 
Ratio FEV1 /FVC 87.8 7.2 67 100 
FEMALE 
Age 34.4 12.2 20 78 
Height 160.9 6.1 149 188 
Sitting height 80.1 3.7 69 91 
FEV1 2.3 0.5 0.9 3.7 
FVC 2.5 0.6 1.1 4.3 
Ratio FEV1/FVC 91 6.8 66 100 
Height was measured in centimetres. 
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Table 7.4 
Correlation coefficients (Pearson R values) between the dependent and in-
dependent variables in the childhood reference population. 
Male non-smokers 
FEV1 
FVC 
Male smokers 
FEV1 
FVC 
Female non-smokers 
FEV1 
FVC 
Female smokers 
FEV1 
FVC 
Standing height 
0.88*** 
0.87*** 
0.70*** 
0.60** 
0.85*** 
0.86*** 
0.77** 
0.78** 
Height was measured in centimetres. 
* p= N/S 
** p < 0.05 
*** p < 0.0001 
Sitting height 
0.87*** 
0.86*** 
0.66** 
0.64** 
0.84*** 
0.85*** 
0.80** 
0.69** 
Age 
0.83*** 
0.84*** 
0.22* 
0.27* 
0.75*** 
0.76*** 
0.33* 
0.37* 
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Table 7.5 
Correlation coefficients (Pearson R values) between the dependent and in-
dependent variables in the adult reference population. 
Male non-smokers 
FEV1 
FVC 
Male smokers 
FEV1 
FVC 
Female non-smokers 
FEV1 
FVC 
Female smokers 
FEV1 
FVC 
Standing height 
0.35** 
0.40** 
0.53*** 
0.56*** 
0.51 *** 
0.56*** 
0.34** 
0.41** 
Height was measured in centimetres. 
* p = N/5 
** p < .05 
*** p < 0.0001 
Sitting height 
0.34** 
0.32** 
0.48*** 
0.47*** 
0.58*** 
0.62*** 
0.62*** 
0.66*** 
Age 
-0.65*** 
-0.60*** 
-0.40** 
-0.02* 
-0.44*** 
-0.37*** 
-0.31 ** 
-0.21 * 
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7.4.2 Models for FEV 1 and FVC 
In children, the final models for FEV 1 and FVC (Table 7.6) contained 
terms for height, age, gender and the interaction of gender with age. Smoking 
status was omitted because it did not have a significant effect in the model. The 
final models for adults (see table 7.6) contained terms for height, age, gender 
and smoking. Adult cigarette smokers had higher predicted values of FEV1 (by 
138 mls) and FVC (by 260 mls) than non-smokers. Table 7.6 also shows the root 
mean square error and R2 values associated with the models. 
Two examples are provided to demonstrate use of the models: 
1. To calculate FVC in a 14 year old female who is 155 cm tall: 
FVC = - 3.506 + (0.03215 x ht) + (0.08453 x age) + (0.43965 x gender) - (0.05029 x gender x 
age) 
= - 3.506 + (0.03215 X 155) + (0.08453 X 14) + (0.43965 X 1) - (0.05029 X 1 X 14) 
= - 3.506 + 4.983 + 1.183 + 0.4396 - 0.70406 
= 2.40 Ii tres 
2. To calculate FEV1 in a 40 year old male smoker who is 175 cm tall: 
FEVl = - 3.469 + (0.04169 x ht) - (0.02133 x age) - (0.23036 x gender) + (0.13786 x Smoking 
status) 
= - 3.469 + (0.04169 X 175) - (0.02133 X 40)- (0.23036 X 0) + (0.13786 X 1) 
= - 3.469 + 7.29575 - 0.8532 - 0 + 0.13786 
= 3.11 litres 
To estimate the 95o/o confidence interval of any predicted value multiply the 
appropriate root mean square error (RMSE) value by 1.96 and add or subtract it 
from the predicted value. In example (1) above the confidence interval is as 
follows: 
95% CI = 2.40 ± 0.373 x 1.96 
= 2.40 ± 0.731 
= (1.67 - 3.13) 
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J Table 7.6 
Models for FEV1 and FVC in 7-19 year old and 20-80 year old Aborigines. 
I 7-19 Year olds 20-80 Year olds ' 
FEV1 FVC FEV1 FVC 
Intercept -3.354 -3.506 -3.469 -5.159 
b (SE) 0.273 0.305 0.661 0.798 
Height 0.03095 0.03215 0.04169 0.05315 
(SE) 0.00260 0.00290 0.00377 0.00455 
• 
:11 Age 0.07321 0.08453 -0.02133 -0.01961 
(SE) 0.01471 0.01646 0.00189 0.00228 
II 
Gender 0.40771 0.43965 -0.23036 -0.23870 
(SE) 0.16092 0.17997 0.06933 0.08369 
' 
1! 
I Current smoker 0.13786 0.26047 
'I 
,I 
I (SE) 0.05181 0.06254 
11 
,, 
Gender x age -0.04455 -0.05029 
(SE) 0.01227 0.01372 
' 
RMSE 0.33 0.37 0.42 0.51 
• 
R2 0.80 0.79 0.62 0.62 
~ 
Coding for gender:. males = 0, females= 1 
~ Coding for smoking status: non-smokers= 0, smoker= 1 I 
Height= standing height in centimetres 
Age= age in years 
Gender x age= Gender times age 
I• 
- indicates not applicable 
II The probability p of all estimates is< 0.05 
SE = Standard error 
' 
RMSE = Root mean square error 
~ 
1: R2 = square of Pearson correlation coefficient 
1 
ii All spirometric values in litres BTPS 
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The following tables have been compiled to allow the prediction of FEV1 
and FVC in Aboriginal adults and children: 
Appendix 6 FEV1 Males 9-19 years old 
Appendix 7 FVC Males 9-19 years old 
Appendix 8 FEV1 Male non-smokers 20-70 years old 
Appendix 9 FVC Male non-smokers 20-70 years old 
Appendix 10 FEV1 Male smokers 20-70 years old 
Appendix 11 FVC Male smokers 20-70 years old 
Appendix 12 FEV1 Females 9-19 years old 
Appendix 13 FVC Females 9-19 years old 
Appendix 14 FEV1 Female non-smokers 20-70 years old 
Appendix 15 FVC Female non-smokers 20-70 years old 
Appendix 16 FEV1 Female smokers 20-70 years old 
Appendix 17 FVC Female smokers 20-70 years old 
7.5 Discussion 
Although 1,000 subjects completed spirometric testing, the exclusion of 
those with technically unsatisfactory tests, signs or symptoms of lung disease, 
bronchial hyperreactivity and airflow obstruction left only 593 subjects for lung 
function modelling (Table 7.1). The 40o/o reduction in numbers reflected the 
high prevalence of respiratory disease in these communities (see chapter 9). 
Nevertheless the numbers available for modelling were comparable to many 
studies used to develop reference values in Caucasian populations (48). 
In the present study, the mean age and height of adult men and women in the 
reference population was similar to that in Thompson et al's study (1). This 
similarity between the two populations was important as it allowed direct 
comparison of predicted values at mean age and height where both sets of 
equations were likely to be most accurate. 
The significant correlations between height, age and ventilatory capacity were 
expected (88). Although height and age were highly correlated (positively in 
children and negatively in adults), both were included as independent 
variables in the modelling because it is recognised that lung growth and 
maturation may occur independently of height (particularly in the late teenage 
years) (88). The finding that sitting height was no better a predictor of lung 
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function than standing height supports the finding of Thompson et al (1). This 
was expected as sitting and standing height are highly correlated. 
The R2 values for the models (see table 7.6) showed that height and age 
accounted for 80% of the variance of FEV 1 and FVC in children, and 62% of the 
variance in adults. These R2 values were comparable to those of Burrows et al 
(88) who used exponential terms of height and age to describe lung function in 
916 non-smokers aged six years and over. The R2 values were also similar to 
those obtained by Thompson et al (1). The standard errors for the models in the 
current study were comparable to many other lung function reference value 
studies (48). Thus the models in the present study probably explained as much 
of the variance in FEV1 and FVC as is possible with linear equations. 
Table 7.7 and figure 7.1 show comparisons of predicted values of FEV1 and FVC 
using the childhood equations from the present study, those of Chandler et al 
(26) and those of Watson et al (52). The values were calculated for children at 
the mean age and height of children in the present study. Both Chandler et al's 
and Watson et al's equations predicted values within the 95o/o CI of the present 
study models. However Chandler et al's equations predicted values within 100 
mls of the present study whereas those of Watson et al did not. The close 
agreement between the present study models and Chandler et al's predictions 
suggested that both models were accurate in mid-childhood. 
Significant differences in predicted spirometric values can occur at the 
"transition" from childhood to adult lung function models (88). Table 7.8 and 
Figure 7.2 show a range of predictions for FEV 1 and FVC at the age of 19 and 20 
years (using the mean height of adult men and women in the present study). 
The predicted values of FEV1 and FVC at age 19, using the childhood equations 
of Chandler et al (26), Watson et al (52) and the present study, are contrasted 
with the predicted values at age 20 using adult equations of the present study 
and Thompson et al (1). These data showed that the childhood equations from 
the present study (at age 19), closely predict the FEV1 and FVC predicted by the 
adult equations from the present study (at age 20) (within 50 mls for males and 
20 mls for females). This consistency suggests that the models developed in the 
present study are robust. Table 7.8 and figure 7.2 also suggest that the models 
of Watson et al, Chandler et al, and Thompson et al do not accurately predict 
ventilatory function in these "transition" years. 
Figures 7.3 to 7.6 compare the predicted spirometric values for adult non-
smokers (at the mean height of adults in the present study) using the equations 
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developed for Aborigines in the present study and by Thompson et al (1), with 
the corresponding values predicted for Caucasians by Morris et al (93). The 
similarity of the predicted values at approximately the mean age of adults (38 
years in men and 34 years in women) between the present study and that of 
Thompson et al suggested that both sets of equations satisfactorily predicted 
spirometric function at this point. However the equations of Thompson et al 
appeared to over-predict ventilatory function in the early adult years and 
exaggerate the decline with age. The validity of the present study's predicted 
values at aged 20 years was enhanced by the concordance with the values 
predicted for 19 year olds by the present study's childhood equations (see 
above). The adult equations of the present study probably predict normal 
spirometric function in Aborigines more accurately than do Thompson et al's 
because the reference population was 50o/o larger, the age distribution was 
wider and subjects with BHR were excluded. 
These data in figures 7.3 to 7.6 also support the observation of Thompson et al 
(1) that FEV1 values in Aborigines are approximately 20% lower than those 
found in Caucasians (of the same standing height, age, and gender), and that 
FVC values are approximately 30% lower. This suggests that Aboriginal 
spirometric volumes are even lower than those found in black Americans, black 
Africans and Indians (48, 83, 84). Although anthropometric differences 
between Aborigines and Caucasians may partially explain the low vital 
capacity (and FEV1), it is possible that compromised lung growth in childhood 
is responsible. Low socio-economic status has been associated with significant 
reductions in FVC in American children (94). It is not known if passive and 
active smoking during childhood, lower respiratory tract infections and other 
factors are affecting lung growth in Aboriginal children. In chapter nine it will 
be shown that petrol sniffing is associated with abnormalities of ventilatory 
function. Whether the small 1 ung volumes in Aborigines are due to 
anthropometric effects, attenuated lung growth or other factors is unresolved. 
The observation that the FVCs of subjects in the present study were 30% lower 
than those found in Caucasians of the same age, gender and height and that 
FEV 1s were only 20% lower (see above) is the most likely reason that the 
FEV1 /FVC ratios in the present study were high (see tables 7.2 and 7.3) in 
comparison with those found in Caucasians (95). This means that ratios that 
would be considered "normal" in Caucasians may not be normal in Aborigines. 
High FEV1 /FVC ratios have also been found in many other non-Caucasian 
races (48) . 
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Cross-sectional studies of 1 ung function are prone to cohort effects and tend to 
over-estimate the true rate of decline of lung function with age (87). It is likely 
that rapid changes in Aboriginal society over recent generations have resulted 
in significant cohort effects which in turn could have influenced pulmonary 
function. Figures 7.3 to 7.6 show that the predicted spirometric values from the 
present study and that of Morris et al, slowly converged with age. This 
suggests that the rate of decline of ventilatory function in healthy adult 
Aborigines is no greater than that in Caucasians. This conclusion contrasted 
with the findings of Thompson et al (1) whose equations suggest Aborigines 
have a greater rate of lung function decline than Caucasians. 
The finding that smokers had larger predicted values for FEV1 and FVC than 
non-smokers was surprising because smokers usually have lower values for 
spirometry than non-smokers (48). However this was partially consistent with 
the findings of Thompson et al (l) although they also found an interaction with 
age that suggested non-smokers had a greater rate of decline in FEV1 and FVC 
than smokers. This was not the case in the present study. The findings in the 
present study could be explained by a health selection effect. It has been 
observed by Gold et al (5) that children previously hospitalised for respiratory 
illness are less likely to commence smoking than children without such a 
history. Gold et al hypothesised that this could produce a "healthy smoker 
effect" where children who are constitutionally less comfortable smoking 
choose not to take up the habit. In the present study, where the prevalence of 
chronic lung disease in non-smokers is high, "healthy smoker effects" could be 
important. Aboriginal people may be less likely to commence or persist with 
cigarette smoking if they have an existing ventilatory impairment. Such a 
health selection effect (bias) could explain why the smokers appeared to have 
better lung function than non-smokers. Alternatively the exclusion criteria 
could have removed smokers with low normal or borderline lung function 
from the reference population leaving asymptomatic smokers with relatively 
good 1 ung function. 
' 
' 
I 
' 
,: 
I 
.... 
1 
I 
II 
,. 
p 
I! 
11 
II 
I 
' 
LI 
Ii 
1! 
II 
~ 
·, 
~ 
11 
11 
II 
II 
Ii 
'I 
~I 
ll 
l~ 
7.6 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
115 
Conclusion 
The equations developed in the present study predict spirometric values 
at the mean height and age of children (and adults) that are similar to 
the findings of other authors. 
The childhood and ad ult equations from the present study predict 
concordant spirometric values at 19 and 20 years of age. 
These spirometric equations predict values at 19 and 20 years of age that 
are discordant with equations developed by previous authors. 
These spirometric equations are probably more valid than previously 
published equations because they were developed from a relatively 
large reference population which was free of symptoms or signs of lung 
disease and BHR. 
Cigarette smokers have higher predicted values of FEV1 and FVC than 
non-smokers. 
The values predicted for FEV 1 in Aborigines by the equations developed 
in the present study are approximately 20o/o lower than those predicted 
for Caucasians of the same height, age and gender. 
The values predicted for FVC in Aborigines by the equations developed 
in the present study are approximately 30% lower than those predicted 
for Caucasians of the same height, age and gender. 
The FEV1 /FVC ratio in healthy Aborigines is higher than that found in 
Caucasians. 
The rate of decline of FEV 1 and FVC in healthy Aborigines appears no 
greater than that observed in Caucasians. 
The rate of decline of FEV 1 and FVC 1n asymptomatic Aboriginal 
smokers appears no greater that found in non-smokers. 
More research is required to investigate the determinants of lung 
function growth and decline in Aborigines. 
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Table 7.7 
Comparison of predicted values of FEV1 and FVC (litres) for the present study, 
Chandler et a l's study (26) and Watson et a l's study (52). Comparison is made at the 
mean age and height for males and females from the present study. 
Males (aged 13, height 153 cm) 
FEV1 
Present study 
Chandler et al 
Watson et al 
FVC 
Present study 
Chandler et al 
Watson et al 
Females (aged 13, height 148 cm) 
FEV1 
Present study 
Chandler et al 
Watson et al 
FVC 
Present study 
Chandler et al 
Watson et al 
Predicted 95% CI 
2.33 
2.28 
1.83 
2.51 
2.58 
2.14 
2.00 
2.03 
1.87 
2.14 
2.04 
2.14 
1.68 - 2.98 
* 
* 
1.78 - 3.24 
* 
* 
1.35 - 2.65 
* 
* 
1.41 - 2.87 
* 
* 
* indicates standard error of estimates was not reported. 
I 
I 
I 
I 
I 
' 
I 
' 
' 
. 
. 
I 
' 
117 
Figure 7.1 
Comparison of predicted FEV 1 and FVC in 13 year old Aboriginal children using the 
equations of Watson et al (52), Chandler et al (26) and the present study. 
Comparison is made at the mean height of male (153 cm) and female (148 cm) 
children from the present study. 
3. 
m Chandler 
0 Veale 
3. 
E3 Watson 
"' Q)
I... 
-
C: 
·- 2. 
Q) 
E 
::J 
-0 
> 2. 
Male FEV1 Male FVC Female FEV1 Female FVC 
Chandler: The predicted values of FEY 1 and FVC using the paediatric equations of 
Chandler et al (26). 
Veale: The predicted spirometric values using the paediatric equations from the present 
study. 
Watson: The predicted spirometric values using the paediatric equations of Watson et al (52) 
The T bars indicate the upper bounds of the 95% confidence interval for Veale. 
FEY 1 and FVC measured in Ii tres. 
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Table 7.8 ' 
Table comparing the predicted spirometric values for non-smokers, at the mean 
height of adults, at the utransition" age of 19 (using the childhood equations of 
' 
Veale, Chandler et al (26) and Watson et al (52)), with the predicted values for non- • 
smokers of the same height but at the age of 20 years (using the adult equations of ,. 
Veale and Thompson et al (1) ). 
I 
Watson* Chandler* Veale Veale Thompson* I 
Age in years 19 19 19 20 20 
Male 175 cm 
' 
FEV1 2.68 3.05 3.45 3.40 3.85 
FVC 3.14 3.51 3.73 3.75 4.39 
Female 160 cm 
FEV1 2.33 2.45 2.55 2.54 2.56 
FVC 2.66 2.5 2.73 2.71 2. 86 
* et al 
All spirometric volumes in litres 
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Figure 7.2 
Graph comparing the predicted spirometric values for non-smokers, at the mean 
height of adults, at the ntransition" age of 19 (using the childhood equations of 
Veale, Chandler et al (26) and Watson et al (52)), with the predicted values for non-
smokers of the same height at the age of 20 years (using the adult equations of Veale 
and Thompson et al (1) ). 
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160 cm 
Watson 19: The predicted spirometric values at age 19 years using the equations of Watson 
et al (52). 
Chandler 19: The predicted spirometric values at age 19 years using the equations of 
Chandler et al (26). 
Veale 19: The predicted spirometric values at age 19 using the paediatric equations from 
the present study. 
Veale 20: The predicted spirometric values at aged 20 using the adult equations from the 
present study. 
Thompson 20: The predicted spirometric values at age 20 using the equations of Thompson et 
al (1 ). 
The T bars indicate the upper bounds of the 95% confidence interval for Veale 19 and Veale 20. 
FEV 1 and FVC measured in litres. 
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Figure 7.3 
Comparison of predicted FEV1 for 175 cm adult non-smoking males using models 
from the present study (Veale), Thompson et al (1) and Morris et al (93). 
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Figure 7.4 
Comparison of predicted FVC for 175 cm adult non-smoking males using models 
from the present study (Veale), Thompson et al (1) and Morris et al (93). 
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Figure 7.5 
Comparison of predicted FEV1 for 160 cm adult non-smoking females using the 
models from the present study (Veale), Thompson et al (1) and Morris et al (93). 
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Figure 7.6 
Comparison of predicted FVC for 160 cm adult non-smoking females using models 
from the present study (Veale), Thompson et al (1) and Morris et al (93). 
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CHAPTERS 
Chronic Cough 
8.1 Introduction 
Chronic cough is an important respiratory symptom that is associated 
with a range of respiratory conditions (96). Jaakkola et al have shown that 
chronic bronchitis (defined by symptoms) in never-smokers and ex-smokers, is 
associated with an accelerated decline of FEV1 with age (97). Thus in 
epidemiological studies the prevalence of chronic cough in never- or ex-
smokers may be an important indicator of the number of non-smoking people 
at risk of either having or developing chronic lung disease. 
In Aboriginal communities the causes, prevalence and significance of chronic 
cough have not been adequately investigated. Such research is important 
because it is readily apparent when visiting Aboriginal communities that cough 
is a common symptom. By studying the prevalence and risk factors 
for chronic cough, and by examining the sensitivity and specificity of chronic 
cough for predicting chronic lung disease (see chapter 9), the author sought 
data that would allow the development of a rational approach to assessing 
chronic cough in isolated communities. 
Many acute and chronic respiratory diseases are associated with the presence 
of excess bronchial secretions or pus and their presence may be detected by 
listening to the quality of a voluntary cough following a deep inspiration. 
Subjects with secretions or pus often have a loose (fruity) sounding cough. It 
has been shown that the detection of an audibly loose cough (positive loose 
cough sign), in the absence of acute respiratory tract infection, correlates with 
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mucus production (98). In the present study a loose cough was interpreted as 
indicating acute or chronic bronchial pathology. 
Petrol sniffing is prevalent among adolescents and young adults in many 
Aboriginal communities (31). The pulmonary consequences of petrol sniffing 
are unknown. In CA4 petrol sniffing is common among 14-25 year olds. In this 
chapter the prevalence of petrol sniffing in CA4 is documented and 
associations with chronic cough and loose cough are exan1ined. 
8.2 Aims 
• 
The aim here was: 
To determine the prevalence of chronic cough and loose cough by age, 
gender, community; 
• To identify the risk factors for chronic and loose cough. 
8.3 Definitions 
Subjects with a history of daily coughing for at least two years were 
defined as having chronic cough. Loose cough was considered to be present 
(positive loose cough test) when a the subject's cough had a moist quality. 
8.4 Methods 
A question was developed to determine the presence of chronic cough. 
Consultation with Ors Thompson and Taylor and staff from the clinics in CYl 
and CY2 confirmed the author's view that the British MRC chronic bronchitis 
question was unsuitable for use in the present study. It was agreed that cough 
is a term understood by most Aboriginal people, either in English or their 
traditional language. Dr Taylor suggested a question be developed in the form 
of a story. Subjects could then be asked if they identified with the cough 
described in the story. The following question was the product of these 
discussions: "Some people cough day after day for years and years. Are you 
like this?" The question was readily understood when pre-tested in CYl and 
CY2. The question had face validity but time did not allow reliability to be 
examined. The cough question was administered at interview via an 
interpreter who understood the purpose of the question. Subjects unable to 
answer the question were coded as unsure. Those coded unsure were grouped 
with those not having the symptom for the ensuing analysis. 
Each subject was examined for the presence of a loose cough by the author who 
was blind to the subject's questionnaire response and current smoking status. 
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Two hundred and thirty six subjects were examined independently by a second 
respiratory physician to assess inter-observer agreement. Kappa scores (for 
inter-observer agreement) were calculated using the n1ethod reviewed by 
Sackett et al (75). 
The method used to determine current smoking status is described in chapter 5. 
The method used to determine whether BHR was present is described in 
chapter 6. To determine if subjects sniffed petrol, a question similar to that 
used to determine alcohol consumption status (see figure 5.1) was used. If 
subjects answered "not at all" then they were regarded as non-sniffers. If they 
said "yes" to any of the other sniffing question options then they were 
identified as petrol sniffers. 
The prevalence of loose cough and chronic cough was determined after 
stratification by age, gender, community and smoking status. An overall 
estimate of the prevalence of each abnormality was also determined after these 
data from all four communities were combined. Chi-square tests were used to 
assess the significance of the differences between the communities. 
Following the uni-variate analyses described above, the "logistic procedure" on 
SAS® (92) was used to calculate adjusted odds ratios for chronic cough and 
loose cough. The outcome variables were coded dichotomously 0/1. The 
independent variables of current smoking status, petrol sniffing status, BHR 
and gender were also coded dichotomously 0/1. Age was treated as a 
continuous variable measured in years. Dummy dichotomous variables were 
created to identify CY2, CA3 and CA4. The parameters were calculated by 
iteratively reweighted least squares and the model fit was assessed using 
maximum likelihood. Coefficients were regarded as significant if p < 0.05. 
Age, gender, BHR, current smoking status, current petrol sniffing status and 
the dummy variables for CY2, CA3 and CA4 were all included in the initial 
models. Current asthma was not considered separately as a risk factor for 
chronic cough or loose cough because it correlated highly with BHR (see 
chapter 6). The least statistically significant variables were removed from the 
models one at a time. 
8.5 Results 
Tables 8.1 to 8.3 show the prevalence of chronic and loose cough by age, 
gender, community and smoking status. Figures 8.1 and 8.2 show these data 
by age, gender and smoking status. 
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8.5.1 Chronic Cough 
In males the prevalence of chronic cough increased with age and was 
similar in smokers and non-smokers (see figure 8.1). There was no significant 
regional variation in the prevalence of chronic cough in male smokers or non-
smokers. 
In females the prevalence of chronic cough increased with age and was higher 
in smokers than in non-smokers (see figure 8.2). There was significant regional 
variation in the prevalence of chronic cough in 20-84 year old female smokers 
(chi-square p < 0.05) (see table 8.3). 
Despite pre-testing, 14% of 5-13 year old children (or their parent or guardian) 
and 2o/o of 14-84 year olds were confused ("unsure") about the chronic cough 
question. The prevalence of loose cough in "unsure" subjects, was not 
significantly different from those without chronic cough. 
8.5.2 Loose Cough 
In males the prevalence of loose cough had an early peak in 14-19 year 
olds and then, following a "trough" in 20-39 year olds, increased in prevalence 
with age (see figure 8.1). The prevalence of loose cough was higher in smokers 
than non-smokers . In male non-smokers there was significant regional 
variation in the prevalence of loose cough at all ages (chi-square p < 0.05) (see 
tables 8.1 to 8.3). Among male smokers there was no significant regional 
variation in the prevalence of loose cough. 
In females the prevalence of loose cough with age followed a similar pattern to 
that of the males although the difference between smokers and non-smokers 
was greater in females (see figure 8.2) . In female non-smokers there was 
significant regional variation in the prevalence of loose cough among 14-19 
year olds and 20-84 year olds (chi-square p < 0.05) (see tables 8.2 and 8.3). In 
female smokers there was no significant regional variation in the prevalence of 
loose cough. 
8.5.3 lnter-o bserver Agreement for Loose Cough 
Two hundred and thirty subjects were examined independently for the 
presence of a loose cough. The Kappa statistic for the level of agreement was 
0.47 (see table 8.4). 
8.5.4 Petrol Sniffing 
The prevalence of self-reported petrol sniffing in 15-25 year olds subjects 
in CA4 was 44% in males and 33 o/o in females (see table 8.5). In CA4 there were 
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no self-reported sniffers under the age of 14 years or over the age of 25 and 
petrol sniffing was unknown in the other communities at the time of the 
present study. Table 8.6 shows the self-reported sniffing pattern among male 
and female sniffers. 
8.5.5 Adjusted Odds Ratios for Chronic and Loose Cough 
The adjusted odds ratios for chronic cough and loose cough are shown 
in table 8.7. Age, petrol sniffing and cigarette smoking were all significantly 
associated with an increase in the odds for chronic cough. There was no 
significant regional variation in the prevalence of chronic cough. Age , petrol 
sniffing and cigarette smoking were also significantly associated with an 
increase in the odds for loose cough. There was significant regional variation in 
the prevalence of loose cough because being from CA3 was associated with a 
reduction in the odds for having this abnormality. 
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Table 8.1 
Prevalence of chronic cough and loose cough in 5-13 year olds by community and 
gender. 
CYl CY2 CA3 CA4 All 95% CI 
Males 
Non-smokers (N) 47 14 42 22 125 NIA 
Smokers (N) 
Chronic Cough 
Non-smokers 8.5 0.0 0.0 9.1 4.8° 1.0-8.6 
Smokers 
Loose Cough 
Non-smokers 10.6 14.3 16.7 45.5 19.2** 12.3-26.1 
Smokers 
Females 
Non-smokers (N) 44 10 37 25 116 NIA 
Smokers (N) 
Chronic Cough 
Non-smokers 9.8 11.1 2.7 4.0 6.3° 1.8-10.8 
Smokers 
Loose Cough 
Non-smokers 13.6 20.0 13.S 24.0 16.4° 9.6-23.1 
Smokers 
Prevalence expressed as the percentage found in smokers and non-smokers. The denominators 
N (for non-smokers and smokers) are located in the first row of each gender stratum. As there 
were only four smokers in this age group their findings are included with the non-smokers. 
o Chi-square for the difference between communities not significant. 
** Chi-square for the difference between communities p < 0.01. 
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Table 8.2 
Prevalence of chronic cough and loose cough in 14-19 year olds by community, 
gender and smoking status. 
CYl CY2 CA3 CA4 All 95% CI 
Males 
Non-smokers (N) 10 4 27 12 53 NIA 
Smokers (N) 10 2 18 13 43 NIA 
Chronic Cough 
Non-smokers 0.0 0.0 7.4 25.0 9.40 1.5-17.2 
Smokers 10.0 0.0 16.7 0.0 9.3° 0.6-17.9 
Loose Cough 
Non-smokers 20.0 0.0 11.1 50.0 20.8* 9.8-31.7 
Smokers 20.0 50.0 27.8 38.5 30.2° 16.4-43.9 
Females 
Non-smokers (N) 11 1 27 14 53 NIA 
Smokers (N) 13 3 7 23 NIA 
Chronic Cough 
Non-smokers 0.0 0.0 4.0 7.1 3.9° 0.0-9.2 
Smokers 30.8 0.0 14.3 22.7° 5.0-40.0 
Loose Cough 
Non-smokers 0.0 0.0 3.7 28.6 9.4 * 1.5-17.2 
Smokers 23.1 33.3 42.9 30.4° 11.6-49.2 
Prevalence data expressed as the percentage found in smokers and non-smokers. The 
denominators N (for non-smokers and smokers) are located in the first row of each gender 
stratum. 
o Chi-square for the difference between communities not significant. 
* Chi-square for the difference between communities p < 0.05. 
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Table 8.3 
Prevalence of chronic cough and loose cough in 20-84 year olds by community, 
gender and smoking status. 
CYl CY2 CA3 CA4 All 95% CI 
Males 
Non-smokers (N) 35 8 31 35 109 NIA . 
Smokers (N) 73 21 47 29 170 NIA 
Chronic Cough 
Non-smokers 14.7 12.5 6.5 17.1 13.0° 6.6-19.3 
Smokers 15.1 10.0 10.6 13.8 13.0° 7.9-18.0 
Loose Cough 
Non-smokers 2.9 25.0 6.5 37.1 16.5*** 9.5-23.4 
Smokers 26.0 19.0 21.3 41.4 26.5° 19.8-33.1 
' 
' 
Females 
Non-smokers (N) 57 9 102 59 227 NIA 
Smokers (N) 78 28 1 18 125 NIA 
' I 
Chronic Cough 
Non-smokers 7.0 0.0 4.9 13.6 7.50 4.0-10.9 
Smokers 14.1 11.1 100.0 5.6 12.9 * 7.0-18.8 
I 
Loose Cough 
Non-smokers 10.5 0.0 7.8 25.4 12.s** 8.4-17.1 
Smokers 33.3 32.0 100.0 22.2 32.0° 23.8-40.0 
Prevalence data expressed as the percentage found in smokers and non-smokers . The 
denominators N (for non-smokers and smokers) are located in the first row of each gender 
stratum. 
o Chi-square for the difference between communities not significant. 
* Chi-square for the difference between communities p < 0.05. 
** Chi-square for the difference between communities p < 0.01. 
*** Chi-square for the difference between communities p < 0.001. 
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Table 8.4 
Inter-observer agreement for loose cough (230 subjects). 
Chance* Observed** Kappa Statistic 
67.5% 83% 0.47 (SE 0.072) 
* = percent agreement expected by chance 
** = percent agreement observed 
*** = 95% Confidence Interval of Kappa Statistic 
Table 8.5 
Petrol sniffing in 14-25 year olds in CA4. 
N Number sniffers 
Males 
Females 
Table 8.6 
39 
42 
17 
14 
95% CI*** 
0.3 - 0.6 
% sniffers 
44 
33 
132 
Self-reported sniffing pattern among 14-25 year old CA4 petrol sniffers as a 
percentage of sniffers by gender. 
Males Females 
A little bit 18.0 57.0 
A moderate amount 12.0 21.5 
Heavily at times 41.0 0.0 
Every day 29.0 21.5 
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Table 8.7 
Adjusted odds ratios for chronic cough and loose cough in 5-84 year olds. 
Chronic Cough 
Age 
Petrol Sniffers 
Cigarette Smokers 
Loose Cough 
Age 
Petrol Sniffers 
Cigarette Smokers 
CA3 
Odds ratio 95% CI p value 
1.02 
3.5 
1.68 
1.01 
3.67 
1.99 
0.60 
1.01-1.03 
1.43-8.68 
1.09-2.58 
1.00-1.02 
1.73-7.79 
1.44-2.76 
0.41-0.89 
< 0.01 
< 0.01 
<0.05 
< 0.05 
< 0.001 
< 0.001 
< 0.05 
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Odds ratio (OR) for age= the increase in odds for outcome with each incremental year of age. 
OR for petrol sniffers = the increase in odds for outcome if the subject was a petrol sniffer. 
OR for smokers= increase in odds for outcome if the subject was a smoker. 
OR for CA3 = the reduction in odds for outcome for subjects tested in CA3. 
The odds ratios for each variable in the model were adjusted for confounding by each other. 
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Figure 8.1 
Chronic cough and loose cough in non-smoking and smoking males by age. 
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Figure 8.2 
Chronic cough and loose cough in non-smoking and smoking females by age. 
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8.6 Discussion 
The pertinent findings were that chronic and loose cough were 
associated with petrol sniffing, cigarette smoking and increasing age. In 
addition the prevalence of loose cough was significantly lower in CA3 
compared with the other three communities and the adjusted odds ratio for 
loose cough associated with the dummy variable for this community was less 
than 1 (see table 8.7). This suggested that the lifestyle or living conditions in 
CA3 were relatively healthy. The generally high prevalence of chronic cough 
in non-smokers suggested that cigarette smoking was not the only important 
risk factor for chronic cough in these communities. These findings (apart from 
the associations with petrol sniffing) were very similar to studies of chronic 
bronchitis and loose cough in Papua New Guinea (PNG) (79). 
These data in tables 8.1 to 8.3 highlight the problem of low numbers and hence 
limited statistical power for researchers of small communities. Despite 
studying over one thousand people, stratification by age, gender, community 
and smoking status, resulted in many cells with low numbers. This was 
particularly the case in CY2. It is recognised that in this situation tests such as 
the chi-square test may be inaccurate, and that logistic regression models may 
be unstable (99, 100). In CY1, CA3 and CA4, where the participation rates were 
high, it is probably legitimate to interpret the prevalence data literally (rather 
than an as estimates) when making comparisons between the communities. 
The data from CY2 were included for completeness but should be interpreted 
with caution because of the poor participation rate. 
Problems were experienced administering the cough question to 5-13 year olds. 
Even with the aid of interpreters it proved difficult to explain the difference 
between a chronic cough (cough every day for years) and a recurrent cough. 
Because "unsures" were coded as not having chronic cough, the prevalence 
data probably under-estimated rather than over-estimated the true prevalence 
of chronic cough. As the prevalence of loose cough in those unsure about the 
chronic cough question was similar to those who denied chronic cough, the 
decision to group unsures with negatives has probabl y not introduced 
important bias. 
A person meeting the criteria for chronic cough in the present study was likely 
also to meet the British MRC criteria for chronic bronchitis because someone 
with daily coughing for two years is likely to have serious lung disease or 
chronic bronchial irritation. By inference the prevalence of chronic bronchitis 
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(MRC definition) in the present study was probably higher than the prevalence 
of chronic cough. This assertion allows some comparison with epidemiological 
studies of chronic bronchitis. 
Petrol sniffing (see tables 8.5 and 8.6) was more prevalent and heavier among 
males than females. Although the scale for petrol sniffing behaviour (like the 
one used for alcohol consumption) is not validated nor standardised and 
combines an assessment of volume and frequency, the findings have some face 
validity and attest to the prevalence of the petrol sniffing in CA4. 
8.6.1 Chronic Cough 
The overall prevalence of chronic cough in the 5-13 year old children 
(<7o/o) was difficult to interpret because of the low numbers and doubts about 
the validity of the question in this age group. In Southhampton (UK) Clifford et 
al (101) found that 18.5% of seven year old non-asthmatic children (n= 1,242), 
and 8.7% of eleven year olds (n=l,218), reported recurrent coughing unrelated 
to upper respiratory tract infections. The lack of respiratory symptom studies 
in other Aboriginal children, make it impossible to make any comparisons 
regarding the prevalence of chronic cough in this age group. 
The prevalence of chronic cough in non-smoking 14-19 year old n1ales in CA4 
(see table 8.2) was high when contrasted with the other three communities. 
Non-smoking adolescents without asthma were expected to have a low 
prevalence of chronic cough because they were beyond the age when childhood 
bronchial infections are prevalent and they didn't smoke. This finding 
suggested that chronic lung disease or bronchial irritants other than smoking 
were prevalent in CA4. 
The prevalence of chronic cough in adult non-smokers was high (see table 8.3) 
when contrasted with the findings in Busselton WA in 1966 where the 
prevalence of chronic bronchitis was 2-3% in non-smokers (102) . In addition, 
the prevalence of chronic cough in adult non-smokers was relatively low in 
CA3, when contrasted with the other three communities. This finding was 
interesting because in chapter 9 it is demonstrated that the prevalence of 
chronic lung disease was also relatively low in this community. 
The multivariate analysis revealed that cigarette smoking, petrol sniffing and 
age were independent risk factors for chronic cough (see table 8.7) . Petrol 
sniffing may partially explain the high prevalence of chronic cough in CA4 14-
19 year old non-smokers (see table 8.2). However, the high prevalence of 
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chronic cough in non-smokers in the communities where petrol sniffing did not 
occur (see table 8.3), suggested that risk factors for chronic cough other than 
petrol sniffing and cigarette smoking were present. 
8.6.2 Loose Cough 
The inter-observer agreement (Kappa statistic 0.47) achieved for loose 
cough was comparable with the findings of Withey et al (103). Withey et al 
examined the repeatability of the loose cough sign in 60 subjects in whom the 
prevalence of loose cough ranged from 17% to 20o/o, and achieved a kappa score 
of 0.53 ( SE of 0.24). Kappa scores ranging from 0.41 to 0.60 were considered by 
Ladis and Koch (76) to indicate moderate strength of agreement. The findings 
in the present study confirm that the loose cough sign is an observation which 
has a moderate level of inter-observer agreement and is suitable for use in 
epidemiological studies of Aboriginal communities. 
The prevalence of loose cough (see tables 8.1 to 8.3) was similar to the findings 
of Torzillo et al (23) and Cullen (102). Torzillo et al examined 1,287 Aboriginal 
people in the Pilbara (WA) and found a loose cough in 15% of 0-19 year olds 
and 20% of adults. It is not known what proportion of the Pilbara subjects were 
smokers. In 1968 Cullen found that 12% of 538 predominantly Caucasian males 
aged 20-39 (and 31 % of 1100 males over the age of 40) from Busselton, WA had 
a positive loose cough sign. The prevalence of smoking in the Busselton males 
was 51 % but the prevalence of loose cough by smoking status was not reported. 
The prevalence of loose cough in the present study was also comparable to the 
results of studies in PNG (79). 
The multivariate analysis showed that cigarette smoking, petrol sniffing and 
age were independent risk factors for loose cough (see table 8.7). However the 
generally high prevalence of loose cough in non-smokers and non-sniffers (see 
table 8.3) suggested that risk factors for loose cough, other than smoking and 
sniffing, were important in these communities. 
Among adults, the regional variation in the prevalence of loose cough reflected 
the regional variation in chronic cough (see table 8.3). The multivariate analysis 
showed that subjects in CA3 were 40% less likely to have loose cough 
(controlling for age, cigarette smoking and petrol sniffing) than subjects in the 
other three communities (see table 8.7). This finding was non-specific because 
loose cough can be secondary to bronchial irritation from inhaled particulate 
matter, bronchial infection, pulmonary infection or chronic lung disease. 
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Nevertheless it does suggest that the people of CA3 were relatively advantaged 
compared with those in the other three communities in terms of lung health. 
8. 7 Con cl us ion 
• Age, petrol sniffing and cigarette smoking were risk factors for chronic 
cough and loose cough. 
• The prevalence of chronic cough and loose cough was high among 
people who did not sniff petrol or smoke cigarettes suggesting that other 
lifestyle or environmental risk factors for chronic lung disease were , , 
• 
• 
• 
present. 
The adjusted odds ratio for loose cough in people from CA3 suggested 
that the lifestyle or environment in that community was relatively 
healthy. 
Petrol sniffing among adolescents in CA4 was prevalent. 
The loose cough sign can be used with a moderate level of inter-observer 
agreement in epidemiological studies of Aboriginal communities. 
' I 
;' 
I 
' 
• 
' 
' 
i 
I 
j, 
' 
.i. 
I 
II 
I 
·r 
140 
CHAPTER9 
Chronic Lung Disease 
9.1 Introduction 
Studies of chronic lung disease (CLO) in Aborigines are needed because 
the relative risk of death from chronic obstructive pulmonary disease (COPD) 
and pneumonia is high in comparison with non-Aboriginal Australians (27). 
Also, many health professionals who have worked in Aboriginal communities 
believe bronchiectasis and COPD are prevalent. 
9.1.1 Definitions 
CLO was the term used in the present study to refer to all lung diseases 
associated with abnormal lung function (ALF). COPD is the diagnosis 
generally given to people who have chronic irreversible airflow obstruction. 
Cigarette smoking is a well recognised cause of COPD. The airflow obstruction 
developed by cigarette s1nokers is probably caused by inflammation and 
fibrosis in respiratory bronchioles, emphysema or both (45). Pathological 
processes that lead to fibrosis of the pulmonary parenchyma or pleura, or 
decreased compliance of the chest wall can lead to a reduced total lung capacity 
and non-obstructive ventilatory defects (so called restrictive ventilatory defect) 
(48). In the present study subjects with non-obstructive ventilatory defects 
were diagnosed as having non-obstructive lung disease (NOLD). 
A variety of definitions have been used to define COPD in epidemiological 
studies of non-Aboriginal people (45). In accordance with ATS guidelines for 
interpreting spirometric function, subjects with a FEV 1,FVC or FEV1/FVC ratio 
greater than two standard deviations below normal were regarded as having 
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abnormal lung function (ALF) (48). Subjects with ALF and an abnormal 
FEY 1 /FYC ratio were diagnosed as having COPD. Subjects with ALF and a 
normal FEY1 /FYC ratio were diagnosed as having NOLD. In this chapter, data 
regarding the prevalence of COPD and NOLD are presented and hypotheses 
regarding the potential causes are explored. 
9.1.2 Potential Risk Factors for CLO 
Studies in other populations suggest that lower respiratory tract 
infections in childhood, cigarette smoking, alcohol consumption and adverse 
living conditions (an unhealthy living environment) are all risk factors for the 
development of CLO. The findings regarding petrol sniffing from the present 
study (see chapter 8) suggest that petrol vapour inhalation may also be a risk 
factor for CLO. These possibilities are discussed further below. 
Gold et al compared spirometric function among Caucasian male non-asthmatic 
children with and without a history of pneumonia or hospitalisation for 
respiratory illness prior to the age of two years (5). Those children with the 
positive history of respiratory illness had mean reductions of FEY 25_75 by 20% 
and FEV 1 by 6o/o up to thirteen years later. Whether or not childhood 
respiratory illness is a risk factor for COPD in adults remains controversial 
(104). It is not known if pneumonia in Aboriginal children is associated with 
spirometric abnormalities or if it is a risk factor for COPD in adults. However 
clinical and radiological studies of Aboriginal adults and children have 
implicated pneumonia as a risk factor for the development of bronchiectasis so 
severe that it caused total lung destruction (see chapter 2). Therefore it is likely 
that a proportion of children with bronchiectasis have ALF that persists into 
adulthood. 
The prevalence of cigarette smoking in many Aboriginal communities is high 
when compared with that found among non-Aboriginal Australians (see 
chapter 5). As smoking is an accepted cause of COPD in other populations (45) 
it is probable that it is also causes COPD in Aborigines. In Aboriginal 
communities cigarette smoking could be influencing the prevalence of CLO by 
augmenting the rate of decline of FEY1 with age in adults (45) or by influencing 
the growth of FEY1 in adolescents (105, 106) . 
Alcohol consumption has been associated with COPD in cohort studies of lung 
function although the mechanism underlying this association is unclear (107). 
Although alcohol use is prevalent in many Aboriginal communities, whether 
this factor has a role in the aetiology of CLO in Aborigines is unknown. 
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The outdoor living environment for many Aboriginal people is polluted by 
high levels of smoke from wood fires and particulate matter in the form of dust 
(11, 28). Whilst indoor smoke from wood fires has been associated with lower 
respiratory tract infections in American Indian children (108) there is little 
evidence that domestic smoke exposure is directly associated with CLD (109). 
Little is known about the effects of chronic inhalation of non-specific dust (110) 
but it has been shown that some dusts are associated with COPD (111). 
Although domestic smoke exposure and environmental dust exposure are 
possible risk factors for CLD in Aboriginal communities, it was beyond the 
scope of the present study to measure exposure to these agents and therefore to 
assess their impact specifically. 
The quality of the indoor living environment and housing may also influence 
the development of CLD but there is little evidence to support this at present 
(112). An assessment of any regional variation in the prevalence of CLD in this 
study provides an opportunity to generate hypotheses regarding the 
importance of environmental factors in the genesis of CLD. However assessing 
the contribution of specific environmental factors is complicated by the 
difficulty of identifying the important elements, quantifying exposure and 
controlling for confounders (110). 
Petrol sniffing is a prevalent activity among adolescents in many communities 
and some sniffers spend up to 24 hours a day inhaling fresh petrol vapour (31). 
In chapter 8 it was shown that petrol sniffing was a risk factor for chronic and 
loose cough. Petrol sniffing may also be a risk factor for CLD. In this chapter 
the relationship between petrol sniffing and ALF is examined. 
9.1.3 Respiratory Symptoms, Signs and CLD 
Although respiratory symptoms and signs are common in Aborigines 
(see chapter 8) their sensitivity and specificity for diagnosing CLD is not 
known. It would be useful for health service staff in remote communities if 
clinical findings could be used to predict ALF as this would assist in the 
identification of people with CLD. For this reason the clinical associations of 
CLD were examined. 
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9.2 Aims 
The aim here was: 
• To determine the prevalence of COPD and NOLD by age, gender and 
community; 
• To identify risk factors for COPD and NOLD; 
• To determine the clinical features of COPD and NOLD . 
9.3 Methods 
The collection of respiratory symptom and sign data is described in 
chapters 6 and 8. The performance of spirometric tests and the method used to 
develop equations to predict FEV1 and FVC are described in chapters 6 and 7. 
Subjects who were unable to blow reproducible forced expirations (ATS 
criteria) were regarded as having technically unsatisfactory spirometric tests 
(91). 
To assess bias resulting from inability to perform spirometric tests to ATS 
criteria (113), the proportion of subjects with technically unsatisfactory 
spirometric tests was documented by age and community. The following 
factors in subjects with technically satisfactory and unsatisfactory spirometric 
tests were examined in four age strata: gender, current smokers, ex-smokers, 
chronic cough, recent wheeze, loose cough, rhonchi and crepitations. 
To explore the risk factors for ALF the prevalence of people who were current, 
ex- or ever-smokers, petrol sniffers and current alcohol users were determined 
for those with and without COPD, NOLD and CLD. Also evidence for regional 
variation in the prevalence of ALF was sought. 
To explore the clinical features of COPD and NOLD the prevalence of chronic 
cough, recent wheeze, loose cough, rhonchi, crepitations, BHR and asthma 
were examined for those with and without ALF. Chi-square or Mantel 
Haenszel chi-square tests were performed to assess the significance of any 
differences between the groups. 
Following the univariate analyses described above, logistic regression using the 
"logistic procedure" on SAS® (92) was used to calculate adjusted odds ratios 
for NOLD, COPD and CLD. The outcome variable was coded dichotomously. 
Current smoking, ex-smoking, ever-smoking, sniffing of petrol, BHR and 
gender were coded dichotomously and used as independent variables. Age in 
years was treated as a continuous variable. Dummy dichotomous variables 
were created to identify CYl, CA3 and CA4. Variables were created to 
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determine if chronic cough, recent wheeze, loose cough, crepitations and 
rhonchi were associated with CLD. The coefficients for each variable were 
calculated by iteratively reweighted least squares and the model fit was 
assessed using maximum likelihood. Coefficients were regarded as significant 
where p < 0.05. Age, gender, BHR, the dummy variables for the communities, 
and the three smoking related variables (one at a time to avoid multiple 
collinearity) were all included in the initial models. The least statistically 
significant variables were removed from the models sequentially. Current 
asthma was not considered separately as a risk factor for CLO because it is 
highly correlated with BHR (see chapter 6). Tests for interactions were not 
performed to keep the models parsimonious and because clinical interpretation 
of significant coefficients would have been problematic. 
9.4 Results 
9.4.1 FEV/FVC Ratio in Adults and Children 
Table 9.1 presents the mean FEV1/FVC ratios in the reference population 
(see chapter 7) stratified by age. The mean FEV1 /FVC ratio in 7-19 year old 
children was 93.7% (SD 5.lo/o). The mean FEV1 /FVC ratio in 20-70 year olds 
was 89.8 o/o (SD 7.1 %). Using the definition outlined above it follows that 7-19 
year olds with FEV1 /FVC ratios below 83.5% and 20-70 year olds with 
FEV1 /FVC ratios below 75.6% had ALF. 
9.4.2 Prevalence of Unsatisfactory Spirometric Function 
The prevalence of subjects with technically unsatisfactory spirometric 
function stratified by age and community is shown in table 9.2. In sixty 
subjects either the FEV1 or FVC was not reproducible but the other index was 
satisfactory. These people were included in the technically satisfactory group. 
Table 9.3 shows the prevalence of current smokers, ex-smokers, chronic cough, 
recent wheeze, loose cough, rhonchi and crepitations in subjects with 
technically satisfactory and unsatisfactory spirometric tests stratified by age. 
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Table 9.1 
Mean observed FEY 1/FYC ratios for children and adults in the reference population. 
FEY 1 /FYC ratio 
Age (Years) N Mean SD 
Children 
7-9 56 94.4 4.4 
10-12 73 92.8 5.7 
13-15 63 93.8 5.1 
16-19 69 93.8 4.9 
7-19 261 93.7 5.1 
Adults 
20-30 146 90.9 5.9 
31-40 50 90.2 6.6 
41-50 82 87.9 7.6 
51-60 39 88.3 9.3 
61-70 14 87.1 9.1 
20-70 331 89.8 7.1 
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Table 9.2 
Prevalence of technically unsatisfactory spirometric tests by age and community. 
Age group N* Tu** %Tut TS# 
7-19 
CYl 
CY2 
CA3 
CA4 
All 
20-39 
CYl 
CY2 
CA3 
CA4 
All 
40-59 
CYl 
CY2 
CA3 
CA4 
All 
60-84 
CYl 
CY2 
CA3 
CA4 
All 
* 
** 
t 
# 
164 30 18 134 
48 14 29 34 
153 7 5 146 
86 4 5 82 
451 55 12 396 
161 13 8 148 
59 14 24 45 
111 2 2 109 
81 2 2 79 
412 31 7 381 
85 13 15 72 
30 11 37 19 
54 1 2 53 
50 3 6 47 
219 28 13 191 
32 9 28 23 
9 7 88 2 
20 1 5 19 
18 3 17 15 
79 20 25 59 
Number of participants by community. 
Number of participants with technically unsati sfactory spirometric tests . 
% of subjects with technically unsatisfactory spirometric tests. 
Number of participants with technically satisfactory tests. 
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Table 9.3 
I 
Prevalence of exploratory variables (as a percentage) in subjects with and without '' 
technically satisfactory spirometric tests by age. 
Technically Technically Chi-square* 
satisfactory unsatisfactory 
7-19 Year olds N=396 N=55 
I~ Females 47 47 
' Current smokers 17 4 p < 0.05 
Ex-smokers 1 1 
Chronic cough 7 7 
! Recent Wheeze 4 0 
Loose Cough 18 24 
Rhonchi 5 4 
Crepitations 2 2 
I 
,1 20-39 Year olds N=381 N=31 
Females 60 64 
Current smokers 53 61 
I 
Ex-smokers 8 13 
Ii 
: Chronic cough 8 17 
1: Recent Wheeze 8 13 I 
Loose Cough 16 10 
Rhonchi 3 0 
Crepitations 4 3 
40-59 Year olds N=191 N=28 
Females 54 46 
Current smokers 41 39 
Ex-smokers 16 32 p < 0.05 
Chronic cough 16 32 p < 0.05 
Recent Wheeze 14 18 
Loose Cough 28 32 
Rhonchi 9 14 
Crepitations 7 18 p < 0.05 
60-84 Year olds N=59 N=20 
Females 34 35 
Current smokers 24 60 p < 0.01 
I I 
(: Ex-smokers 20 5 
1, 
' I Chronic cough 12 17 
I 
Recent Wheeze 22 5 
I 
Loose Cough 25 45 
' 
'· Rhonchi 10 15 
Crepita tions 27 15 
* chi-square for the significant differences between the two groups. 
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9.4.3 Abnormal Lung Function 
A total of 49 subjects had COPD and the mean FEV 1 / FVC ratio in this 
group was 66% (SD 6.2). A total of 45 subjects had NOLD and the mean 
FEV 1 /FVC ratio in this group was 91 o/o (SD 6.9). Figure 9.1 shows the 
prevalence of ALF stratified by age and gender. Figures 9.2 and 9.3 show the 
prevalence of ALF stratified by age and community for males and females. 
9.4.4 ALF in 7-19 and 20-39 year olds 
Table 9.4 shows the prevalence of COPD and NOLD in 7-19 and 20-39 
year olds stratified by community and gender. Tables 9.7 and 9.8 show the 
distribution of the "exploratory variables" for those with COPD, NOLD and 
normal 1 ung function in these age groups. In 7-19 year olds sniffing petrol, 
recent wheeze and loose cough were significantly more prevalent among those 
with ALF. In 20-39 year olds BHR, asthma, recent wheeze, and crepitations 
were more significantly prevalent among those with ALF. 
9.4.5 ALF in 40-59 and 60-84 year olds 
Table 9.5 shows the prevalence of COPD and NOLD in 40-59 and 60-84 
year olds stratified by community and gender. Tables 9.9 and 9.10 show the 
prevalence of the exploratory variables for these age groups. In 40-59 year olds 
ex-smokers, rhonchi and crepitations were more prevalent among those with 
ALF. In 60-84 year olds BHR, asthma and recent wheeze were more prevalent 
in those with ALF. 
9.4.6 ALF in 20-84 year olds 
Table 9.6 shows the prevalence of COPD and NOLD in 20-84 year olds 
stratified by community and gender. This table was included as a summary for 
adults. Table 9.11 shows the prevalence of the exploratory variables in this 
group by ALF status. In 20-84 year olds ex-smokers, BHR, asthma, recent 
wheeze, loose cough, rhonchi and crepitations were more prevalent among 
those with ALF. Current alcohol use was least prevalent among those with 
CLD. 
9.4.7 Prevalence of COPD by Age, Gender and Region 
Figure 9.4 shows the prevalence of COPD stratified by age and gender. 
Figures 9.5 and 9.6 show the prevalence of COPD stratified by age and 
community for males and females. 
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9.4.8 Adjusted Odds Ratios for CLD (ALF), COPD and NOLD 
The adjusted odds ratios for CLD, COPD and NOLD are shown in table 
9.12. Increasing age, ex-smoking, BHR and petrol sniffing were associated with 
increased odds for having CLD. A reduction in the odds for CLD was 
associated with living in CA3. 
Increasing age, ex-smoking and BHR were associated with an increase in the 
odds for having COPD. Living in CA3 was associated with a reduction in the 
odds. Gender was not an independent predictor for COPD. 
Male gender and sniffing petrol were independent risk factors for NOLD. Age 
was not an independent predictor for this abnormality. Living in CYl was 
independently associated with a significant reduction in the odds for having 
NOLD. 
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Table 9.4 
Prevalence of Abnormal Lung Function in 7-19 year olds and 20-39 year olds by 
gender and community. 
N % NOLDt %COPD %CLO 95% cr0 
Males 7-19 
CYl 66 1.5 0.0 1.5 0.0-4.4 
CY2 20 0.0 0.0 0.0 0.0-14.5 
CA3 85 5.9 0.0 5.9 0.9-10.9 
CA4 39 23.1 0.0 23.1 9.8-36.3 
All 210 7.1 0.0 7.1 3.6-10.6 
Females 7-19 
CYl 68 0.0 0.0 0.0 0.0-5.3 
CY2 14 14.3 0.0 14.3 0.0-32.6 
CA3 61 1.6 0.0 1.6 0.0-4.7 
CA4 43 2.3 0.0 2.3 0.0-6.8 
All 186 2.2 0.0 2.2 0.0-4.3 
Males 20-39 
CYl 57 0.0 8.8 8.8 1.5-16.2 
CY2 18 0.0 0.0 0.0 0.0-15.0 
CA3 46 6.5 4.3 10.8 1.8-19.8 
CA4 31 19.4 0.0 19.4 5.5-33.3 
All 152 5.9 4.6 10.5 5.6-15.4 
Females 20-39 
CYl 91 1.1 1.1 2.2 0.0-5.2 
CY2 27 3.7 0.0 3.7 0.0-10.8 
CA3 63 0.0 4.8 4.8 0.0-10.1 
CA4 48 4.2 0.0 4.2 0.0-9.9 
All 229 1.7 1.7 3.4 1.1-5.7 
t Non-obstructi ve lung d isease. 
a 95% confidence interva l of the percentage w ith CLO. 
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Table 9.5 
Prevalence of Abnormal Lung Function in 40-59 year olds and 60-84 year olds by 
gender and community. 
N % NOLDt %COPD %CLO 95 % CI 0 
Males 40-59 
CYl 31 0.0 29.0 29.0 13.1-44.9 
CY2 9 0.0 22.2 22.2 0.0-49.3 
CA3 24 4.2 8.3 12.5 0.0-25.7 
CA4 24 33.3 12.5 45.8 0.0-65.7 
All 88 10.2 18.2 28.4 18.9-37.8 
Females 40-59 
CYl 41 2.4 19.5 21.9 9.2-34.5 
CY2 10 0.0 20.0 20.0 0.0-44.8 
CA3 29 0.0 0.0 0.0 0.0-11.1 
CA4 23 0.0 4.3 4.3 0.0-12.6 
All 103 1.0 10.7 11.7 5.5-17.9 
Males 60-84 
CYl 20 5.0 40.0 45.0 23.2-66.8 
CY2 2 0.0 0.0 0.0 0.0-51.0 
CA3 8 0.0 12.5 12.5 0.0-35.4 
CA4 9 22.2 11.1 33.3 2.5-64.1 
All 39 7.7 25.6 33.3 18.5-48.1 
Females 60-84 
CYl 3 0.0 0.0 0.0 0.0-43.9 
CY2 
CA3 11 0.0 0.0 0.0 0.0-27.7 
CA4 6 0.0 16.7 16.7 0.0-46.5 
All 20 0.0 5.0 5.0 0.0-14.5 
t Non-obstructive lung disease. 
a 95% confidence interval of the percentage with CLD. 
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Table 9.6 
Prevalence of Abnormal Lung Function in 20-84 year olds by gender and 
community. 
N % NOLDt %COPD %CLO 95 % CI 0 
Males 20-84 
., 
CYl 108 0.9 20.4 21.3 13.6-29.2 
: 
I CY2 29 0.0 6.9 6.9 0.0-16.1 
CA3 78 5.1 6.4 11.5 4.4-18.6 
CA4 64 25.0 6.3 31.3 19.9-42.6 
I! 
II All 279 7.5 11.8 19.3 14.8-23.9 
" 
Females 20-84 
u CYl 135 1.5 6.7 8.2 3.6-12.8 
I 
CY2 37 2.7 5.4 8.1 0.0-16.9 
CA3 103 0.0 2.9 2.9 0.0-6.1 
CA4 77 2.6 2.6 5.2 0.0-10.2 
All 352 1.4 4.5 5.9 3.4-8.4 
t Non-obstructive lung disease. 
,I 
a 95% confidence interval of the percentage with CLD. 
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Table 9.7 
Prevalence of exploratory variables (as a percentage) in 7-19 year olds by Abnormal 
Lung Function status. 
Normal NOLDt COPD Chisqt 
N 377 19 0 
Current smoker 16.4 21.0 
Ex-smoker 1.3 0.0 
Ever-smoker 17.8 21.1 
Petrol sniffer 4.8 26.3 p < 0.001 
Alcohol drinker 13.5 26.3 
BHR 0.8 0.0 
Asthma 0.3 0.0 
Chronic cough 6.8 11.1 
Recent wheeze 3.5 15.8 p < 0.01 
Loose cough 16.5 47.4 p < 0.001 
Rhonchi 5.1 10.5 
Crep ita ti ons 1.9 0.0 
t Non-obstructive lung disease. 
t The probability that the differences between the groups are significan t using chi-square 
or Mantel-Haenszel chi-square. 
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Table 9.8 
Prevalence of exploratory variables (as a percentage) in 20-39 year olds by Abnormal 
Lung Function status. 
N 
Current smoker 
Ex-smoker 
Ever-smoker 
Petrol sniffer 
Alcohol drinker 
BHR 
Asthma 
Chronic cough 
Recent wheeze 
Loose cough 
Rhonchi 
Crepitations 
Normal 
357 
52.9 
7.8 
60.8 
2.2 
57.1 
2.8 
1.1 
8.2 
7.0 
16.3 
2.5 
3.1 
t Non-obstructive lung disease. 
NOLDt 
13 
61.5 
7.7 
69.2 
0.0 
61.5 
23.1 
7.7 
7.7 
7.7 
30.8 
7.7 
23.1 
COPD 
11 
54.6 
9.1 
63.6 
0.0 
54.6 
36.4 
18.2 
9.1 
27.3 
9.1 
0.0 
9.1 
Chisqt 
p < 0.001 
p < 0.001 
p < 0.05 
p < 0.01 
t The probability that the differences between the groups are significant using chi-square 
or Mantel-Haenszel chi-square. 
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Table 9.9 
Prevalence of exploratory variables (as a percentage) in 40-59 year olds by Abnormal 
Lung Function status. 
N 
Current smoker 
Ex-smoker 
Ever-smoker 
Petrol sniffer 
Alcohol drinker 
BHR 
Asthma 
Chronic cough 
Recent wheeze 
Loose cough 
Rhonchi 
Crepitations 
Normal 
154 
40.3 
13.0 
53.3 
0.0 
37.0 
5.2 
2.0 
15.7 
12.3 
26.6 
7.1 
3.9 
t Non-obstructive lung disease. 
NOLDt 
10 
30.0 
30.0 
60.0 
0.0 
30.0 
0.0 
0.0 
30.0 
10.0 
50.0 
0.0 
10.0 
COPD 
27 
48.2 
29.6 
77.8 
0.0 
25.9 
14.8 
3.7 
14.8 
22.2 
29.6 
22.2 
22.2 
Chisqt 
p < 0.05 
p < 0.05 
p < 0.01 
t The probability that the differences between the groups are significant using chi-square 
or Mantel-Haenszel chi-square. 
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Table 9.10 
Prevalence of exploratory variables (as a percentage) in 60-84 year olds by Abnormal 
Lung Function status. 
N 
Current smoker 
Ex-smoker 
Ever-smoker 
Petrol sniffer 
Alcohol drinker 
BHR 
Asthma 
Chronic cough 
Recent wheeze 
Loose cough 
Rhonchi 
Crep ita ti ons 
Normal 
45 
20.0 
15.6 
35.6 
0.0 
17.8 
4.4 
4.4 
8.9 
13.3 
24.4 
6.7 
26.7 
t Non-obstructive lung disease. 
NOLDt 
3 
33.3 
33.3 
66.7 
0.0 
0.0 
0.0 
0.0 
0.0 
33.3 
66.7 
33.3 
0.0 
COPD 
11 
36.4 
36.4 
72.7 
0.0 
9.1 
36.4 
27.3 
27.3 
54.6 
18.2 
18.2 
36.4 
Chisq+ 
p < 0.01 
p < 0.05 
p < 0.05 
+ The probability that the differences between the groups are significant using chi-square 
or Mantel-Haenszel chi-square. 
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Table 9.11 
Prevalence of exploratory variables (as a percentage) in 20-84 year olds by Abnormal 
Lung Function status. 
N 
Current smoker 
Ex-smoker 
Ever-smoker 
Petrol sniffer 
Alcohol drinker 
BHR 
Asthma 
Chronic cough 
Recent wheeze 
Loose cough 
Rhonchi 
Crepitations 
Normal 
556 
46.8 
9.9 
56.7 
1.4 
48.4 
3.6 
1.6 
10.3 
9.0 
19.8 
4.2 
5.2 
t Non-obstructive lung disease. 
NOLDt 
26 
46.2 
19.2 
65.4 
0.0 
42.3 
11.5 
3.9 
15.4 
11.5 
42.3 
8.0 
15.4 
COPD 
49 
46.9 
26.5 
73.5 
0.0 
28.6 
24.5 
12.2 
16.3 
30.6 
22.5 
16.3 
22.5 
Chisq+ 
p < 0.005 
p < 0.05 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.05 
p < 0.005 
p < 0.001 
t The probability that the differences between the groups are significant using chi-square 
or Mantel-Haenszel chi-square. 
Figure 9.1 
Prevalence of Chronic Lung Disease (ALF) by age and gender. 
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Figure 9.2 
Prevalence of Chronic Lung Disease (ALF) in males by age and community. 
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Figure 9.3 
Prevalence of Chronic Lung Disease (ALF) in females by age and community. 
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Figme 9.4 
Prevalence of COPD by age and gender. 
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Figure 9.5 
Prevalence of COPD in males by age and community. 
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Figure 9.6 
Prevalence of COPD in females by age and community. 
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Table 9.12 
Adjusted odds ratios for Chronic Lung Disease, COPD and Non-obstructive Lung 
Disease (NOLD). 
CLD (ALF) 
Age 
CA3 
Ex-Smokers 
Petrol Sniffers 
BHR 
COPD 
Age 
CA3 
Ex-smokers 
BHR 
NOLD 
Males 
Petrol Sniffers 
CY1 
Odds ratio 
1.04 
0.5 
2.2 
4.2 
5.7 
1.07 
0.4 
2.3 
9.1 
4.6 
3.0 
0.17 
95% CI 
1.03-1.06 
0.3-0.9 
1.1-4.1 
1.5-11.8 
2.7-12.0 
1.05-1.09 
0.2-0.9 
1.1-5.1 
3.7-22.1 
2.2-9.7 
1.1-8.4 
0.06-0.49 
Odds ratio for males= the increase in odds for ALF in males. 
p value 
p < 0.0001 
p < 0.05 
p < 0.05 
p < 0.01 
p < 0.0001 
p < 0.0001 
p < 0.05 
p < 0.05 
p < 0.0001 
p < 0.0001 
p < 0.05 
p < 0.001 
Odds ratio for CYl = the reduction in odds for ALF for subject resident in CYl. 
Odds ratio for petrol sniffers = the increase in odds for ALF if subject sniffed petrol. 
Odds ratio for age= the increase in odds for ALF with each incremental year of age. 
Odds ratio for CA3 = the reduction in odds for ALF for subject resident in CA3. 
Odds ratio for ex-smokers= increase in odds for ALF if subject was an ex-smoker. 
Odds ratio for BHR = the increase in odds for ALF if PD20FEV1 was < 3.9 µmols histamine. 
The odds ratios in the models are adjusted for confounding by each identified variable. 
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9.5 Discussion 
The critical observations about CLO were that the western lifestyle of 
CYl was associated with a high prevalence of COPD and a low prevalence of 
NOLD and that the lifestyle in CA3 and CA4 was associated with less COPD 
but a higher prevalence of NOLD. The multivariate analysis and the 
distribution of disease between the communities suggested that cigarette 
smoking was a risk factor for COPD and that petrol sniffing was a risk factor 
for NOLD. There was no evidence that current alcohol use was directly 
associated with CLO. 
9.5.1 Technical Issues 
In CY2 the high technically unsatisfactory proportion (and the relatively 
poor participation rate) precluded the drawing of firm conclusions about the 
prevalence of CLO in that community (see table 9.2). The relatively high rates 
of technically unsatisfactory spirometric tests in CY2 (and to a lesser extent in 
CYl) were due to embarrassment about performing the tests, particularly 
among adolescents, and failure to comprehend the instructions regarding the 
manoeuvres (eg taking in a full breath). Also they may have reflected the high 
prevalence of CLO because these data in table 9.3 show that a high percentage 
of 40-59 year old people with unsatisfactory spirometric tests were ex-smokers. 
Later in this chapter it is shown that ex-smokers were at increased risk of 
having CLO. Data from CY2 were included in this chapter for completeness. 
The proportions with technically unsatisfactory tests in CA3 and CA4 were 
low. It is unlikely that technical difficulties in the present study lead to over 
estimation of the prevalence of CLO. 
Although subjects in the present study were divided into those with COPD and 
NOLD, some of the people with COPD may have had a mixed ventilatory 
defect with a low FEV1 and FVC and abnormal FEV 1/FVC ratio. The author 
elected to ignore this distinction because further sub-division into other 
categories of CLO would have created smaller groups and analytical problems. 
9.5.2 Prevalence of COPD 
Table 9.4 shows that none of the 7-19 year old children had COPD. The 
overall prevalence of COPD among adults (see table 9.6) was high in 
comparison with most population-based studies performed in the United States 
of America (USA) where the prevalence of doctor diagnosed emphysema or 
ventilatory impairment (usually FEV 1 less than 60 or 65% predicted) has been 4 
to 6o/o among adult men and 1 to 3% for women (45). Although the criteria for 
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defining COPD in these studies differed from those in the present study, the 
comparison suggests that the prevalence of COPD in the present study was 
high. 
The increase in the prevalence of COPD with age (see figures 9.4 to 9.6) was 
consistent with the results of studies of CLD in Papua New Guinea (79) and 
COPD in the USA (45). The increase is probably a manifestation of 
accumulating exposure to risk factors for COPD with age. 
9.5.3 Prevalence of NOLD 
No comparable epidemiological studies of NOLD in other populations 
were located. Clinical experience suggests that the prevalence of NOLD in 
non-Aboriginal Australians is considerably less than the prevalence of COPD. 
In men, the overall prevalence of NOLD was 7.1 o/o in 7-19 year olds and 7.5 % in 
20-84 year olds. This was probably higher than would be found if studies of 
NOLD were performed among non-Aboriginal Australians. One of the 
interesting features of NOLD was marked regional variation in the prevalence 
among males. The prevalence was very high in CA4 and low in CY1. In CA3 
males the prevalence was higher than in CY1 but starkly less than that in CA4. 
The low prevalence of NOLD in CY1 and the reduction in odds for NOLD 
associated with living in that community (see table 9.12) suggests that life in 
this community conferred some protection against the development of this type 
of disease. This is discussed further in section 9.5.5 which examines the 
possible causes of NOLD 
The overall prevalence of NOLD in females aged 7-19 years was 2.2% and 
among 20-84 year olds was 1.4%. Mirroring the finding in men, the prevalence 
of NOLD among women from CY1 was low. Although NOLD in females was 
significantly less prevalent than in males, the prevalence was probably higher 
than would be anticipated among non-Aboriginal Australians. 
The prevalence of NOLD did not significantly increase with age in contrast to 
the prevalence of COPD. This suggests that the disease(s) that cause NOLD in 
the present study possibly had their genesis early in life rather than as a result 
of accumulating exposure to risk factors for lung disease. 
9.5.4 The Associations and Clinical Features of COPD 
The adjusted odds ratio for COPD in ex-smokers suggested that these 
people were 130% more likely to have COPD than current smokers or never-
smokers (see table 9 .12). This was cir cums tan tial evidence that cigarette 
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smoking is an important risk factor for COPD and that subjects with COPD are 
more likely to give up smoking than those without this disease. The failure of 
current smoking to be directly associated with COPD may have reflected the 
dichotomous coding for smoking status, the low numbers of cigarettes 
consumed daily by some smokers (see chapter 5) and the verity that studies of 
non-Aboriginal people reveal only a minority of smokers eventually develop 
abnormal 1 ung function ( 45). In addition it is recognised that the signal to noise 
ratio in cross-sectional studies* designed to measure the impact of smoking is 
high because of individual variation in lung function and confounding (111). 
The second observation that suggested cigarette smoking was a risk factor for 
COPD was that the prevalence of COPD was highest in CYl where the 
prevalence of smoking was high (68o/o in males and 56% in females) and 
conversely the prevalence of COPD was lowest among CA3 and CA4 females 
where smoking was least prevalent. 
Although the conclusion that cigarette smoking was a cause of COPD has 
biological credibility (because it is a recognised cause of COPD in non-
Aboriginal people), the present study design and numbers did not allow an 
assessment of the temporal relationship between cigarette smoking and COPD 
nor of dose response. Further research is required to examine longitudinally 
the impact of cigarette smoking on Aboriginal lung function and to determine 
if there are factors (eg NOLD in childhood) that put some smokers at particular 
risk for developing COPD. 
The prevalence of BHR among those with COPD was significantly higher than 
in those without CLD (see tables 9.11 and 9.12). This partly reflected the 
finding that approximately 12% of those with COPD had asthma. However in 
1985 Yan et al observed that the prevalence of BHR (PD20FEV1 less than 3.9 
µmols of histamine) was 45% among non-asthmatic adults with respiratory 
symptoms and FEV1/FVC ratios less than 70% (90). In the present study the 
prevalence of BHR among those with COPD was comparatively low. 
BHR in non-Aboriginal people has been associated with cigarette smoking, 
airways inflammation and airflow obstruction but the inter-relationships 
* Longitudinal studies, by diminishing the noise of variation in lung function between 
individuals, are superior to cross-sectional studies for detecting the spirometric effects of 
smoking. 
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between these factors are complex and poorly understood (45). In the study by 
Yan et al cited above, 87o/o of the subjects with COPD were ever-smokers 
whereas in the present study the prevalence of ever-smokers among those with 
COPD was 73% (see table 9.11). This small difference in the prevalence of ever-
smokers between these two studies was an unlikely explanation for the low 
prevalence of BHR among those with COPD in the present study. However the 
low prevalence of BHR may be an indication that the mix of pathological 
conditions that underlie COPD in the present study was different from the Yan 
et al study and that more subjects in the present study had disease that was not 
due to cigarette smoking (or asthma). 
, 
The low adjusted odds ratios for COPD (and CLO) for subjects from CA3 (see , 
table 9.12 and figures 9.2, 9.3, 9.5 and 9.6) supported anecdotal reports of a low 
prevalence of CLO in that community (see chapter 3). The adjusted odds ratio 
showed that CA3 subjects were 50-60% less likely to have COPD (and CLO) 
than subjects in the other three communities. However the apparent protective 
effect was not strong and so could be secondary to sampling bias despite the 
high participation rate. Furthermore although the odds for COPD was reduced 
in this community, the prevalence of COPD was still at least as high as that 
found in the USA and 5-6% of men had NOLD. In conclusion it is tentatively 
concluded that the lifestyle in CA3 was associated with factors which confer 
some protection against the development of COPD. 
The reasons for the apparently reduced odds for having COPD for people from 
CA3 are not known. The prevalence of COPD (2.9%) in CA3 women could be 
viewed as a baseline prevalence (without the influence of smoking) because 
only one woman smoked. The people of CA3 were probably exposed to similar 
amounts of environmental dust and smoke as people in other communities so it 
is unlikely that confounding by these agents reduced the odds for COPD in this 
community. It was noteworthy that in CA3 there was a difference in 
prevalence of both COPD and NOLD between men and women. As the men 
and women of CA3 shared the same environment, the most noticeable 
difference between the two groups was that 56% of men and 1 % of women 
smoked. This could be interpreted as suggesting that either men in this 
community had some constitutional susceptibility to COPD"" from factors other 
"" Although in the present study the prevalence of COPD was higher in males than females, (see 
figure 9.1) the multivariate analysis did not show that male gender was an independent risk 
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than smoking, or as further evidence that smoking was an important cause of 
COPD in CA3. If smoking was an important cause of COPD in all the 
communities studied then the reduced odds for COPD in CA3 might be 
partially a product of confounding by regional variation in smoking pattern 
(see chapter 5). It is possible that the lifestyle in CA3 conferred protection 
against the development of COPD by fostering a cultural milieu which limits 
the use of substances that cause COPD. 
In PNG COPD has been found to be more prevalent in women than men, to 
increase in prevalence with age and be unrelated to smoking home grown 
tobacco (brus) (79). In PNG domestic wood smoke pollution and lower 
respiratory tract infections in infancy have been considered aetiological 
possibilities for COPD but no firm conclusions have been reached regarding 
their roles. The findings in the present study confirm that factors other than 
cigarette smoking may cause COPD. Further research is required to identify 
these factors. 
Table 9.11 shows that the symptoms and signs recorded in the present study 
had low sensitivities for detecting COPD. Only 20% of subjects reported 
chronic cough, 30% recent wheeze and less than 25o/o had loose cough or 
abnormalities of auscultation. These low sensitivities suggest that 
measurement spirometric function is necessary to detect COPD. The 
prevalence of chronic cough among those with COPD was lower than clinical 
experience might predict. The low prevalence may reflect the constraining 
criteria for a positive response to the question. The chronic cough question 
used in the present study appears to have little clinical utility. 
9.5.5 The Associations and Clinical Features of NOLD 
One of the remarkable findings about NOLD was the high prevalence in 
CA4 males (see table 9.4 and 9.6). The multivariate analysis revealed that male 
gender and sniffing petrol were significant risk factors for this disorder and 
that living in CA4 was not an independent risk factor (see table 9.12). 
Theoretically petrol sniffing could cause NOLD by promoting the development 
of pulmonary fibrosis or by significantly retarding the growth of FEV1 and FVC 
during the adolescent years. The high prevalence of NOLD in the CA4 adults 
could be due to a high prevalence of people who had previously sniffed petrol. 
The strength of the relationship between petrol sniffing and NOLD and the 
factor. This suggested that ma1es did not have any constitutional predisposition for developing 
COPD. 
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biological plausibility that this noxious substance might damage pulmonary 
tissue suggests that sniffing petrol is a risk factor for NOLD in Aboriginal 
communities. Although sniffing petrol was strongly associated with NOLD, 
only 26o/o of 7-19 year olds with NOLD were current sniffers suggesting that in 
this age group other aetiological factors were also important. 
Bronchiectasis in Aboriginal communities has been associated with poor living 
conditions, early lower respiratory tract infections with concurrent 
dehydration, unspecified spirometric abnormalities and lung destruction (see 
chapter 2). In non-Aboriginal people with bronchiectasis, abnormalities of 
ventilatory function are commonly seen but no specific pattern of pulmonary 
dysfunction is recognised (114). Most patients with diffuse bronchiectasis have 
airflow obstruction but those with large amounts of atelectasis and fibrosis may 
have mixed obstructive/restrictive patterns or a largely restrictive pattern. 
Given that pneumonia is known to be prevalent and often recurrent in some 
Aboriginal communities (see chapter 2) it is possible that bronchiectasis (or 
some more subtle pathophysiological consequence of childhood pneumonia) 
could be an important cause of NOLD in the present study. 
The prevalence and adjusted odds ratio for NOLD for people living in CY1 
were low (see tables 9.4, 9.6 and 9.12). The magnitude of the reduction in the 
prevalence and the high participation rate in CY1 meant it was unlikely that 
sampling bias accounted for the finding. Because some NOLD was possibly a 
manifestation of pulmonary damage caused by early childhood pneumonia (eg 
bronchiectasis) the low prevalence of NOLD in CY1 may be secondary to the 
low prevalence of pneumonia*. The relatively good standard of housing in CY1 
maybe the reason the prevalence of pneumonia in childhood was reported to 
be low in that community. Conversely it follows that the poorer standard of 
housing in CA3 and CA4 and the coexistent high incidence of lower respiratory 
tract infections in childhood might partially explain the higher prevalence of 
NOLD in those communities. 
The inference from the present study that housing conditions influence the 
prevalence of pneumonia and NOLD together with the observation by Harris et 
* In chapter three it was noted that community health service staff had observed that 
pneumonia in childhood was uncommon in CY1 and CY2, common in CA3 (but rarely serious 
enough to cause evacuation) and common CA4 (and often serious enough to require 
evacuation to Alice Springs). 
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al (53) that the incidence of hospitalisation for pneumonia in Bourke children 
fell following housing improvements from 1968-69 to 1983-84 (see chapter 2) 
provide support for the notion that there is a causal link between living 
conditions for Aboriginal people and the prevalence of lung disease. 
The prevalence of BHR among those with NOLD was low at 11.5%. None of 
the children with NOLD had BHR. Of the adults with NOLD, 3.So/o had 
asthma. The findings regarding BHR in NOLD suggest that most of the people 
with this type of ventilatory impairment did not have associated airways 
inflammation. 
Among the 7-19 year olds with NOLD, 11 % had chronic cough, 16% had recent 
wheeze, 47% had loose cough, 11 % had rhonchi and none had crepitations (see 
table 9.7). It is likely that the low prevalence of chronic cough reflected the 
stringent criteria that were required for a positive response in the 
questionnaire. The clinical findings in the adults with NOLD were similar to 
the 7-19 year olds although crepitations were heard in 15% of the subjects (see 
table 9.11). These findings suggest that respiratory symptoms and clinical signs 
are inadequate for identifying subjects with NOLD. 
9.5.6 Synthesis and Diagnostic Possibilities for COPD 
The findings discussed above suggest that some COPD was related to 
cigarette smoking and that 12% was due to asthma. COPD in non-Aboriginal 
smokers is believed to be secondary to small airways disease, emphysema or a 
combination of both. Whether COPD in Aborigines who smoke is due to 
similar pathological processes is unknown. Furthermore, little is known about 
the pathological basis of COPD in never-smokers. The clinical findings were of 
no _practical clinical help in detecting or characterising the underlying 
abnormalities in those with COPD. 
Some of the people with COPD 1n the present study may have had 
bronchiectasis because airflow obstruction is known to occur in people with 
this condition (114) and there are reasons to believe this condition may be 
prevalent (see chapter 2). 
The role of environmental factors in the development of COPD in Aborigines 
remains unknown. The substantial number of never-smokers among those 
with COPD and the reduced odds for COPD amongst those from CA3 suggest 
that unidentified environmental factors may be important for the development 
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of COPD. Further research needs to focus on the risk factors and pathological 
basis for COPD in Aboriginal non-smokers. 
9.5.7 Synthesis and Diagnostic Possibilities for NOLD 
NOLD has been shown to be associated with petrol sniffing and the 
author contends that the present study supports the hypothesis that some 
NOLD is secondary to damage resulting from childhood pneumonia. 
Bronchiectasis, pulmonary fibrosis and impaired lung growth in childhood are 
possible pathological processes that could mediate these associations. A small 
proportion of adults with NOLD had asthma. The clinical findings were non-
specific and therefore unhelpful in characterising the abnormalities present. 
Whether the prevalence of crepitations of 23% among 20-39 year olds with 
NOLD was an indication that this group had a high prevalence of pulmonary 
fibrosis is unknown. Further investigation of a group of subjects with NOLD 
and matched controls using CXRs, lung volume measurement and carbon 
monoxide diffusion capacity measurement would help characterise the 
abnormalities underlying this condition. 
Further research needs to elucidate the factors which influence lung growth in 
childhood and adolescence, the impact of living conditions and the sequelae of 
childhood pneumonia. 
9 . 5 . 7 . 1  
O t h e r  p o s s i b l e  r i s k  f a c t o r s  f o r  C L D  
I t  i s  n o w  r e c o g n i s e d  t h a t  m a t e r n a l  s m o k i n g  d u r i n g  p r e g n a n c y  m a y  
a d v e r s e l y  e f f e c t  f o e t a l  l u n g  g r o w t h .  T h i s  e f f e c t  i s  i n d e p e n d e n t  o f  b i r t h  w e i g h t .  
H a n r a h a n  e t  a l  s t u d i e d  t h e  l u n g  f u n c t i o n  o f  8 0  h e a l t h y  i n f a n t s  a n d  f o u n d  t h a t  
t h e  i n f a n t s  o f  n o n - s m o k i n g  m o t h e r s  h a d  s i g n i f i c a n t l y  b e t t e r  f l o w  r a t e s  
t h r o u g h o u t  t h e  v e ~ t i l a t o r y  c y c l e  t h a n  i n f a n t s  b o r n  t o  s m o k i n g  m o t h e r s  ( A m  R e v  
R e s p  D i s  1 9 9 2 ; 1 4 5 : 1 1 2 9 - 3 5 ) .  T h i s  f i n d i n g  w a s  c o n s i s t e n t  w i t h  t h e  h y p o t h e s i s  
t h a t  m a t e r n a l  s m o k i n g  i m p a i r s  a i r w a y  d e v e l o p m e n t  i n  u t e r o .  I n  t h e  p r e s e n t  
s t u d y  i t  i s  p o s s i b l e  t h a t  t h e r e  w e r e  c o h o r t  e f f e c t s  o n  l u n g  f u n c t i o n  d u e  t o  t h e  
c h a n g i n g  p a t t e r n s  o f  m a t e r n a l  s m o k i n g  a n d  t h a t  m a t e r n a l  s m o k i n g  c o n t r i b u t e d  
t o  t h e  h i g h  p r e v a l e n c e  o f  C L D  i n  s o m e  r e g i o n s .  
S e c o n d l y ,  i t  i s  n o w  r e c o g n i s e d  t h a t  l o w  b i r t h  w e i g h t  m a y  b e  a s s o c i a t e d  w i t h  
c l i n i c a l l y  s i g n i f i c a n t  a b n o r m a l i t i e s  o f  v e n t i l a t o r y  f u n c t i o n  t h a t  p e r s i s t  i n t o  a d u l t  
l i f e .  I n  a  r e t r o s p e c t i v e  c o h o r t  s t u d y  o f  5 7 1 8  B r i t i s h  m e n  B a r k e r  e t  a l  s h o w e d  t h a t  
d e a t h  f r o m  c h r o n i c  o b s t r u c t i v e  a i r w a y s  d i s e a s e  w a s  a s s o c i a t e d  w i t h  l o w  b i r t h  
w e i g h t  a n d  w e i g h t  a t  o n e  y e a r  ( B M J  1 9 9 1 ; 3 0 3 : 6 7 1 - 7 5 ) .  I n  t h e  r e p o r t  o f  t h e  
N a t i o n a l  A b o r i g i n a l  H e a l t h  S t r a t e g y  W o r k i n g  P a r t y  o f  M a r c h  1 9 8 9  i t  i s  n o t e d  
t h a t  A b o r i g i n a l  i n f a n t s  a r e  m o r e  f r e q u e n t l y  b o r n  u n d e r w e i g h t  t h a n  n o n -
A b o r i g i n a l  A u s t r a l i a n  c h i l d r e n .  I t  i s  p o s s i b l e  t h a t  i n t r a u t e r i n e  g r o w t h  
r e t a r d a t i o n  i s  a  s i g n i f i c a n t  r i s k  f a c t o r  f o r  C L D  i n  A b o r i g i n a l  c o m m u n i t i e s .  
F i n a l l y ,  a l t h o u g h  e a r l y  r e s p i r a t o r y  t r a c t  i n f e c t i o n s  m a y  b e  a  r i s k  f a c t o r  f o r  t h e  
d e v e l o p m e n t  o f  C L D  s u c h  i n f e c t i o n s  m a y  a c t u a l l y  b e  m a r k e r s  f o r  c h i l d r e n  w i t h  
d i m i n i s h e d  l u n g  f u n c t i o n .  B a r k e r  e t  a l  s h o w e d  t h a t  b r o n c h i t i s  o r  p n e u m o n i a  i n  
i n f a n c y  ( a g e <  1  y e a r )  w a s  a s s o c i a t e d  w i t h  a  0 . 1 7  l i t r e  r e d u c t i o n  i n  a d u l t  F E V
1  
i n d e p e n d e n t  o f  b i r t h  w e i g h t  ( a n d  m a t e r n a l  s m o k i n g  h a b i t ) .  M a r t i n e z  e t  a l  h a v e  
s h o w n  t h a t  d i m i n i s h e d  l u n g  f u n c t i o n  i s  a  r i s k  f a c t o r  f o r  t h e  s u b s e q u e n t  
d e v e l o p m e n t  o f  l o w e r  r e s p i r a t o r y  t r a c t  i n f e c t i o n s .  T h e r e f o r e  t h e  r o l e  o f  e a r l y  
l o w e r  r e s p i r a t o r y  t r a c t  i n f e c t i o n s  i n  t h e  d e v e l o p m e n t  o f  c h r o n i c  l u n g  d i s e a s e  
r e m a i n s  c o n t r o v e r s i a l .  
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9.5.8 Clinical Implications of CLD 
The present study has shown that spirometry is the only reliable method 
for detecting people with either COPD or NOLD. Funding should be made 
available to Aboriginal community health services to purchase spirometers* 
because it has been shown in this study that CLD is a significant public health 
problem. The performance of spirometric function in Aboriginal communities 
could lead to a wider recognition of the importance of CLD and could be used 
as a focus for heal th promotion. 
Clinical orthodoxy encourages the early identification of people with CLD so 
that people at risk of developing more advanced lung disease can be counselled 
about risk factors for CLD and so appropriate therapy (eg for asthma) can be 
instituted. Therefore screening for CLD should probably become routine in 
Aboriginal health services. It has been recommended that all Aboriginal people 
with CLD receive pneumococcal immunisation to reduce the incidence of 
pneumococcal pneumonia (115) and people with CLD should also have an 
annual influenza immunisation (116). The findings in the present study 
suggest that approximately 20% of adult males and 5% of females would 
benefit from detection of their CLD and these vaccinations. 
The high prevalence of COPD and NOLD was the major finding of this study. 
In non-Aboriginal people it has been shown that reduced ventilatory function 
is an independent risk factor for death from respiratory disease, ischaemic heart 
disease and other causes (117, 118). If the four study communities are similar to 
other rural Aboriginal communities in Australia, it is possible that high levels 
of COPD, NOLD and cigarette smoking explain a considerable proportion of 
the premature mortality suffered by the Aboriginal nation (27). 
* Provision would also need to be made for training health personnel in the use of the 
spiromcters and interpretation of results. 
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' Conclusion 
The overall prevalence of COPD in adult males was 11.8% and in adult 
females was 4.S o/o . 
' 
COPD was not detected in children . 
Ex-smokers were at increased risk for having COPD . 
Increasing age was an independent risk factor for COPD . 
The lifestyle in CA3 was associated with a reduction in the likelihood of 
subjects having COPD. 
COPD was significantly associated with BHR however the prevalence of 
BHR among those with CLO was low in comparison with other studies. 
Approximately 12 % of those with COPD had asthma . 
The overall prevalence of NOLD was approximately 7% in males and 2% 
in females. 
Aboriginal people living in the community with the most adequately 
maintained houses had a reduced risk of developing NOLD. 
Petrol sniffing and male gender were independent risk factors for 
NOLD. 
Respiratory symptoms and signs had poor sensitivity for detecting CLD . 
Explanations other than petrol sniffing, cigarette smoking and asthma 
need to be invoked to explain the high prevalence of COPD and NOLD . 
Future research needs to focus on the factors which influence the growth 
and decline of lung function in Aborigines . 
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CHAPTERlO 
Summary and Conclusion 
10.1 Introduction 
This chapter summarises the study' s main findings and explores their 
research and public health and implications. There is an emphasis on ethical 
and process issues, the importance of smoking, the prevalence of asthma and 
atopy, the characteristics of normal lung function and the nature and 
distribution of chronic lung disease. 
10.2 Ethics, Consultation and Feedback 
This study showed that the National Health and Medical Research 
Council's guidelines for health research in Aboriginal and Torres Strait Islander 
communities are practical and facilitate community cooperation (3). Their 
implementation was labour and time intensive but resulted in a process that 
was orientated towards community needs. The author's willingness to consult 
and adapt to meet community concerns and the involvement of community 
members were crucial to the study's success. 
The commitment to appropriate feedback was welcomed. Early feedback was 
valued as was the creation of permanent reports for inclusion in medical 
records. In the communities where English literacy was low, personal copies of 
written reports were of less interest. With time, interest shifted from a focus on 
individual results to an emphasis on the collective implications. Community 
elders accorded high priority to discussions with children about health issues 
emerging from the research. 
10.3 Cigarette Smoking 
The study confirmed that cigarette smoking is an important public 
health problem for Aboriginal people. Aborigines have a high prevalence of 
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diabetes, hypertension and obesity, so smoking places them at great risk from 
cardiovascular as well as respiratory disease (64). 
The prevalence of smoking varied by gender and region. In Cape York the 
prevalence was approximately 70%. In central Australia smoking was less 
prevalent but probably increasing among women. The most frequently 
reported age for commencing smoking was 13 years. There was regional 
variation in the number of cigarettes smoked daily. Self-reported cigarette use 
was highest in Cape York. If the uptake of smoking in teenagers cannot be 
reduced in central Australia the prevalence of smoking may rise to that in Cape 
York. 
There was a strong association between cigarette smoking and alcohol 
consumption. This linkage suggests that initiatives to encourage smoking 
cessation should consider the context in which it occurs. 
Knowledge of the health consequences of smoking was limited. This finding 
suggested that most people were not in a position to make informed decisions 
about smoking. In one community this knowledge was associated with a 
reduction in the odds for being a current smoker. This observation raises the 
possibility that initiatives to increase knowledge would reduce the prevalence 
of smoking. It seems likely that adequately resourced Aboriginal health 
services could develop educational programs and strategies that would 
discourage the commencement of smoking and help smokers quit. 
10.4 Asthma and Atopy 
Childhood asthma was almost non-existent and among adults the 
prevalence was low in comparison with that found in non-Aboriginal 
Australians. There was significant regional variation in the prevalence of atopy 
and asthma. The only risk factor identified for asthma was allergy to cats . The 
prevalence of asthma in the Cape York children was low despite exposure to 
levels of Der pl allergen sufficient to cause sensitisation and wheezing in non-
Aboriginal children. In CY1 there was no evidence that asthma or atopy were 
associated with non-Aboriginal HLA DR and DQ alleles. The prevalence of 
BHR among adults was similar to that found among non-Aboriginal 
Australians but in children the prevalence was relatively low. The risk factors 
for BHR were HOM allergy, feline allergy and cigarette smoking. The 
prevalence of atopy among adults was similar to that found among non-
Aboriginal Australian adults. However in children it was significantly lower 
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than that found among their non-Aboriginal peers so it seems that the 
Aboriginal children have delayed atopy acquisition. 
The asthma findings are interesting because asthma is said to be a commonly 
observed clinical problem among urban Aboriginal children. Environmental 
factors might be crucial for the expression of asthma in Aborigines. It needs to 
be determined whether asthma in urban Aboriginal children is associated with 
an atopy acquisition rate that is higher than that observed in this rural study. 
10.5 Normal Lung Function 
The values predicted for FEV1 among healthy people in the present 
study were approximately 20% lower than those predicted for Caucasians of 
the same height, age and gender and for FVC they were 30% lower. The 
FEV1 /FVC ratio was consequently high in comparison with Caucasians. 
Asymptomatic cigarette smokers had higher predicted values of FEV1 and FVC 
than non-smokers. The rate of decline of FEV1 and FVC with age in healthy 
smokers and non-smokers appeared comparable to that observed in 
Caucasians. 
The spirometric function reference value equations developed in the present 
study are the first complementary set for Aboriginal adults and children. 
Although it is recognised that black Americans and other indigenous people 
also have low spirometric values in comparison with Caucasians, the values 
predicted for the asymptomatic Aborigines in this study were even lower. This 
suggested that either Aboriginal people have a particular genetic 
predisposition to comparatively low spirometric values or that most of the 
population have compromised lung function. The finding that asymptomatic 
smokers had better lung function than non-smokers could be secondary to a 
health selection effect because it has been observed that children previously 
hospitalised for respiratory illness are less likely to commence smoking than 
children without such a history (5). 
The equations developed during the present study will allow informed 
assessment of individual lung function in rural Aborigines. This will benefit 
practitioners who assess respiratory problems and health services that screen 
for respiratory disease. Also epidemiologists now have a tool to identify CLO. 
More research is required to investigate the determinants of lung growth and 
decline in Aborigines. 
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10.6 Chronic Lung Disease 
The prevalence of CLD was high in comparison with that found among 
non-Aboriginal Australians. Respiratory symptoms and signs were not useful 
for identifying or characterising subjects with chronic obstructive pulmonary 
disease (COPD) or non obstructive lung disease (NOLD). 
The prevalence of COPD was 11.8% in males and 4.5% in females . COPD was 
not detected in children. Ex-smokers were at increased risk of having COPD. 
Increasing age was an independent risk factor for COPD. The traditional 
lifestyle in CA3 was associated with an independent reduction in the risk of 
having COPD but confounding by smoking pattern may have influenced the 
result. Twelve percent of subjects with COPD had asthma. BHR was 
associated with COPD but the prevalence of BHR among those with COPD was 
low compared with that found in non-Aboriginal people with this disease. 
The prevalence of NOLD was 7% in males and 2% in females. Petrol sniffing 
and male gender were significant independent risk factors for NOLD. Age was 
not an independent risk factor for this abnormality. Subjects from the 
community with the most adequate houses (CY1) were significantly less likely 
to have NOLD than subjects from communities where the housing was of a 
poor standard and where serious lower respiratory tract infections in childhood 
are said to be common. 
The findings suggest that initiatives that lead to more Aboriginal people living 
in decentralised family groups in adequately maintained houses on their land 
have the potential to reduce the burden of COPD and NOLD. The mechanisms 
by which these factors reduce the prevalence of CLD need further 
investigation. 
The high prevalence of COPD and NOLD 1n the present study probably 
explains why respiratory disease is an important cause of hospitalisation and 
death among Aborigines. Furthermore, the findings may have other 
implications for mortality because in non-Aboriginal people, impaired lung 
function is also a risk factor for death from cardiovascular disease and other 
disorders . Thus the significance of CLO as a cause of death among Aboriginal 
people has probably been under-estimated in the past. 
The low prevalence of symptoms amongst those with CLD means that CLD can 
only be reliably detected with a spirometer. The present study findings suggest 
that all Aboriginal medical services should be equipped with spirometers so 
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that people can be screened for CLD. All people with CLD should be 
counselled about smoking and petrol sniffing (when relevant) and they should 
also be offered pneumococcal and influenza immunisation (115) . 
Further research which explores the factors which affect the growth and decline 
of lung function in Aborigines is needed. Many children may be failing to 
achieve their full spirometric potential by the end of adolescence. Because it is 
often asymptomatic and yet a major cause of premature Aboriginal death, 
community awareness regarding the importance of CLD needs to be enhanced. 
10.7 Conclusion 
Cigarette smoking, petrol sniffing, COPD and NOLD are major public 
health problems for Australian Aborigines. Knowledge of the health 
consequences of smoking is poor. Asthma is present in 3-5% of adults but it is 
almost non-existent in children. Aboriginal people have lower predicted 
spirometric values based on age, gender and height compared with other 
indigenous people and Caucasians . 
The "traditional" lifestyle of CA3 was associated with significantly less COPD 
than the lifestyle in the three less traditional communities. The reasons for this 
are yet to be identified but possibly the lifestyle has fostered circumstances that 
have limited substance abuse. There was no evidence that the lifestyle in CA3 
protected individuals from NOLD. 
The lifestyle in the community where housing was most adequate (CYl) was 
associated with significantly less NOLD than the lifestyle in the communities 
where housing was less adequate. The low prevalence of respiratory tract 
infections that are reported to accompany the provision of adequate housing 
are a biologically plausible mechanism by which adequate housing could 
protect people from developing NOLD. 
This study lends support to the contention that decentralised living in family 
groups yields health advantages for Aborigines, that initiatives to improve 
Aboriginal housing will lead to a fall in the prevalence of N OLD, and that 
appropriate smoking education programs are imperative. The report of the 
national Aboriginal health strategy working party (28) offers a policy which, if 
implemented, would make healthy lifestyle options, culturally appropriate 
health education services and adequate housing available to more Aborigines. 
This study reinforces the need for the full implementation of that strategy. 
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Appendices 
Erratum 
The footnote for appendices 6-17 should read: 
L95 = lower limit of the reference range (5th percentile). 
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Appendix 1 
Prevalence of atopy (as a percentage) to DP, DF, cockroach and dust by community 
and age. 
CYl CY2 CA3 CA4 All 
Number 
5-7 51 17 28 23 119 
8-12 95 28 58 31 212 
13-19 54 16 86 so 206 
20-84 278 102 186 149 715 
5-84 478 163 358 253 1252 
DP 
5-7 10 0 4 22 10 
8-12 16 18 10 16 15 
13-19 24 25 17 24 21 
20-84 31 30 16 27 26 
5-84 25 24 14 25 22 
DF 
5-7 10 0 4 13 8 
8-12 14 7 5 19 11 
13-19 17 12 9 24 15 
20-84 25 26 11 21 21 
5-84 20 19 9 20 17 
Cockroach 
5-7 8 0 7 4 6 
8-12 14 7 12 10 12 
13-19 24 12 14 10 15 
20-84 23 16 11 11 17 
5-84 20 13 12 10 15 
Dust 
5-7 2 0 0 0 1 
8-12 5 4 2 0 3 
13-19 5 0 2 2 3 
20-84 10 7 2 5 6 
5-84 8 5 2 3 5 
I 
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Appendix 2 
Prevalence of atopy (as a percentage) to cat, plantain, rye grass and Alternaria by 
' 
comm unity and age. 
I 
CYl CY2 CA3 CA4 All 
Number 
' 
llll 5-7 51 17 28 23 119 
II, 
8-12 95 28 58 31 212 
13-19 54 16 86 50 206 
20-84 278 102 186 149 715 
I, 5-84 478 
: 
163 358 253 1252 
1: 
Cat 
1, 5-7 0 0 0 4 1 
I. 8-12 1 0 0 0 0 
13-19 5 0 0 0 1 
20-84 8 1 0 2 3 
5-84 5 1 0 2 2 
Plantain 
i 5-7 0 0 0 0 0 
8-12 0 0 0 0 0 
13-19 2 0 0 0 0 
20-84 2 1 0 2 1 
5-84 1 1 0 1 1 
Rye Grass 
5-7 0 0 0 0 0 
Ii 8-12 1 0 2 0 1 
13-19 2 0 1 2 1 
20-84 5 2 2 2 3 
5-84 4 1 1 2 2 
II Alternaria 1, 
5-7 0 0 0 0 0 
8-12 1 0 0 0 0 
11 
Ii 13-19 2 0 1 0 1 
I: 
20-84 2 1 0 1 1 
5-84 1 1 0 1 1 
Ii 
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Appendix 3 
Prevalence of atopy (as a percentage) to dog, horse, feathers and ragweed by 
community and age. 
Ii CYl CY2 CA3 CA4 All 
Number 
5-7 51 17 28 23 119 
1, 1, 
8-12 95 28 58 31 212 
13-19 54 16 86 50 206 
20-84 278 102 186 149 715 
5-84 478 163 358 253 1252 
,, 
;I Dog 
I 
5-7 0 0 NIA NIA 0 
8-12 1 0 NIA NIA 1 
13-19 2 0 NIA NIA 0 
20-84 4 2 NIA NIA 3 
5-84 2 1 NIA NIA 2 
Horse 
5-7 2 0 NIA NIA 1 
8-12 0 0 NIA NIA 0 
13-19 0 0 NIA NIA 0 
20-84 2 1 NIA NIA 2 
5-84 1 1 NIA NIA 1 
J, 
Feathers 
1, 
5-7 0 0 NIA NIA 0 
8-12 0 0 NIA NIA 0 
13-19 0 0 NIA NIA 0 
1: 20-84 0 0 NIA NIA 0 
5-84 0 0 NIA NIA 0 
,, 
Ragweed 
5-7 0 0 NIA NIA 0 
8-12 0 0 NIA NIA 0 
1, 
13-19 0 6 NIA NIA 1 
' 
11 20-84 2 1 NIA NIA 2 
' 5-84 1 1 NIA NIA 1 ' 1, 
11 
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Appendix 4 
Prevalence of atopy (as a percentage) to Timothy grass, Aspergillus, acacia and 
bottlebrush by community and age. 
CYl CY2 CA3 CA4 All 
Number 
5-7 51 17 28 23 119 
8-12 95 28 58 31 212 
13-19 54 16 86 so 206 
20-84 278 102 186 149 715 
5-84 478 163 358 253 1252 
Timothy Grass 
5-7 0 0 NIA NIA 0 
8-12 1 0 NIA NIA 1 
13-19 2 0 NIA NIA 1 
20-84 3 1 NIA NIA 3 
5-84 2 1 NIA NIA 2 
Aspergillus 
5-7 0 0 NIA NIA 0 
8-12 0 0 NIA NIA 0 
13-19 0 0 NIA NIA 0 
20-84 3 2 NIA NIA 3 
5-84 2 1 NIA NIA 2 
Acacia 
5-7 NIA NIA 0 4 2 
8-12 NIA NIA 3 3 3 
13-19 NIA NIA 0 6 2 
20-84 NIA NIA 2 3 2 
5-84 NIA NIA 1 4 2 
Bottle Brush 
5-7 NIA NIA 4 0 2 
8-12 NIA NIA 2 3 2 
13-19 NIA NIA 0 4 1 
20-84 NIA NIA 1 3 2 
5-84 NIA NIA 1 3 2 
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Appendix 5 
Prevalence of atopy (as a percentage) to eucalyptus, melaleuca and pine (Australian) 
by comm unity and age. 
CYl CY2 CA3 CA4 All 
Number 
5-7 51 17 28 23 119 
8-12 95 28 58 31 212 
13-19 54 16 86 50 206 
20-84 278 102 186 149 715 
5-84 478 163 358 253 1252 
Eucalyptus 
5-7 NIA NIA 0 0 0 
8-12 NIA NIA 0 0 0 
13-19 NIA NIA 0 0 0 
20-84 NIA NIA 0 3 1 
5-84 NIA NIA 0 2 1 
Melaleuca 
5-7 NIA NIA 4 4 4 
8-12 NIA NIA 2 0 1 
13-19 NIA NIA 0 4 1 
20-84 NIA NIA 0 3 2 
5-84 NIA NIA 1 3 2 
Pine 
5-7 NIA NIA 0 0 0 
8-12 NIA NIA 0 0 0 
13-19 NIA NIA 0 0 0 
20-84 NIA NIA 0 1 1 
5-84 NIA NIA 0 1 0 
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Appendix 6 
FEV1 in litres for Aboriginal males aged 9-19 years. 
Age 
Ht 9 10 11 12 13 14 15 16 
110 0.71 0.78 0.86 0.93 1.00 1.08 1.15 1.22 
L95 0.03 0.10 0.17 0.24 0.31 0.37 0.43 0.50 
115 0.86 0.94 1.01 1.08 1.16 1.23 1.30 1.38 
L95 0.19 0.26 0.33 0.40 0.47 0.53 0.60 0.66 
120 1.02 1.09 1.16 1.24 1.31 1.38 1.46 1.53 
L95 0.35 0.42 0.49 0.56 0.63 0.70 0.76 0.83 
125 1.17 1.25 1.32 1.39 1.47 1.54 1.61 1.69 
L95 0.51 0.58 0.65 0.72 0.79 0.86 0.92 0.99 
130 1.33 1.40 1.47 1.55 1.62 1.69 1.77 1.84 
L95 0.66 0.74 0.81 0.88 0.95 1.02 1.09 1.15 
135 1.48 1.56 1.63 1.70 1.78 1.85 1.92 2.00 
L95 0.82 0.89 0.97 1.04 1.11 1.18 1.25 1.31 
140 1.64 1.71 1.78 1.86 1.93 2.00 2.08 2.15 
L95 0.97 1.05 1.12 1.20 1.27 1.34 1.41 1.47 
145 1.79 1.87 1.94 2.01 2.08 2.16 2.23 2.30 
L95 1.13 1.20 1.28 1.35 1.42 1.49 1.56 1.63 
150 1.95 2.02 2.09 2.17 2.24 2.31 2.39 2.46 
L95 1.28 1.36 1.43 1.51 1.58 1.65 1.72 1.79 
155 2.10 2.18 2.25 2.32 2.39 2.47 2.54 2.61 
L95 1.43 1.51 1.58 1.66 1.73 1.81 1.88 1.95 
160 2.26 2.33 2.40 2.48 2.55 2.62 2.70 2.77 
L95 1.58 1.66 1.74 1.81 1.89 1.96 2.03 2.11 
165 2.41 2.48 2.56 2.63 2.70 2.78 2.85 2.92 
L95 1.73 1.81 1.89 1.97 2.04 2.12 2.19 2.26 
170 2.57 2.64 2.71 2.79 2.86 2.93 3.01 3.08 
L95 1.88 1.96 2.04 2.12 2.19 2.27 2.34 2.42 
175 2.72 2.79 2.87 2.94 3.01 3.09 3.16 3.23 
L95 2.03 2.11 2.19 2.27 2.34 2.42 2.50 2.57 
180 2.88 2.95 3.02 3.10 3.17 3.24 3.32 3.39 
L95 2.17 2.26 2.34 2.42 2.49 2.57 2.65 2.72 
185 3.03 3.1 0 3.18 3.25 3.32 3.40 3.47 3.54 
L95 2.32 2.40 2.48 2.56 2.64 2.72 2.80 2.87 
L95= lower limit of the 95% confidence interval around the estimate . 
202 
17 18 19 
1.29 1.37 1.44 
0.56 0.62 0.68 
1.45 1.52 1.60 
0.73 0.79 0.85 
1.60 1.68 1.75 
0.89 0.95 1.01 
1.76 1.83 1.91 
1.05 1.12 1.18 
1.91 1.99 2.06 
1.22 1.28 1.34 
2.07 2.14 2.22 
1.38 1.44 1.51 
2.22 2.30 2.37 
1.54 1.61 1.67 
2.38 2.45 2.52 
1.70 1.77 1.83 
2.53 2.61 2.68 
1.86 1.93 1.99 
2.69 2.76 2.83 
2.02 2.09 2.15 
2.84 2.92 2.99 
2.18 2.24 2.31 
3.00 3.07 3.14 
2.33 2.40 2.47 
3.15 3.23 3.30 
2.49 2.56 2.63 
3.31 3.38 3.45 
2.64 2.71 2.78 
3.46 3.53 3.61 
2.80 2.87 2.94 
3.62 3.69 3.76 
2.95 3.02 3.09 
203 
Appendix 7 
FVC in litres for Aboriginal males aged 9-19 years. 
' 
',j 
:i:: Age 
ll Ht 9 10 11 12 13 14 15 16 17 18 19 
110 0.79 0.88 0.96 1.04 1.13 1.21 1.30 1.38 1.47 1.55 1.64 
L95 0.03 0.12 0.19 0.27 0.35 0.43 0.50 0.57 0.65 0.72 0.79 
115 0.95 1.04 1.12 1.21 1.29 1.37 1.46 1.54 1.63 1.71 1.80 
I L95 0.20 0.29 0.36 0.44 0.52 0.60 0.67 0.75 0.82 0.89 0.96 
Ii 
1.11 1.20 1.28 1.37 1.45 120 1.54 1.62 1.70 1.79 1.87 1.96 
I L95 0.36 0.45 0.53 0.61 0.69 0.77 0.84 0.92 0.99 1.06 1.13 
125 1.27 1.36 1.44 1.53 1.61 1.70 1.78 1.86 1.95 2.03 2.12 
L95 0.53 0.61 0.69 0.78 0.86 I 0.93 1.01 1.09 1.16 1.23 1.31 
130 1.43 1.52 1.60 1.69 1.77 1.86 1.94 2.03 2.11 2.19 2.28 
L95 0.69 0.78 0.86 0.94 1.02 1.10 1.18 1.26 1.33 1.40 1.48 ,, 
: 
135 1.59 1.68 1.76 1.85 1.93 2.02 2.10 2.19 2.27 2.36 2.44 
•• L95 0.85 0.94 1.02 1.11 1.19 1.27 1.35 1.42 1.50 1.57 1.65 
140 1.76 1.84 1.92 2.01 2.09 2.18 2.26 2.35 2.43 2.52 2.60 
1: L95 1.01 1.10 1.18 1.27 1.35 1.43 1.51 1.59 1.67 1.74 1.82 
145 1.92 2.00 2.09 2.17 2.25 2.34 2.42 2.51 2.59 2.68 2.76 
L95 1.17 1.26 1.35 1.43 1.51 1.60 1.68 1.76 1.83 1.91 1.99 
150 2.08 2.16 2.25 2.33 2.42 2.50 2.58 2.67 2.75 2.84 2.92 
L95 1.33 1.42 1.51 1.59 1.68 1.76 1.84 1.92 2.00 2.08 2.15 
155 2.24 2.32 2.41 2.49 2.58 2.66 2.74 2.83 2.91 3.00 3.08 
,, L95 1.49 1.58 1.66 1.75 1.84 1.92 2.00 2.09 2.17 2.24 2.32 
160 2.40 2.48 2.57 2.65 2.74 2.82 2.91 2.99 3.07 3.16 3.24 
L95 1.64 1.73 1.82 1.91 2.00 2.08 2.17 2.25 2.33 2.41 2.49 
165 2.56 2.64 2.73 2.81 2.90 2.98 3.07 3.15 3.24 3.32 3.40 
L95 1.80 1.89 1.98 2.07 2.16 2.24 2.33 2.41 2.49 2.57 2.65 
170 2.72 2.80 2.89 2.97 3.06 3.14 3.23 3.31 3.40 3.48 3.57 
L95 1.95 2.04 2.13 2.22 2.31 2.40 2.49 2.57 2.65 2.74 2.82 
I: 175 2.88 2.97 3.05 3.13 3.22 3.30 3.39 3.47 3.56 3.64 3.73 
L95 2.10 2.20 2.29 2.38 2.47 2.56 2.64 2.73 2.81 2.90 2.98 
180 3.04 3.13 3.21 3.30 3.38 3.46 3.55 3.63 3.72 3.80 3.89 
L95 2.26 2.35 2.44 2.53 2.63 2.71 2.80 2.89 2.97 3.06 3.14 
185 3.20 3.29 3.37 3.46 3.54 3.62 3.71 3.79 3.88 3.96 4.05 
L95 2.41 2.50 2.60 2.69 2.78 2.87 2.96 3.05 3.13 3.22 3.30 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 8 
FEV1 in litres for Aboriginal male non-smokers aged 20-70 years. 
II j 
II 
:1 Age 
Ht 20 25 30 35 40 45 50 55 60 65 70 
160 2.77 2.67 2.56 2.45 2.35 2.24 2.13 2.03 1.92 1.81 1.71 
1: 
II L95 1.93 1.82 1.72 1.61 1.51 1.40 1.29 1.19 1.08 0.97 0.86 
[, 
1: 
II 
II 165 2.98 2.88 2.77 2.66 2.56 2.45 2.34 2.24 2.13 2.02 1.92 
1,, 
L95 2.14 2.04 1.93 1.83 1.72 1.61 1.51 1.40 1.29 1.18 1.07 
170 3.19 3.08 2.98 2.87 2.76 2.66 2.55 2.44 2.34 2.23 2.12 
L95 2.35 2.25 2.14 2.04 1.93 1.82 1.72 1.61 1.50 1.39 1.28 11 
175 3.40 3.29 3.19 3.08 2.97 2.87 2.76 2.65 2.55 2.44 2.33 
1, L95 2.56 2.46 2.35 2.24 2.14 2.03 1.92 1.82 1.71 1.60 1.49 
I 
180 3.61 3.50 3.40 3.29 3.18 3.08 2.97 2.86 2.76 2.65 2.54 
L95 2.77 2.66 2.56 2.45 2.35 2.24 2.13 2.02 1.92 1.81 1.70 
185 3.82 3.71 3.60 3.50 3.39 3.28 3.18 3.07 2.96 2.86 2.75 
L95 2.97 2.87 2.76 2.66 2.55 2.44 2.34 2.23 2.12 2.01 1.90 11 I• 
II 
;,, 190 4.03 3.92 3.81 3.71 3.60 3.49 3.39 3.28 3.17 3.07 2.96 Ii 
Ii L95 3.18 3.07 2.97 2.86 2.75 2.65 2.54 2.43 2.33 2.22 2.11 Ii 
195 4.23 4.13 4.02 3.91 3.81 3.70 3.59 3.49 3.38 3.27 3.17 
L95 3.38 3.27 3.17 3.06 2.96 2.85 2.74 2.64 2.53 2.42 2.31 
200 4.44 4.34 4.23 4.12 4.02 3.91 3.80 3.70 3.59 3.48 3.38 
L95 3.58 3.48 3.37 3.26 3.16 3.05 2.94 2.84 2.73 2.62 2.51 
I 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 9 
FVC in litres for Aboriginal male non-smokers aged 20-70 years. 
II 
II! 
II• Age 
aJ 
Ht 20 25 30 35 40 45 50 55 60 65 70 
160 2.95 2.85 2.76 2.66 2.56 2.46 2.36 2.27 2.17 2.07 1.97 
11 L95 1.93 1.84 1.74 1.64 1.55 1.45 1.35 1.25 1.15 1.05 0.95 
165 3.22 3.12 3.02 2.92 2.83 2.73 2.63 2.53 2.43 2.34 2.24 
L95 2.20 2.11 2.01 1.91 1.82 1.72 1.62 1.52 1.42 1.32 1.22 
I 
I 170 3.48 3.39 3.29 3.19 3.09 2.99 2.90 2.80 2.70 2.60 2.50 
II L95 2.47 2.38 2.28 2.18 2.08 1.99 1.89 1.79 1.69 1.59 1.49 
175 3.75 3.65 3.55 3.46 3.36 3.26 3.16 3.06 2.97 2.87 2.77 
L95 2.74 2.64 2.54 2.45 2.35 2.25 2.15 2.05 1.95 1.85 1.75 
180 4.02 3.92 3.82 3.72 3.62 3.53 3.43 3.33 3.23 3.13 3.04 
Ii L95 3.00 2.91 2.81 2.71 2.61 2.52 2.42 2.32 2.22 2.12 2.02 
ii 
185 4.28 4.18 4.09 3.99 3.89 3.79 3.69 3.60 3.50 3.40 3.30 
II 
L95 3.26 3.17 3.07 2.97 2.88 2.78 2.68 2.58 2.48 2.38 2.28 
190 4.55 4.45 4.35 4.25 4.16 4.06 3.96 3.86 3.76 3.66 3.57 
I 
L95 3.52 3.43 3.33 3.23 3.14 3.04 2.94 2.84 2.74 2.64 2.54 
195 4.81 4.72 4;62 4.52 4.42 4.32 4.22 4.13 4.03 3.93 3.83 
L95 3.78 3.69 3.59 3.49 3.39 3.30 3.20 3.10 3.00 2.90 2.80 
200 5.08 4.98 4.88 4.78 4.69 4.59 4.49 4.39 4.29 4.20 4.10 
L95 4.04 3.94 3.85 3.75 3.65 3.55 3.45 3.36 3.26 3.16 3.06 
1, L95= lower limit of the 95% confidence interval around the estimate. 
11 
n 
206 
I 
Appendix 10 
' FEV1 in litres for Aboriginal male smokers aged 20-70 years. 
11 j 
Age 
11~ 
Ht 20 25 30 35 40 45 50 55 60 65 70 
160 2.91 2.81 2.70 2.59 2.49 2.38 2.27 2.17 2.06 1.95 1.85 
I L95 2.07 1.96 1.86 1.75 1.64 1.54 1.43 1.32 1.21 1.10 0.99 
I! 
!, 
11 165 3.12 3.01 2.91 2.80 2.69 2.59 2.48 2.37 2.27 2.16 2.05 I' 
ii I L95 2.28 2.18 2.07 1.96 1.86 1.75 1.64 1.53 1.42 1.32 1.21 
170 3.33 3.22 3.12 3.01 2.90 2.80 2.69 2.58 2.48 2.37 2.26 11 
L95 2.49 2.39 2.28 2.17 2.07 1.96 1.85 1.74 1.64 1.53 1.42 
I' 
175 3.54 3.43 3.32 3.22 3.11 3.00 2.90 2.79 2.68 2.58 2.47 
L95 2.70 2.60 2.49 2.38 2.28 2.17 2.06 1.95 1.84 1.74 1.63 
180 3.75 3.64 3.53 3.43 3.32 3.21 3.11 3.00 2.89 2.79 2.68 
L95 2.91 2.80 2.70 2.59 2.48 2.38 2.27 2.16 2.05 1.94 1.83 
; 
185 3.95 3.85 3.74 3.63 3.53 3.42 3.31 3.21 3.10 2.99 2.89 
L95 3.12 3.01 2.90 2.80 2.69 2.58 2.47 2.37 2.26 2.15 2.04 
II I• 
I 
190 4.16 4.06 3.95 3.84 3.74 3.63 3.52 3.42 3.31 3.20 3.10 
I 
L95 3.32 3.21 3.11 3.00 2.89 2.79 2.68 2.57 2.46 2.35 2.24 
,I 
195 4.37 4.27 4.16 4.05 3.95 3.84 3.73 3.63 3.52 3.41 3.31 
L95 3.52 3.42 3.31 3.20 3.10 2.99 2.88 2.77 2.67 2.56 2.45 
200 4.58 4.47 4.37 4.26 4.15 4.05 3.94 3.83 3.73 3.62 3.51 
L95 3.72 3.62 3.51 3.40 3.30 3.19 3.08 2.97 2.87 2.76 2.65 
I L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 11 
FVC in litres for Aboriginal male smokers aged 20-70 years. 
Age 
Ht 20 25 30 35 40 45 so 55 60 65 70 
160 3.21 3.12 3.02 2.92 2.82 2.72 2.62 2.53 2.43 2.33 2.23 
L95 2.20 2.10 2.00 1.90 1.81 1.71 1.61 1.51 1.41 1.31 1.20 
165 3.48 3.38 3.28 3.18 3.09 2.99 2.89 2.79 2.69 2.60 2.50 
L95 2.47 2.37 2.27 2.17 2.08 1.98 1.88 1.78 1.68 1.58 1.48 
170 3.74 3.65 3.55 3.45 3.35 3.25 3.16 3.06 2.96 2.86 2.76 
L95 2.74 2.64 2.54 2.44 2.34 2.25 2.15 2.05 1.95 1.85 1.74 
175 4.01 3.91 3.81 3.72 3.62 3.52 3.42 3.32 3.23 3.13 3.03 
L95 3.00 2.90 2.81 2.71 2.61 2.51 2.41 2.31 2.21 2.11 2.01 
180 4.28 4.18 4.08 3.98 3.88 3.79 3.69 3.59 3.49 3.39 3.30 
L95 3.27 3.17 3.07 2.97 2.88 2.78 2.68 2.58 2.48 2.38 2.27 
185 4.54 4.44 4.35 4.25 4.15 4.05 3.95 3.86 3.76 3.66 3.56 
L95 3.53 3.43 3.33 3.24 3.14 3.04 2.94 2.84 2.74 2.64 2.54 
190 4.81 4.71 4.61 4.51 4.42 4.32 4.22 4.12 4.02 3.93 3.83 
L95 3.79 3.69 3.60 3.50 3.40 3.30 3.20 3.10 3.00 2.90 2.80 
195 5.07 4.98 4.88 4.78 4.68 4.58 4.49 4.39 4.29 4.19 4.09 
L95 4.05 3.95 3.85 3.76 3.66 3.56 3.46 3.36 3.26 3.16 3.06 
200 5.34 5.24 5.14 5.05 4.95 4.85 4.75 4.65 4.55 4.46 4.36 
L95 4.31 4.21 4.11 4.01 3.91 3.82 3.72 3.62 3.52 3.42 3.31 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 12 
FEV1 in litres for Aboriginal females aged 9-19 years. 
1\ 1 
' 
I 
I 
, Age 
Ht 9 10 11 12 13 14 15 16 17 18 19 
110 0.72 0.74 0.77 0.80 0.83 0.86 0.89 0.92 0.95 0.97 1.00 
J L95 0.04 0.07 0.09 0.12 0.14 0.16 0.19 0.21 0.23 0.25 0.27 
11: 
115 0.87 0.90 0.93 0.96 0.99 1.01 1.04 1.07 1.10 1.13 1.16 
L95 0.20 0.23 0.25 0.28 0.30 0.33 0.35 0.37 0.39 0.42 0.44 
I 120 1.03 1.05 1.08 1.11 1.14 1.17 1.20 1.23 1.25 1.28 1.31 
L95 0.36 0.38 0.41 0.44 0.46 0.49 0.51 0.53 0.56 0.58 0.60 
I 
125 1.18 1.21 1.24 1.27 1.29 1.32 1.35 1.38 1.41 1.44 1.47 
I L95 0.51 0.54 0.57 0.60 0.62 0.65 0.67 0.70 0.72 0.74 0.76 
1, I 130 1.33 1.36 1.39 1.42 1.45 1.48 1.51 1.54 1.56 1.59 1.62 
L95 0.67 0.70 0.73 0.76 0.78 0.81 0.83 0.86 0.88 0.90 0.93 
135 1.49 1.52 1.55 1.58 1.60 1.63 1.66 1.69 1.72 1.75 1.78 
L95 0.83 0.86 0.88 0.91 0.94 0.97 0.99 1.02 1.04 1.07 1.09 
140 1.64 1.67 1.70 1.73 1.76 1.79 1.82 1.84 1.87 1.90 1.93 
L95 0.98 1.01 1.04 1.07 1.10 1.12 1.15 1.18 1.20 1.23 1.25 
145 1.80 1.83 1.86 1.89 1.91 1.94 1.97 2.00 2.03 2.06 2.09 
11 
L95 1.13 1.17 1.20 1.22 1.25 1.28 1.31 1.33 1.36 1.38 1.41 
150 1.95 1.98 2.01 2.04 2.07 2.10 2.13 2.15 2.18 2.21 2.24 
11 L95 1.29 1.32 1.35 1.38 1.41 1.44 1.46 1.49 1.52 1.54 1.57 
155 2.11 2.14 2.17 2.19 2.22 2.25 2.28 2.31 2.34 2.37 2.40 
L95 1.44 1.47 1.50 1.53 1.56 1.59 1.62 1.65 1.67 1.70 1.72 
160 2.26 2.29 2.32 2.35 2.38 2.41 2.44 2.46 2.49 2.52 2.55 
L95 1.59 1.62 1.65 1.68 1.72 1.74 1.77 1.80 1.83 1.86 1.88 
165 2.42 2.45 2.48 2.50 2.53 2.56 2.59 2.62 2.65 2.68 2.70 
L95 1.74 1.77 1.80 1.84 1.87 1.90 1.93 1.96 1.98 2.01 2.04 
170 2.57 2.60 2.63 2.66 2.69 2.72 2.75 2.77 2.80 2.83 2.86 
L95 1.89 1.92 1.95 1.99 2.02 2.05 2.08 2.11 2.14 2.16 2.19 
175 2.73 2.76 2.79 2.81 2.84 2.87 2.90 2.93 2.96 2.99 3.01 
L95 2.04 2.07 2.10 2.14 2.17 2.20 2.23 2.26 2.29 2.32 2.35 
180 2.88 2.91 2.94 2.97 3.00 3.03 3.05 3.08 3.11 3.14 3.17 
L95 2.18 2.22 2.25 2.29 2.32 2.35 2.38 2.41 2.44 2.47 2.50 
185 3.04 3.07 3.09 3.12 3.15 3.18 3.21 3.24 3.27 3.30 3.32 
L95 2.33 2.36 2.40 2.43 2.47 2.50 2.53 2.56 2.59 2.62 2.65 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 13 
FVC in litres for Aboriginal females aged 9-19 years. 
1/,i Age 
Ht 9 10 11 12 13 14 15 16 17 18 19 
I 
110 0.78 0.81 0.85 0.88 0.91 0.95 0.98 1.02 1.05 1.09 1.12 
L95 0.02 0.05 0.08 0.11 0.14 0.17 0.20 0.23 0.25 0.28 0.30 
115 0.94 0.97 1.01 1.04 1.08 1.11 1.14 1.18 1.21 1.25 1.28 
L95 0.19 0.22 0.25 0.28 0.31 0.34 0.37 0.40 0.42 0.45 0.48 
I 120 1.10 1.13 1.17 1.20 
' 
1.24 1.27 1.30 1.34 1.37 1.41 1.44 
I L95 0.35 0.39 0.42 0.45 0.48 0.51 0.54 0.57 0.59 0.62 0.65 
125 1.26 1.29 1.33 1.36 1.40 1.43 1.47 1.50 1.53 1.57 1.60 
' L95 0.52 0.55 0.58 0.61 0.65 0.68 0.71 0.73 0.76 0.79 0.82 
130 1.42 1.46 1.49 1.52 1.56 1.59 1.63 1.66 1.69 1.73 1.76 
L95 0.68 0.71 0.75 0.78 0.81 0.84 0.87 0.90 0.93 0.96 0.99 
135 1.58 1.62 1.65 1.68 1.72 1.75 1.79 1.82 1.86 1.89 1.92 
L95 0.84 0.88 0.91 0.94 0.98 1.01 1.04 1.07 1.10 1.13 1.15 
140 1.74 1.78 1.81 1.85 1.88 1.91 1.95 1.98 2.02 2.05 2.08 
L95 1.00 1.04 1.07 1.11 1.14 1.17 1.20 1.23 1.26 1.29 1.32 
·1 145 1.90 1.94 1.97 2.01 2.04 2.07 2.11 2.14 2.18 2.21 2.25 
II L95 1.16 1.20 1.23 1.27 1.30 1.33 1.37 1.40 1.43 1.46 1.49 
150 2.06 2.10 2.13 2.17 2.20 2.24 2.27 2.30 2.34 2.37 2.41 
L95 1.32 1.36 1.39 1.43 1.46 1.50 1.53 1.56 1.59 1.62 1.65 
155 2.22 2.26 2.29 2.33 2.36 2.40 2.43 2.46 2.50 2.53 2.57 
L95 1.48 1.51 1.55 1.59 1.62 1.66 1.69 1.72 1.76 1.79 1.82 
160 2.39 2.42 2.45 2.49 2.52 2.56 2.59 2.63 2.66 2.69 2.73 
" L95 1.63 1.67 1.71 1.74 1.78 1.82 1.85 1.88 1.92 1.95 1.98 
I 165 2.55 2.58 2.61 2.65 2.68 2.72 2.75 2.79 2.82 2.85 2.89 
L95 1.79 1.83 1.86 1.90 1.94 1.97 2.01 2.04 2.08 2.11 2.14 
~ 170 2.71 2.74 2.78 2.81 2.84 2.88 2.91 2.95 2.98 3.02 3.05 
I L95 1.94 1.98 2.02 2.06 2.10 2.13 2.17 2.20 2.24 2.27 2.30 
I' II 175 2.87 2.90 2.94 2.97 3.00 3.04 3.07 3.11 3.14 3.18 3.21 
1, L95 2.09 2.13 2.17 2.21 2.25 2.29 2.33 2.36 2.40 2.43 2.46 
1, 180 3.03 3.06 3.10 3.13 3.17 3.20 3.23 3.27 3.30 3.34 3.37 
11,, L95 2.25 2.29 2.33 2.37 2.41 2.44 2.48 2.52 2.55 2.59 2.62 
II 185 3.19 3.22 3.26 3.29 3.33 3.36 3.39 3.43 3.46 3.50 3.53 
L95 2.40 2.44 2.48 2.52 2.56 2.60 2.64 2.67 2.71 2.74 2.78 
. 
I 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 14 
FEV1 in litres for Aboriginal female non-smokers aged 20-70 years. 
11 
11 I 
I Age 
" 
II Ht 20 25 30 35 40 45 50 55 60 65 70 
,, 140 1.71 1.60 1.50 1.39 1.28 1.18 1.07 0.96 0.86 0.75 0.64 
Ii 
!I L95 0.86 0.76 0.65 0.54 0.44 0.33 0.22 0.11 0.01 0.00 0.00 
ll 
I• 
ii 145 1.92 1.81 1.71 1.60 1.49 1.39 1.28 1.17 1.07 0.96 0.85 
L95 1.08 0.97 0.86 0.76 0.65 0.54 0.44 0.33 0.22 0.11 0.00 
I 
150 2.13 2.02 1.91 1.81 1.70 1.59 1.49 1.38 1.27 1.17 1.06 
L95 1.29 1.84 1.08 0.97 0.86 0.76 0.65 0.54 0.43 0.32 0.22 
I 
Cl 155 2.34 2.23 2.12 2.02 1.91 1.80 1.70 1.59 1.48 1.38 1.27 I L95 1.50 1.39 1.29 1.18 1.08 0.97 0.86 0.75 0.64 0.54 0.43 I 
l 
160 2.54 2.44 2.33 2.22 2.12 2.01 1.90 1.80 1.69 1.58 1.48 
L95 1.71 1.60 1.50 1.39 1.29 1.18 1.07 0.96 0.85 0.75 0.64 
I 
I 165 2.75 2.65 2.54 2.43 2.33 2.22 2.11 2.01 1.90 1.79 1.69 
L95 1.92 1.81 1.71 1.60 1.49 1.39 1.28 1.17 1.06 0.95 0.84 
170 2.96 2.85 2.75 2.64 2.53 2.43 2.32 2.21 2.11 2.00 1.89 
L95 2.12 2.02 1.91 1.81 1.70 1.59 1.48 1.38 1.27 1.16 1.05 
11:1 
175 3.17 3.06 2.96 2.85 2.74 2.64 2.53 2.42 2.32 2.21 2.10 
L95 2.33 2.22 2.12 2.01 1.90 1.80 1.69 1.58 1.47 1.36 1.25 
:n 
,, 
180 3.3 ~ 3.27 3.16 3.06 2.95 2.84 2.74 2.63 2.52 2.42 2.31 
195 2.53 2.43 2.32 2.21 2.11 2.00 1.89 1.78 1.68 1.57 1.46 
1: 
!\ 
' 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 15 
FVC in litres for Aboriginal female non-smokers aged 20-70 years. 
Age 
Ht 20 25 30 35 40 45 50 55 60 65 70 
140 1.65 1.55 1.45 1.36 1.26 1.16 1.06 0.96 0.87 0.77 0.67 
L95 0.63 0.53 0.43 0.34 0.24 0.14 0.04 0.00 0.00 0.00 0.00 
145 1.92 1.82 1.72 1.62 1.52 1.43 1.33 1.23 1.13 1.03 0.94 
L95 0.90 0.80 0.71 0.61 0.51 0.41 0.31 0.21 0.11 0.01 0.00 
150 2.18 2.08 1.99 1.89 1.79 1.69 1.59 1.50 1.40 1.30 1.20 
L95 1.17 1.07 0.98 0.88 0.78 0.68 0.58 0.48 0.38 0.28 0.18 
155 2.45 2.35 2.25 2.15 2.06 1.96 1.86 1.76 1.66 1.57 1.47 
L95 1.44 1.34 1.25 1.15 1.05 0.95 0.85 0.75 0.65 0.55 0.45 
160 2.71 2.62 2.52 2.42 2.32 2.22 2.13 2.03 1.93 1.83 1.73 
L95 1.71 1.61 1.51 1.42 1.32 1.22 1.12 1.02 0.92 0.82 0.72 
165 2.98 2.88 2.78 2.69 2.59 2.49 2.39 2.29 2.20 2.10 2.00 
L95 1.97 1.87 1.78 1.68 1.58 1.48 1.38 1.28 1.18 1.08 0.98 
170 3.25 3.15 3.05 2.95 2.85 2.76 2.66 2.56 2.46 2.36 2.26 
L95 2.23 2.14 2.04 1.94 1.85 1.75 1.65 1.55 1.45 1.35 1.25 
175 3.51 3.41 3.32 3.22 3.12 3.02 2.92 2.82 2.73 2.63 2.53 
L95 2.50 2.40 2.30 2.20 2.11 2.01 1.91 1.81 1.71 1.61 1.51 
180 3.78 3.68 3.58 3.48 3.38 3.29 3.19 3.09 2.99 2.89 2.80 
L95 2.75 2.66 2.56 2.46 2.37 2.27 2.17 2.07 1.97 1.87 1.77 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 16 
FEV1 in litres for Aboriginal female smokers aged 20-70 years. 
Ht 
Age 
20 25 30 35 40 45 50 55 60 65 70 
140 1.85 1.74 1.63 1.53 1.42 1.31 1.21 1.10 0.99 0.89 0.78 
L95 1.00 0.89 0.78 0.68 0.57 0.46 0.35 0.25 0.14 0.03 0.00 
145 2.06 1.95 1.84 1.74 1.63 1.52 1.42 1.31 1.20 1.10 0.99 
L95 1.21 1.11 1.00 0.89 0.78 0.68 0.57 0.46 0.35 0.24 0.13 
150 2.27 2.16 2.05 1.95 1.84 1.73 1.63 1.52 1.41 1.30 1.20 
L95 1.43 1.32 1.21 1.11 1.00 0.89 0.78 0.67 0.56 0.45 0.34 
155 2.47 2.37 2.26 2.15 2.05 1.94 1.83 1.73 1.62 1.51 1.41 
L95 1.64 1.53 1.42 1.32 1.21 1.10 0.99 0.88 0.78 0.67 0.56 
160 2.68 2.58 2.47 2.36 2.26 2.15 2.04 1.94 1.83 1.72 1.62 
L95 1.85 1.74 1.63 1.53 1.42 1.31 1.20 1.09 0.99 0.88 0.77 
165 2.89 2.78 2.68 2.57 2.46 2.36 2.25 2.14 2.04 1.93 1.82 
L95 2.05 1.95 1.84 1.74 1.63 1.52 1.41 1.30 1.19 1.08 0.97 
170 3.10 2.99 2.89 2.78 2.67 2.57 2.46 2.35 2.25 2.14 2.03 
L95 2.26 2.16 2.05 1.94 1.83 1.73 1.62 1.51 1.40 1.29 1.18 
175 3.31 3.20 3.09 2.99 2.88 2.77 2.67 2.56 2.45 2.35 2.24 
L95 2.47 2.36 2.25 2.15 2.04 1.93 1.82 1.71 1.61 1.50 1.39 
180 3.52 3.41 3.30 3.20 3.09 2.98 2.88 2.77 2.66 2.56 2.45 
L95 2.67 2.56 2.46 2.35 2.24 2.13 2.03 1.92 1.81 1.70 1.59 
L95= lower limit of the 95% confidence interval around the estimate. 
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Appendix 17 
FVC in litres for Aboriginal female smokers aged 20-70 years. 
1, l 
I 1,, · Age 
I~ 11 
Ht 20 25 30 35 40 45 50 55 60 65 70 
140 1.91 1.81 1.72 1.62 1.52 1.42 1.32 1.22 1.13 1.03 0.93 
I\ I, L95 0.88 0.79 0.69 0.59 0.49 0.39 0.29 0.19 0.09 0.00 0.00 
145 2.18 2.08 1.98 1.88 1.78 1.69 1.59 1.49 1.39 1.29 1.20 
, ' 
1,' L95 1.16 1.06 0.96 0.86 0.76 0.67 0.57 0.46 0.36 0.26 0.16 
150 2.44 2.34 2.25 2.15 2.05 1.95 1.85 1.76 1.66 1.56 1.46 
L95 1.43 1.33 1.23 1.14 1.04 0.94 0.84 0.74 0.64 0.53 0.43 
Ir 155 2.71 2.61 2.51 2.41 2.32 2.22 2.12 2.02 1.92 1.83 1.73 
L95 1.70 1.60 1.50 1.40 1.31 1.21 1.11 1.01 0.90 0.80 0.70 
160 2.97 2.88 2.78 2.68 2.58 2.48 2.39 2.29 2.19 2.09 1.99 
L95 1.97 1.87 1.77 1.67 1.57 1.47 1.37 1.27 1.17 1.07 0.97 
11 
165 3.24 3.14 3.04 2.95 2.85 2.75 2.65 2.55 2.46 2.36 2.26 
L95 2.23 2.13 2.04 1.94 1.84 1.74 1.64 1.54 1.44 1.34 1.23 
170 3.51 3.41 3.31 3.21 3.11 3.02 2.92 2.82 2.72 2.62 2.53 
·: 
L95 2.50 2.40 2.30 2.20 2.10 2.00 1.90 1.80 1.70 1.60 1.50 ll: 
I 
E 
175 3.77 3.67 3.58 3.48 3.38 3.28 3.18 3.09 2.99 2.89 2.79 
I 
1, L95 2.76 2.66 2.56 2.46 2.36 2.26 2.16 2.06 1.96 1.86 1.76 
I 
I 180 4.04 
I• 
3.94 3.84 3.74 3.65 3.55 3.45 3.35 3.25 3.15 3.06 
ll 
11 
L95 3.02 2.92 2.82 2.72 2.62 2.52 2.42 2.32 2.22 2.12 2.02 
L95= lower limit of the 95% confidence interval around the estimate. 
11 
I, 
